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ABSTRACT 
 
Title: Evolutionary Epigenetics of Modern Human Populations 
Running title: Human Evolutionary Epigenetics 
 
Epigenetic variability is a new mechanism for the study of human microevolution, because it 
creates both phenotypic diversity within an individual and within population. This mechanism 
constitutes an important reservoir for adaptation in response to new stimuli and recent studies 
have demonstrated that selective pressures shape not only  the genetic code but also DNA 
methylation profiles.  
The aim of this thesis is the study of the role of DNA methylation changes in human adaptive 
processes, considering the Italian peninsula and macro-geographical areas. A whole-genome 
analysis of DNA methylation profile across the Italian penisula identified some genes whose 
methylation levels differ between individuals of different Italian districts (South, Centre and 
North of Italy). These genes are involved in nitrogen compound metabolism and genes 
involved in pathogens response. Considering individuals with different macro-geographical 
origins (individuals of Asians, European and African ancestry) more significant DMRs 
(differentially methylated regions) were identified and are located in genes involved in 
glucoronidation, in immune response as well as in cell comunication processes. A "profile" of 
each ancestry (African, Asian and European) was described. Moreover a deepen analysis of 
three candidate genes (KRTCAP3, MAD1L and BRSK2) in a cohort of individuals of 
different countries (Morocco, Nigeria, China and Philippines) living in Bologna, was 
performed in order to explore genetic and epigenetic diversity.  
Moreover this thesis have paved the way for the application of DNA methylation for the 
study of hystorical remains and in particular for the age-estimation of individuals starting from 
biological samples (such as teeth or blood). Noteworthy, a mathematical model that 
considered methylation values of DNA extracted from cementum and pulp of living 
individuals can estimate chronological age with high accuracy (median absolute difference 
between age estimated from DNA methylation and chronological age was 1.2 years).
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Chapter 1 
 
EPIGENETICS AND DNA METHYLATION 
1.1. EPIGENETICS AND DNA METHYLATION: OVERVIEW AND DEFINITIONS 
We are in the middle of an epidemic of epigenetics’ related studies In the 
database of ISI Web of Knowledge, more than 5000 articles published in 2011 
contain epigenetic(s) in the title (Figure 1). The term epigenetics was originally 
introduced in 1942 by a British developmental biologist, palaeontologist, 
geneticist and philosopher, named Conrad Hal Waddington. His writingS were 
recently published in the article reprinted in this issue (Waddington 2012). There 
Waddington proposed the term "epigenetics" for studies of the "causal 
mechanisms" by which "genes of the genotype bring about phenotypic effects". 
 
Figure 1. Number of articles with epigenetic or 
epigenetics in their title. This number is calculated 
from the ISI Web of Knowledge using the search 
for term "epigenetic*" in the article titles. 
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Today the term epigenetics refers to modifications of DNA and chromatin 
(heterochromatin and euchromatin) that affect gene expression without altering 
the sequences of the DNA itself. These changes are stable, but at the same time 
can be modulated by many factors such as physiological or pathological 
circumstances, as well as by the environment itself (Holliday 2006). Among the 
broad number of epigenetic modifications, in this thesis we will focus on DNA 
methylation that has been extensively investigated in the last years and represents 
the most promising (but still unexplored) mechanism for the study of human 
evolution. 
DNA methylation is a molecular mechanism that entails the covalent addition of 
a methyl group in the fifth carbon of the pyrimidine ring of a cyotsine (m5C) 
that, in plant and animal genomes, is usually part of a CpG dinucleotide. DNA 
methylation affects the architecture of genomic DNA within nucleus and it is 
involved in fundamental cellular processes such as regulation of transposons, 
transcriptional silencing, genomic imprinting and X chromosome inactivation 
(Yoder, Walsh, and Bestor 1997; P. A. Jones and Takai 2001; Henderson and 
Jacobsen 2007).  
 
1.2. DISTRIBUTION OF MCPG AND CPG DINUCLEOTIDES IN GENOMIC DNA 
In the human genome, the density of these CpGs is non-random and they also 
appear to be under-represented with respect to what expected. This happened 
during evolution due to the presence of spontaneous deaminase activity in nuclei 
(for review see Peter A. Jones and Baylin 2002). This enzymatic reaction 
transforms methylated cytosine into thymine, while the unmethylated cytosine is 
transformed into uracil. Subsequent control and repair mechanisms recognize 
uracil as an extraneous base on DNA and substitute it, while this substitution 
does not happen where thymine is involved as it is a common base on DNA. As 
described in a recent review (Giuliani et al. 2015) this high rate of mutation of 
Human Evolutionary Epigenetics | EPIGENETICS AND DNA 
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m5C to thymine likely led to a reduction of CpG dinucleotides in mammalian 
genomes over the course of evolution (Razin and Riggs 1980). Regions with a 
higher CpGs content than the genomic average (i.e. "CpG islands") are supposed 
to be approximately 29,000 throughout the human genome, although this 
estimate could vary according to CpG island definition, and 60% of them co-
localize with gene promoters. The DNA methylation status of these CpG islands 
is subjected to dynamic changes during development and cell differentiation and 
it can affect gene expression levels (Lander et al. 2001; Antequera 2003). In 
particular, DNA methylation could have different effects according to the 
position of the involved CpGs. For instance, methylation of CpG islands at 
transcription start sites (TSSs) is usually associated with inactivation of gene 
expression by physical interfering with transcription factors or, indirectly, by 
recruiting chromatin modification enzymes. On the contrary, methylation of 
CpGs located in gene bodies might even stimulate transcription and influence 
splicing mechanisms. Many methylated CpGs are also found in repeated 
sequences, most of which are derived from transposable elements, suggesting 
that they could play a fundamental role in genome stability, acting as suppressors 
of transposable elements expression (Peter A Jones 2012). Vertebrate promoters 
can be divided in two classes - low CpGs (LCG) and high CpGs (HCG) - 
according to their CpGs content. Most of LCG are methylated and are associated 
to tissue-specific genes, while HCG are usually hypo-methylated and are related 
to broadly expressed genes. Some authors suggested that one possible 
evolutionary reason for such bimodal distribution is that broadly expressed genes 
have selectively avoided DNA methylation because their consequent inactivation 
would have been deleterious (Elango and Yi 2008). DNA methylation can occur 
in different genomic regions and  DNA methylation takes place not only in CpG 
islands, in fact recent studies (Doi et al. 2009; Irizarry et al. 2009) have 
highlighted the importance of methylation changes in the shores, i.e. the regions 
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nearby the CpGs island. It is known that DNA methylation of these regions is 
closely associated with transcriptional inactivation. 
The papers of Doi et al. and Irizarry et al. anticipate the study of shores and they 
have demonstrated the importance of these genomic regions. In these studies 
they defined "shores" all the regions outside the island up to 2000 bp. In 
particular,  the study by Doi et al. demonstrated that the DMRs (differentially 
methylated regions) that distinguish different types of tissue and tumor tissue 
from healthy tissue are 13 times more frequently in the shores of the island, 
despite these regions have a lower density of CpGs. 
Human Evolutionary Epigenetics |  
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Chapter2 
 
EVOLUTIONARY RELEVANCE OF DNA METHYLATION 
Several theories have been proposed to explain the role that epigenetic variations 
might have played in human evolutionary history. The fact that DNA 
methylation constitutes a source of phenotypic variability, together with recent 
evidences showing that some epigenetic changes can escape transgenerational 
erasure mechanisms, suggests that these modifications have the potential to 
influence evolutionary processes.  
2.1. PHYLOGENETIC CONSERVATION OF DNA METHYLATION PROCESSES 
Comparative studies of DNA methylation suggested the conservation of this 
mechanism across different evolutionary timescales (for review see Mendizabal et 
al. 2014). Several studies have investigated highly divergent animal species that 
span over a billion years of evolution (honey bee, skilworm, sea anemone and sea 
squirt) and observed a strong conservation of DNA methylation patterns across 
this species (over 75% of genes are consistently methylated in all species) and 
that DNA methylation in these species is restricted to gene body. However the 
data generated in these studies across species usually regarded DNA extracted 
from whole animal bodies, without any cell sorting and this constitutes a limit 
that nowadays is still unsolved (tissues and cell specifity of this mechanism will be 
described in Chapter 3) (Zemach et al. 2010; Feng et al. 2010; Sarda et al. 2012). 
Recently many studies raised questions about epigenetic divergence by 
considering humans and closely related primates to investigate molecular 
mechanisms at the basis of the evolution of the human lineage. A study of Pai 
and colleagues (2011) considered DNA methylation patterns in livers, hearts, and 
kidneys from multiple humans and chimpanzees and they argued that some gene 
expression differences between species might be explained in part by 
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corresponding differences in methylation levels. Moreover they suggested that 
inter-tissue methylation patterns are often conserved between humans and 
chimpanzees, a phenomenon that is also reported by Irizarry and colleagues 
(2009) that described conserved tissue specific patterns of DNA methylation 
between humans and mice (diverged around 80 Ma) .  
Interestingly this and other studies (Pai et al. 2011; Molaro et al. 2011; Martin et 
al. 2011; Hodges et al. 2011; Zeng et al. 2012; Wang et al. 2012; Hernando-
Herraez et al. 2013) identified an enrichment of DMR in genes associated with 
neurological functions in the human lineage in different tissues, such as sperm, 
peripheral blood and prefrontal cortex.  
 
2.2. RECENT THEORIES REGARDING THE ROLE OF DNA METHYLATION IN 
HUMAN EVOLUTION 
Some authors postulated some theories regarding the evolutionary mechanisms 
that impact on epigenetic variability (reviewed and described in Giuliani et al. 
2015). We will briefly describe them as follows:  
 Shea et al. (Shea, Pen, and Uller 2011) listed two different epigenetic 
mechanisms that could have shaped human evolution by producing 
selection-based and detection-based effects, respectively. The first 
mechanism is similar to that through which natural selection acts on 
genes, that is, a specific epigenetic pattern is maintained across 
generations and is inherited by the offspring from the parents. The 
second mechanism is based on an "environment detection" process, for 
which parents experience a particular environment and transmit an 
epigenetic pattern apt to cope with it. They also considered a third 
channel of information linked to somatic cells identity and related to the 
fact that cells belonging to a certain tissue carry information about tissue 
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differentiation. The authors suggested that in multicellular organisms 
information conflicts could arise, since a single locus is not able to carry 
different information (i.e. about cell differentiation and about selection- 
or detection-based effects of specific epigenetic profiles). Obviously the 
only way to avoid this conflict is to consider the possibility that each 
locus carries only one type of information, but that different loci could 
carry different type of information. For example, regarding DNA 
methylation mechanism, some specific CpG sites are involved in somatic 
differentiation and they could not be involved also in mechanisms 
producing selection-based effects at the same time.  
 Gluckman et al. (Gluckman, Hanson, and Spencer 2005) described a set 
of theories, known as “predictive adaptive responses”, based on the 
hypothesis that conditions experienced in utero may confer advantages in 
a later phase of life. It is important to note that it is not known to what 
extent epigenetic variants are transmitted per se or arise via de novo 
mutations at each generation (Rando and Verstrepen 2007). 
 Jablonka and Lamb (Jablonka and Lamb 2005) argued that since DNA 
methylation can alter gene expression, and consequently phenotypes, 
epialleles can be subjected to natural selection, as through alleles at 
genetic loci. 
 a recent study (Klironomos, Berg, and Collins 2013) hypothesizes that 
variants beneficial in a population could be of genetic and epigenetic 
origin and that both of them contribute to increased fitness.  However, 
changes in DNA methylation could be lost more rapidly and need a more 
strenght of selective pressures to be fixed in the population. The authors 
claimed that under very strong selective pressures the use of epigenetic 
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mechanisms to encode new and potential adaptive phenotypes could be 
advantageous with respect to the use of genetic ones. The authors 
suggested that once a phenotype has been produced by DNA 
methylation changes, the related genetic variation is not under selection 
and viceversa and thus the strength of selective forces on genetic variants 
could be reduced by epigenetic variations . In this way, they hypothesized 
that DNA methylation process can constitute a strategy for populations 
to "buy time" in order to face the new environmental conditions, until a 
new potentially adaptive geneti mutation arises. In Figure 2 is reported a 
summary for the methylation hypothesis (Giuliani et al. 2015) in which 
epigenetic changes could be important to buy time until genetic 
adaptation arise or when the intensity of the stimulus is not constant over 
time. 
 
Figure 2. Theory of Klironomos et al to explain the 
role of epigenetic and genetic adaptation. [Figure 
published in Annals of Human Biology, Giuliani et 
al. 2015] 
 Feinberg and Irizarry (2009) proposed a fascinating idea for the role that 
epigenetic mechanisms could have played in human evolution. They 
suggest that some genetic variants may exert an effect on the variability 
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of a certain trait, without altering the mean phenotype. According to 
authors' hypothesis, propensity to stochastically vary is mediated 
epigenetically and populations carrying genetic variants associated to this 
higher propensity to variability might have an advantage (or a 
disadvantage) in changing environments.  
In conclusion DNA methylation could contributes not only to create inter 
individual variability but also to create inter population variability and could 
constitutes a reversible way to adapt to new stressors typical of a certain 
environment. In this sense the differences observed among populations could be 
an important tool in order to deepen the influence of the environment on 
population. These differences should be important to describe differences that 
naturally occurs and that could potentially constitute a new strategy for 
adaptation but also to identify patterns that could contribute to the variability 
observed in response to drugs or external/internal stimuli. In the Figure 3 
(published in Giuliani et al. 2015) different strategies of adaptation to 
environmental stimuli are reported, according to the time in which they arise. 
Epigenetics is a molecular mechanism that play a role in human adptations and 
this reversible mechanism seems to play a role in many situations, flanking the 
classical way to adapt which is by genetic and cultural changes. 
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Figure 3. Type of human adaptations. Epigenetics 
is a reversible way to adapt to new stressors that 
can play a role in many situations; it is a further 
level of adaptation to consider in addition to 
genetic and cultural changes. 
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Chapter 3 
 
DNA METHYLATION VARIABILITY IN HUMANS 
DNA methylation is a dynamic and extremely variable process, this variability can 
be considered as a source of phenotypic plasticity fundamental for the 
mechanisms of adaptation. 
The variability can be observed at different levels and may involve different pools 
of CpGs, located in crucial parts of the genomes (promoters, genes body, 
trascription factor binding sites etc.). As previously mentioned the DNA 
methylation of certain regions varies depending on the tissue and cell type, 
several studies identified "tissue differently methylated sites" (tDMR)  for many 
tissues, depicting a sort of signature for each tissue (Lister et al. 2009). 
Differentially methylated loci were also observed when different populations 
living in different countries were considered. Moreover also the diet constitutes a 
factor that can impact on the methylation profiles, both during lifetime (Bacalini 
et al. 2014) and in evolutionary time. It is also noteworthy that folates play a 
fundamental role since they constitute a key component in the biochemical 
pathways that regulated DNA methylation. Also over a lifetime, as a result of the 
changes in physiological and pathological stimuli, DNA methylation profiles 
undergo continuous remodelling. Various authors described the phenomenon of 
the "epigenetic drift" that occurs during normal aging (Teschendorff, West, and 
Beck 2013). Studies of identical twins are an exceptional model and allowed us to 
describe "pure" epigenetic variability, that is also the one that take place 
independently of the genetic background during the life of the individual. In the 
following sections we will briefly discuss physiological processes that could 
impact on DNA methylation patterns. 
Human Evolutionary Epigenetics | DNA METHYLATION VARIABILITY 
IN HUMANS 
12 
 
3.1. TISSUE SPECIFIC DNA METHYLATION MODIFICATIONS 
DNA methylation is an important regulator of tissue differentiation and this 
means that the levels of DNA methylation of certain CpG sites are closely 
dependent on the tissue in analysis. This constitutes a level of variability that 
should be taken into account during the experimental designs. Recent studies 
showed that tDMR (= tissue differentially methylated regions) are sparse across 
the genome (Slieker et al. 2013; Lokk et al. 2014). The study by Slieker et al. 
(2013) showed that tissue-specific DNA methylation was most evident in regions 
outside CpG islands or CpG island flanking regions. The authors suggested that 
the role of tDMRs located outside CpG islands might involve the regulation of 
splicing and alternative transcription. Moreover, the results of Lokk et al (2014) 
showed a clear correlation between DNA methylation in the gene promoter areas 
and the gene expression, while this study did not find a positive correlation 
between gene bodies methylation and mRNA expression as other authors 
suggested. They also suggested that the percentage of variance explained by 
tissues is higher than the one explained by individuals.  
These characteristics are the basis of one of the major problems in these types of 
studies: the cellular heterogeneity (Jaffe and Irizarry 2014). In fact, every cell type 
presumably has its epigenetic profile and the measure of methylation patterns 
from DNA extracted from a pool of cells inevitably leads to a measure of an 
average methylation, calculated considering DNA from all the different cells. The 
"ideal" experiment should include a first step of cell sorting (for example with 
FACS - Fluorescence Activated Cell Sorting) and then the analysis of 
methylation. However this is not a cost effective procedure to be introduced in a 
everyday laboratory workflow and its major limitation is that it could be 
performed only on fresh tissues/cells. To solve the heterogeneity issue, some 
authors who worked on blood (the most easy tissue to obtain) discussed the 
possibility to normalize the data on the basis of cell counts. Other authors, 
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instead, working on genome wide data, described valid statistical models, based 
on DNA methylation signature, that can estimate the proportion of cell types in 
whole blood (NK, T lymphocytes etc..) (Houseman et al. 2012). This is a valid 
approach that has been utilized also by Guintivano et al. (2013) to estimate 
neuron and non-neuron components in brain samples. 
3.2.  AGE RELATED DNA METHYLATION MODIFICATIONS 
Although the epigenetic changes in cancer and other diseases have been 
intensively studied, here we consider only the changes and the variability in the 
levels of DNA methylation that physiologically accumulates. This can be of great 
interest both from an adaptive point of view, since humans during their life must 
continually adapt to stresses that can come from outside and inside of individual 
body, both from a practical point of view, because age-related epigenetic 
modifications constitute a promising tool for estimating the age from ancient and 
historical samples and from forensic findings. 
DNA hypomethylation during aging is the most observed phenomenon not only 
in humans but also in many species such as salmon (Berdyshev et al. 1967) and 
rats (Vanyushin et al. 1973). Some regions and CGs are hypermethylated during 
aging as recent literature suggests, in particular at CpG islands (Rodríguez-
Rodero et al. 2010; Bell et al. 2012; Christensen et al. 2009). Despite the tissue 
specificity that could be critic in this type of analysis (Thompson et al. 2010), 
recent studies identified age-dependent CpG signatures that do not depend from 
sex, pathology or tissue type. Recently some studies investigated association 
between age and DNA methylation in saliva and in blood (Bocklandt et al. 2011; 
Hannum et al. 2013) 
Some authors identified CpGs that reveal linear DNA methylation changes 
during aging and it is likely that they constitutes good candidates for age 
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prediction (Hannum et al. 2013; Bocklandt et al. 2011; Koch and Wagner 
2011)The most detailed study was published in 2013 by Steve Horvath (Horvath 
2013),  who used a collection of online DNA methylation data sets for defining 
an age predictor based on DNA methylation data. 
3.2.1. DNA-based methods for the age estimation on historical 
samples 
Currently there are many methods to estimate the age of an individual from 
ancient remains, based on both morphological and molecular data. However 
it is known that these methods give only a rough estimation of the age of the 
individual. Moreover there are also some methodological matters, since DNA 
from historical and ancient samples is a low integrity molecule and moreover 
few tissues can be collected from post mortem remains (mainly bones and 
teeth). The issue of what constitutes the standard reference for the estimation 
of skeletal age-at-death, especially for adults, is the subject of remarkable 
debate in both physical and forensic anthropology (Franklin 2010). Regarding 
morphological features it is well established that their variability progressively 
increases from birth to old age, so the older the sample is, the less accurate 
the age estimation is (AlQahtani, Hector, and Liversidge 2014; Brooks and 
Suchey 1990). DNA-based methods for age estimation, such as 4977 bp 
deletion of mtDNA and telomeres lenght, are usually not suitable if the time 
period between death and sampling is too long and the age is assigned to a 
wide age-range, with very limited accuracy (Meissner and Ritz-Timme 2010). 
The amino acid racemization in dentine represents the best method (±8.7 
years with 95% confidence) but it can be used only if postmortem interval is 
not more than 20 years (Franklin 2010; Meissner and Ritz-Timme 2010).  
3.2.2. Age prediction from DNA methylation on forensics samples 
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Recently DNA methylation has been applied in forensic anthropology. In 
fact DNA methylation is more stable than RNA molecules and this is a good 
characteristic for forensic samples. DNA methylation applications are 
extensively described in a recent review (Vidaki, Daniel, and Court 2013) and 
it was firstly used in the early 90s for sex typing using the methylation status 
of a macro-satellite. This approach could be use as complementary analysis in 
case of sex-reversed individuals (Naito et al. 1993). DNA methylation is also 
used for the authentication of DNA samples, as it is known that DNA 
synthesized in vitro is generally unmethylated. DNA methylation profile in 
this case can be used to validate the material found in crime scene. DNA 
methylation in forensics is also used to distinguish monozygotic (MZ) twins, 
that are identical in term of genetic background. At this purpose, it is of 
particularly interest a recent study that suggests that MZ twins can be 
distinguished using the methylation status of 377 CpGs sites (Li et al. 2011). 
Moreover another field of applications is the identification of body fluids, 
recent studies showed that body fluid can be identified using DNA 
methylation status of few CpGs. In fact the best biomarker for this purpose 
is a CpG site whose methylation level is extremely high in the tissue of 
interests and extremely low in all others tissues. Nowadays with this method 
it is possible to distinguish with high confidence blood, saliva, semen, and 
vaginal secretions, while for others tissues genome-wide experiments should 
be yet validated. Age estimation is a very promising scenario in this context 
that could help the investigation. At this purpose the model built by Horvath 
seems to be the more indicated, in fact for this purpose it is important to 
consider more than one CpGs site and more than one region to increase the 
accuracy of the age prediction. In fact it is likely that the higher it is the 
number of CpGs that are considered, the more reliable could be the age 
estimation based on DNA levels. 
Human Evolutionary Epigenetics | DNA METHYLATION VARIABILITY 
IN HUMANS 
16 
 
3.3. DNA METHYLATION, GEOGRAPHY AND POPULATION HISTORY 
Phenotypic plasticity is one of the main conceptual bases of population 
epigenetic studies, since epigenetic information allows a single genotype to 
assume multiple epigenotypes, thus enabling the expression of different 
phenotypes. This is particularly emphasized in plants, because they are obligated 
to cope with environmental conditions, since they do not have the possibility to 
migrate away looking for a more apt environment. Different studies, summarized 
in (Giuliani et al. 2015) (Appendix A) highlight a link between ethnic group 
identity and DNA methylation variability. Here we will described only the more 
recent and broad population study published in 2013 by Heyn and colleagues 
(Heyn et al. 2013) that constitutes the source of a free epigenome wide database 
to work with. This study analyzed genome-wide methylation (Illumina 450k 
BeadChip) in three populations with different ethnicity: Americans of African 
ancestry, Americans of Asian ancestry and Americans of European origins. The 
study identified 439 CpG sites (pop-CpGs) that distinguish the examined 
populations, pointing out that this pattern is associated with CpGs that regulate 
gene expression and that many pop-CpGs are located within or nearby 
transcription binding sites for NFKB, a transcription factor involved in the 
immune defence. Accordingly, the authors proposed that local selective 
pressures, such as a specific pathogens landscape, could shape epigenetic 
variation in genes involved in immune or xenobiotic responses.  
Moreover, this study considered the link between genetic and epigenetic 
variability and showed that two third of pop-CpGs were associated with the 
individuals’ genetic background, suggesting that part of population-specific DNA 
methylation variation could be linked to genetic differences between populations 
and that genetic background drives and modulates DNA methylation levels 
(Heyn et al. 2013).  
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DNA methylation differences were also recently investigated at Italian level 
(Campanella et al. 2014),. This is the first study that, using genome-wide DNA 
methylation profiles of more than 1000 individuals, looked for DNA methylation 
changes associated with voluntary south-to-north migration that occurred within 
Italy. The study identified some diferentially methylated CpG comparing south-
to-north migrants with people who lived  in north-western Italy. They 
hypothesized that these changes could indicate an adaptive response to a new 
environment. 
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Chapter 4 
AIM OF THE THESIS 
The study of epigenetic variability is a new and important mechanism for the 
study of microevolution, because it creates both phenotypic diversity within an 
individual and within population without genetic variation (Richards 2008). These 
mechanisms constitute an important reservoir for rapid adaptation in response to 
internal and external stimuli. The aim of this thesis is the study of how DNA 
methylation changes may influence human adaptive processes. Moreover this 
thesis paves the way for the application of DNA methylation for the study of 
hystorical remains.  
This thesis can be theoretically divided in 2 areas of research, linked by the final 
goal that is the investigation of the role that epigenetic mechanisms play in 
human biodiversity. (1) The study of the DNA methylation variability across 
human populations, considering Italian and macro-geographical levels (2) The 
study of the DNA methylation modifications that naturally occur over time to 
identify potential biomarkers for age-estimation. 
 
4.1. DNA METHYLATION VARIABILITY ACROSS HUMAN POPULATIONS: 
ITALIAN AND WORLDWIDE VARIABILITY 
4.1.1. Aim  
With this thesis we aim at elucidating the role of DNA methylation variability in 
different populations, in particular we looked for epigenetic structure, trying to 
elucidate the evolutionary relevance of  this mechanism in different populations. 
We investigated epigenetic variability at macro-geographical and Italian level 
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4.1.2. Cohorts and Methods 
#1 Italian variability, we analyzed with a gene candidate approach (IGF2 and H19 
genes) DNA methylation profiles of 376 individuals homogeneous for gender 
(males) and age (age range 30-51), but differing for geographical origin and place 
of living, i.e. four Italian regions (Northern, Central and Southern Italy, and 
Sardinia). Moreover genome wide analysis (Illumina Infinium 
HumanMethylation450 BeadChip) of 47 individuals according to geographical 
origin (North, Centre and South) was performed to identify signature of 
epigenetic structure in Italy. 
#2 Macro-geographical variability, starting from the row data available in the public 
database GEO we used an original pipeline for the analysis of Infinium 450k data 
of 288 individuals of different ancestry (96 Americans of European ancestry, 96 
African-Americans and 96 Han Chinese Americans). This pipeline considers the 
concomitant variation of a group of adjacent CpG probes (region-centric 
approach), rather than the methylation level of a single CpG probe. Indeed, 
changes in DNA methylation usually involve a group of adjacent CpG sites, 
whose methylation levels vary in a coordinated way and in the same direction, 
thus potentially affecting chromatin structure. Based on the results from this 
study, we focused on DNA methylation of three genes (BRSK2, MAD1L1 and 
KRTCAP2) in blood of individuals with different ancestry and different country 
of birth (Nigeria, Morocco, Philippines, China and Italy) but who lived in 
Bologna. Moreover, we performed the analysis of genetic variability in the 
surrounding regions of the selected candidate genes 
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4.2. RELATIONSHIP BETWEEN DNA METHYLATION VARIABILITY AND AGE 
4.2.1. Aim  
DNA methylation changes over time constitute a interesting field of research in 
anthropology for two main reasons: (1) it allow individuals adaptations during life 
to be studied, in fact DNA methylation variability, that accumulates during life, 
can be considered a potential reservoir to cope with internal and external 
stressors; (2) sites whose DNA methylation level varies according to 
chronological age, can be used as markers of age in anthropology. The purpose 
of this thesis is mainly to make use of this knowledge to put the basis for age 
estimation from remains, starting from modern teeth. 
4.2.2. Cohorts and Methods 
#1 A genome wide DNA methylation analysis (Illumina Infinium 
HumanMethylation450 BeadChip) on whole blood of a small cohort of 64 
subjects of different ages showed 3 region the CpG islands of ELOVL2, FHL2, 
and PENK genes, whose methylation level strongly correlates with age. A larger 
cohort of 501 subjects from 9 to 99 years, including 7 cord blood samples was 
considered to confirm the DNA methylation correlation between ELOVL2, 
FHL2, and PENK DNA methylation and age. 
#2 Since identifying DNA-based methods to estimate the age of a person is 
crucial in several fields, such as physical anthropology, biodemography, forensics, 
evolutionary and ancient DNA studies, in this thesis we analyzed DNA 
methylation levels of few CpGs located in three genes (ELOVL2, FHL2 and 
PENK) of cementum, dentin and pulp of 21 modern teeth of individuals - from 
17 to 77 yrs - and we built a model to predict age. 
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Chapter 5 
 
MATERIALS AND METHODS 
5.1. COHORTS ANALYZED 
5.1.1 Italian variability 
 376 individuals homogeneous for gender (males) and age (age range30-51) were 
considered in the candidate gene analysis. Individuls were recruited following an 
accurate sampling strategy on a preliminary surname-based study (Boattini et al. 
2012) in order to consider the most representative and informative Italian 
sample, with an ancient regional ancestry. These individuals were analyzed at 
candidatte gene levels following the procedures described in the section below. 
Moreover PBMC (peripheral blood mononuclear cells) of 47 Italian individuals 
were analyzed at genome wide level (Illumina 450k array). This cohort is 
constituted by 17 individuals (6 malea sn 11 females, mean age=70.8±5.5 yr) 
living in Milan  and born in North Italy (NI), 16 individuals (7 males and 8 
females, mean age=70.8±7.7 yr) living in Bologna and born in Emilia Romagna 
region (Centre of Italy, CI) and 14 individuals (9 males and 5 females, mean 
age=67.6±8.5 yr) living and born in Calabria (South of Italy, SI). 
 
5.1.2. Macro-geographical variability  
For the world wide analysis we considered data already published and stored in 
the public database GEO, Gene Expression Omnibus under accession number 
GSE36369. DNA methylation data on lymphoblastoid cell lines (LCLs) of 96 
Americans of European ancestry (EUR), 96 Americans of African ancestry 
(AFR) and 96 Han Chinese Americans (EAS) were considered. LCLs considered 
were included in the Human Variation panel (sample sets HD100AA, 
HD100CAU, HD100CHI, Coriell Cell Repositories). Mean age was 37.3 ± 16.2 
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yr for EUR, 29.4 ± 9.9 for AFR and 36.2±15.7 for EAS. Moreover DNA from 
whole blood of individuals of different ancestry was used to replicate the results. 
The methylation data regarding blood samples of 10 Americans of European 
ancestry, 10 Asian American were described in the study of Heyn and colleagues 
(2013) (GSE36369) while DNA methylation data of 10 Americans of African 
ancestry have been previously published (Alisch et al. 2012) (GSE36064).  
Whole blood of 30 individuals from Morocco (N=16), Nigeria (N=14), 
Philippines (N=13) and China (N=17) were collected in Bologna before 1997 
and stores at -20°C.  
 
5.1.3. Age-dependent variability 
32 mother-offspring couples were analyzed at genome-wide level (Illumina 450k 
array) to identify regions of variability with age. The age range was 42–83 and 9–
52 years for mothers and offspring, respectively. The top 5 significant loci 
mapped within the CpG islands of ELOVL2, FHL2 and PENK genes and were 
analyzed in a large cohort of 501 subject from 9 to 99 years incluing 7 cord blood 
samples.  
Regarding the teeth collection, 21 teeth of individual between 17 and 77 years 
were used to extract DNA from 3 tissues, cementum, dentin and pulp and DNA 
was also extracted from the whole teeth of 12 teeth of individuals between 24 
and 77 years. The soft tissues were removed with a scalpel and the teeth were 
washed with distilled water to eliminate blood residues. Cementum was collected 
scraping the root with a scalpel. The crown was removed using a diamond-
cutting disc; pulp and dentine were recovered from the internal cavity of the 
tooth using a dental burr. DNA was also extracted from the whole tooth of 12 of 
them by crushing in a mortar. 
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5.2. EXPERIMENTAL PROCEDURES 
5.2.1. DNA extraction and bisulphite treatment of DNA.  
Genomic DNA was extracted from 150 l of whole peripheral blood using the 
QIAamp 96 DNA Blood Kit (QIAGEN, Hilden, Germany).  For Infinium 
HumanMethylation450 BeadChip, sodium bisulphite conversion of 600 ng of 
DNA was performed using the EZ DNA Methylation-Gold Kit (Zymo Research 
Corporation, Orange, CA). For Sequenom EpiTYPER assay, 1000 ng of DNA 
were bisulphite converted using the EZ-96 DNA Methylation Kit (Zymo 
Research Corporation, Orange, CA) with the following modifications respect to 
manufacture’s protocol: bisulphite conversion was performed with thermal 
conditions that repeatedly varied between 55°C for 15 min and 95°C for 30s for 
21 cycles; after desulphonation and cleaning steps, bisulphite-treated DNA was 
eluted in 100 l of water. 
 
5.2.2. Genome-wide DNA methylation analysis  
Whole-genome methylation analysis of the DNA was performed using the 
Infinium HumanMethylation450 BeadChip (Illumina, San Diego, CA) (Bibikova 
et al. 2011), that allows to assess the methylation level of 485,764 cytosine 
positions over the entire genome. CpG probes are distributed in CpG islands, 
CpG shores and CpG shelves and in not-CpG rich intra- and inter-genic regions. 
Figure 4 modified here but edited by Dedeurwaerder et al (2011), summarized 
the  locations and coverage of the probes included in the 450K array. 
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Figure 4. Overview of the coverage of the Infinium 
Methylation 450K array. Histograms show the 
percentage of cytosines covered by this technology 
according to their relation to CpG islands and to 
their genomic location. Original figure is edited by 
Dedeurwaerder et al.,2011. 
 As described in the official Illumina website, the Infinium Methylation Assay 
uses two different bead types to detect CpG methylation. One bead type (the U 
bead) matches the unmethylated CpG site while the M bead type matches the 
methylated site. The Figure 5, reportes in the Illumina official website, the 
unmethylated CpG target site matches with the U probe, enabling single-base 
extension and detection is reported. It has a single-base mismatch to the M 
probe, which inhibits extension. If the CpG locus of interest is methylated, the 
reverse situation occurs. Illumina 450k array was used to assess DNA 
methylation in Italian samples (Chapter 6.2.) 
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Figure 5. Infinium methylation 450k chemistry 
(figure of the Illumina official website) 
 
5.2.3. Region-specific DNA methylation analysis  
Quantitative analysis of methylation status of CpG sites in candidate genes was 
performed by the EpiTYPER assay (Sequenom, San Diego, CA), a MALDI-
TOF mass spectrometry-based method. 10 ng of bisulphite-treated DNA were 
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PCR-amplified and then processed following manufacture’s instructions. 
Bisulphite specific primers were reported in Table 1.  
Region Primer Forward Primer Reverse 
H19 AGGAAGAGAGGGGTTTGGGAGAGTTT
GTGAGGT 
CAGTAATACGACTCACTATAGGGA
GAAGGCTATACCTACTACTCCCTA
CCTACCAAC 
IGF2_AS AGGAAGAGAGTGGATAGGAGATTGAG
GAGAAA 
CAGTAATACGACTCACTATAGGGA
GAAGGCTAAACCCCAACAAAAACC
ACT 
IGF2_islan
d 
AGGAAGAGAGTATAGGGGTGGTTTGT
TAGGTTAGG 
CAGTAATACGACTCACTATAGGGA
GAAGGCTAAATCAAAAAAAACCCC
AAAAAAAC 
IGF2_shor
e 
AGGAAGAGAGGAAGGGGTTGGTTAGT
AGGTGTTTGT 
CAGTAATACGACTCACTATAGGGA
GAAGGCTCCTAAACCCCTTTCCCA
CTCTCTAA 
ELOVL2 AGGAAGAGAGGTAAATTTGTAGGAATA
GAGTTATTTTTTT 
CAGTAATACGACTCACTATAGGGA
GAAGGCTCCCCTCTCCCACAAAAA
CC 
FHL2 AGGAAGAGAGTTTTTTATGGTTATTTG
TGGTGTTT 
CAGTAATACGACTCACTATAGGGA
GAAGGCTCCCTTTATTTACCAAAAC
TCCTTTC 
PENK AGGAAGAGAGAGGGGTTTTATGATGA
AAAGAATTT 
CAGTAATACGACTCACTATAGGGA
GAAGGCTAAAAAAATCCCAAAAATT
TCCAAAC 
BRSK2 AGGAAGAGAGTTTGGTATTTGGTGTTA
AGTGGTTT 
CAGTAATACGACTCACTATAGGGA
GAAGGCTAAAAACTAATCTCCACT
CTTCATAACA 
KRTCAP3 AGGAAGAGAGGGTAAGGGTAGTTTTA
GGGTAAGGA 
CAGTAATACGACTCACTATAGGGA
GAAGGCTAAACCTAAACCTTCTCA
ACAACC 
MAD1L1 AGGAAGAGAGTGAAGATTTATTTTTGG
AGTGGGTA 
CAGTAATACGACTCACTATAGGGA
GAAGGCTTAACACCAACCAAAACA
CACCTAA 
Table 1 Primer sequence of the amplicon analyzed 
in this thesis using MALDI TOF MS (Sequenom 
EpiTyper) 
Human Evolutionary Epigenetics | MATERIALS AND METHODS 
27 
 
5.3. STATISTICAL ANALYSIS 
For gene candidate analysis an R package was used to test if bisulphite 
conversion reaction runs to completion (Thompson et al. 2009). CpG sites with 
missing values in more than the 20% of the samples were removed, as well as 
samples with missing values in more than the 20% of CpG sites.  
 
Genome wide DNA methylation values were in part obtained by public database 
(GSE36369 and GSE36064). Color bias adjustement, background level 
adjustment and quantile normalization across arrays was performed using the 
lumi package (Du, Kibbe, and Lin 2008). The pipeline is described in detail in 
Appendix A in the paper published by Bacalini et al. 2015 entitled "A meta-analysis 
on age-associated changes in blood DNA methylation: results from an original analysis pipeline 
for Infinium 450k data". Probes on chromosome X and Y, probes containing 
missing -values and those with a SNP frequency >1% in the probe sequence 
were removed (as suggested in Heyn et al. 2013). 
For Class A and Class B, BOPs methylation values were compared between 
groups  using the MANOVA function from the R package car. BOPs containing 
one or 2 CpG probes were excluded from the analysis and MANOVA was 
applied on sliding windows of 3 consecutive CpGs within the same BOP. For 
each BOP, the lowest p-value among those calculated for the different sliding 
windows was retained. For Class C and Class D, the methylation values of single 
CpG site was compared between groups using the ANOVA function from the R 
package car. Benjamini-Hochberg False Discovery Rate correction was 
performed using the function mt.rawp2adjp from the R package multtest. Gene 
ontology annotation of selected DMRs was performed using gene ontology 
enrichment analysis and visualization tool http://cbl-gorilla.cs.technion.ac.il/ 
(Eden et al. 2009). 
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Genetic analysis (Chapter 6.4.4) was performed considering single nucleotide 
polymorphism (SNPs) located in the regions selected (KRTCAP3, MAD1L1 and 
BRSK2 genes) of 1511 individuals belonging to 15 human populations included 
in the 1000 Genomes project (phase 3). These variants were used to perform 
population structure analyses. The dataset was filtered using R to retain only 
biallelic SNPs, then using PLINK the dataset was filtered to prune SNPs 
according to their linkage disequilibrium (only loci in linkage equilibrium were 
retained). Loci in LD were filtered out by using a sliding windows approach 
(Alexander, Novembre, and Lange 2009). Discriminant analysis of principal 
component was performed using adegenet package to investigate genetic 
structure (Jombart and Ahmed 2011; Jombart, Devillard, and Balloux 2010). 
Patterns of differentiation among population was investigated computing Fst 
index. Fst was calculated using PopGenReport package and for differentiation 
patterns between YRI, CEU and CHB Fst index was calculated by an in-house 
Perl script on the basis of Weir and Cockerham formula (Cockerham and Weir 
1986).  
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Chapter 6 
 
RESULTS AND DISCUSSION - POPULATION EPIGENETICS 
The purpose of this chapter is to address the DNA methylation patterns in 
different populations. We analyzed epigenetic diversity across Italy, considering 
individuals of North, Centre and South of Italy at gene candidate level (Section 
6.1.) as well as at genome-wide level (Section 6.2.). Moreover we investigated 
DNA methylation variability across macro-geographic areas (Section 6.3) and in 
conclusion we deepened the analysis of genetic and epigenetic variability of three 
candidate genes (KRTCAP3, MAD1L1 and BRSK2) selected on the basis of the 
comparisons between individuals of Asian, African and European origin (Section 
6.4). 
6.1. GENE-CANDIDATE APPROACH FOR  THE STUDY OF ITALIAN DNA 
METHYLATION VARIABILITY 
We wondered if DNA methylation of a single locus, such as IGF2/H19, could be 
explained by geographic origin and place of living of the individuals studied. Moreover we 
investigated the impact of environmental stimuli - different along the Italian peninsula - 
on methylation patterns of this locus. 
To better understand the intricate relationship between spatial 
(geography/ancestry) and DNA methylation variability, we considered a cohort 
constituted of 376 individuals homogeneous for gender (males) and age (age 
range 30-51) recruited in the Genographic project (according to surname criteria 
(Boattini et al. 2012)), but differing for geographical origin and place of living, i.e 
four Italian regions (Northern, Central and Southern Italy, and Sardinia) 
(Pirazzini et al. 2012). 
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To this aim we measured DNA methylation of four target regions in the 
imprinted IGF2/H19 locus, previously analyzed by other groups (Heijmans et al. 
2007; Ollikainen et al. 2010). The regions analyzed were the following: IGF2AS, 
3 kb from a CpG island, in exon 3 of IGF2AS transcript, within the IGF2 DMR 
0; H19, upstream the transcription start site of H19 gene, partially overlapping a 
CpG island (H19 DMR); IGF2_island, within a CpG island in the last exon of 
IGF2 gene (DMR 2); IGF2_shore, in the shore upstream the island targeted by the 
IGF2_island amplicon. A graphic representation of the genomic localization of 
the region analyzed is reported in Figure 6. IGF2AS and H19 have been 
previously analyzed by Heijmans et al. and Ollikainen et al., while IGF2_island and 
IGF2_shore were analyzed here for the first time. We selected this locuse because 
it is one of the most studied in literature (Heijmans et al. 2007; Ollikainen et al. 
2010). We also observed that in certain regions of this locus DNA methylation 
diversity accumulates during aging of monozygotic twins. Therefore we 
concluded that an effect of environment on DNA methylation of this locus 
could be possible (Pirazzini et al. 2012).  
 
Figure 6. Genomic localization of amplicon 
analyzed in IGF2/H19 locus, considering, 
differentially methylated regions known by 
literature and CpGs islands. 
The mean DNA methylation levels observed in IGF2AS, IGF2_shore, 
IGF2_island and H19 were 49%, 60%, 43% and 36% respectively. Notably 
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IGF2AS and H19 DNA methylation values were comparable to those previously 
reported in literature (Heijmans et al. 2007; Ollikainen et al. 2010). 
Considerable inter-individual variation in DNA methylation values was observed 
within each CpG unit. We then evaluated if the observed variability in 
methylation levels of the IGF2/H19 locus could be explained by ancestry and 
place of living of the four populations studied. Mean methylation levels of each 
CpG unit were calculated for the four geographical areas. The results showed 
that the methylation patterns were comparable throughout all the samples. No 
evident differences were detectable according to sample ancestry/geography, 
except for few CpGs (i.e. CpG 20 of IGF2_island amplicon). Principal 
component analysis (PCA) was used to capture the most interesting patterns of 
variation in each amplicon for the four geographical areas. The percentages of 
variance explained by principal component 1 (PC1) values are reported in Figure 
7. No statistically significant difference was observed between PC1 values, as 
confirmed by ANOVA. 
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Figure 7. DNA methylation variability of 
IGF2/H19 locus in Italy. Distribution of the 
groups considered in the analysis (A). Average of 
DNA methylation levels according to geographic 
origin of the individual (B). Principal component 
analysis of the methylation levels of the 4 
amplicons considered (C). 
This data showed that methylation variability cannot be explained on the basis of 
the geographic provenience of subjects. This implies that the genetic structure of 
the Italian population does not influence the methylation pattern of the analyzed 
loci. and that there are no environmental cues specifically associated with Italian 
macro-areas able to generate clear population epigenetic signatures in the 
IGF2/H19 locus. 
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6.2. GENOME-WIDE APPROACH FOR  THE STUDY OF ITALIAN DNA 
METHYLATION VARIABILITY 
We did not find any differences in DNA methylation of  IGF2/H19 locus according 
to geographic origin, however since DNA methylation patterns could vary across the 
genome we investigated genome-wide DNA methylation profiles in individuals coming 
from North, Centre and South of the Italian peninsula. 
To this purpose we measured DNA methylation levels in peripheral blood 
mononuclear cell (PBMCs) of 47 Italian individuals using Illumina 450k array 
(genome-wide approach). This cohort is constituted by 17 individuals (6 males 
and 11 females, mean age=70.8 ± 5.5) living in Milan and born in North of Italy 
(NI), 16 individuals (7 males and 8 females, mean age=70.8 ± 7.7) living in 
Bologna and born in Centre of Italy (Emilia Romagna region, CI) and 14 
individuals (9 males and 5 females, mean age=67.6 ± 8.5)  living and born in 
Calabria (South of Italy, SI).  
6.2.1. Identification of differentially methylated regions between 
individuals from North, Centre and South of Italy  
To identify DMRs between the three populations we used an original pipeline of 
analysis that we described recently (Bacalini et al. 2015) and that is here briefly 
summarized. The approach is based on the analysis of groups of adjacent CpGs, 
in fact DNA methylation patterns of groups of CpGs is more likely to be 
associated with functional variation than DNA methylation values of a single 
CpG site. We divided Infinium 450k probes in four Classes: i) Class A: probes in 
CpG islands and CpG islands-surrounding sequences (shores and shelves) that 
map in regions nearby genes; ii) Class B: probes in CpG islands and CpG islands-
surrounding regions (shores and shelves) which do not map in genic regions; iii) 
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Class C: probes in genic regions which are not CpG rich; iv) Class D: probes in 
non-genic regions which are not CpG rich. With the term "blocks of probes" 
(BOPs) we refer to groups of Class A and Class B CpG probes localized in the 
same island/shore/shelf. Class C and Class D were analyzed by a single CpG 
approach because CpGs sites are are too distant to support an analysis by groups 
of adjacent probes.  
Here only the results for Class A probes are reported. In Class A, we identified 
6857 BOPs able to discriminate individuals from Centre of Italy from Southern 
individuals (q-value < 0.05). Gene ontology enrichment analysis was performed 
considering all genes with a p-value < 10-3 (197 unique BOPs) and showed that 
there is an enrichment of DMR involved in nitrogen compound transport (GO: 
0071705; FDR q-value=ns). This category includes genes involved in the 
movement of nitrogen-containing compounds into, or out of, a cell or between 
cells by means of some biological structure or a pore (PLEKHA8, RPSA, SRSF9, 
SRSF11, RAB3A, OAZ3, SRSF6, TAPBP, RBM8A, SLC44A1, SMPD3, 
SLC35B4, UPF3A, UBF3A, UBE2Q1). It is interesting beacause nitrogen is 
contained in many drugs, antibiotics and organic compounds, for example 
ammonium nitrate has been used as fertilizer and a major source of reactive 
nitrogen is associated with the growing use of fossil fuels for energy, as described 
(UNEP, United Nations Environment Programme 2007). In Class A we 
identified 11208 BOPs that distinguish Northern individuals from Southern 
individuals. Gene ontology enrichment analysis was performed considering all 
genes with a q-value<10-3 (1289 BOPs) and showed that there is an enrichment 
of DMR involved in cellular nitrogen compound metabolic process 
(GO:0034461 FDR q-value=2.7*10-2), nitrogen compound metabolic process 
(GO:0006807, FDR q-value=1.52*10-2). In Class A, we identified 16161 BOPs 
able to discriminate individuals from Centre of Italy from Nothern 
individuals (q-value < 0.05). Gene ontology enrichment analysis was performed 
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considering all genes with a q-value<10-3 (4998 unique BOPs) and showed that 
there is an enrichment of DMR involved in macromolecule metabolic process 
(GO:0044260, FDR q-value = 2.64*10-22, GO:0043170 FDR, q-value = 7.71*10-
20), primary metabolic pathway (GO:0044238, FDR q-value = 3.84*10-19) and 
gene expression (GO: 0010467, FDR q-value=3.25*10-19). 
6.2.2. Identification of epigenetic profile of individual of North, Centre 
and South of Italy 
In order to understand the sites that most vary in Italy we considered all the 
genes that include a DMR in the pairwise comparisons for Class A probes 
previously reported (here we selected BOPs containing at least 2 adjacent CpG 
sites for which the DNA methylation difference between the 2 groups analyzed 
was higher than 0.15 (Du et al. 2010). We then performed a gene ontology 
enrichment analysis and we demonstrated that DNA methylation differences 
across Italy mainly involved genes of immunoglobulin mediated immune 
response (GO: 0002381, FDR q-value=1.03*10-3), B cell mediated immunity 
(GO: 0019724, , FDR q-value=9.3*10-3), regulation of interleukin-10 secretion 
and detection of bacterium. These results, visualized in Figure 8, by a TreeMap 
obtained by REVIGO analysis (Supek et al. 2011), suggested that microbial 
distribution across Italy is one of the major forces that shapes epigenetic profiles. 
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Figure 8. TreeMap obtained by a REVIGO 
analysis of all genes that contain a DMR 
considering all comparisons in Italy. Each rectangle 
is a GO terms that are joined into "superclusters" 
of related biological process, Size of the rectangle 
reflecte the p-values of the gene ontology 
enrichment analysis. 
To provide an unambiguous epigenetic profile that include the most informative 
CpGs for each group of the Italian peninsula (North, Centre, South), from the 
list of Class A BOPs we selected a short list of DMRs whose DNA methylation 
status was remarkably different. To this aim, as previously described, we 
considered only the BOPs containing at least 2 adjacent CpG sites for which the 
DNA methylation difference between the 2 groups analyzed was higher than 0.15 
(Du et al. 2010). Figure 9 reported 32 BOPs whose DNA methylation levels 
characterized individuals of Southern Italy. Figure 10 reported 30 BOPs whose 
DNA methylation is characteristic of individuals from Centre of Italy and Figure 
11 reported 38 BOPs whose DNA methylation status characterized individual of 
Northern Italy. DMR are located in genes involved in immune response (such as 
HLA-DRB5, HLA-DRB1, HLA-DQB1), in olfactory receptors (OR2L13 gene) 
and in metabolism and energy homeostasis (LPGAT1) (Traurig et al. 2013), as 
well as in a gene involved in cells communication with the microenvironment 
(DDR1 gene) (Borza and Pozzi 2014; Phan et al. 2013) and in chronic pain and 
inflammation (HCN2 gene) (Emery, Young, and McNaughton 2012).  
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Figure 9. Epigenetic profile of individuals living in 
South of Italy. Venn diagram represents with blue 
color the DMRs selected. In the table chromosome, 
genomic position (GRCh37/hg19 assembly), the CpG 
element, the gene name and the CpGs - located in the 
BOP - that better distinguish between groups, are 
reported. 
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Figure 10. Epigenetic profile of individuals living 
in Centre of Italy. Venn diagram represents with 
blue color the DMRs selected. In the table 
chromosome, genomic position (GRCh37/hg19 
assembly), the CpG element, the gene name and 
the CpGs - located in the BOP - that better 
distinguish between groups, are reported. 
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Figure 11. Epigenetic profile of individuals living 
in North of Italy. Venn diagram represents with 
blue color the DMRs selected. In the table 
chromosome, genomic position (GRCh37/hg19 
assembly), the CpG element, the gene name and 
the CpGs - located in the BOP - that better 
distinguish between groups are reported. 
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6.3. GENOME-WIDE APPROACH FOR  THE STUDY OF DNA METHYLATION 
DIVERSITY ACROSS MACRO-GEOGRAPHIC REGIONS 
After the analysis of DNA methylation variability in Italy we questioned if DNA 
methylation profiles vary across macro-geographic areas and what are the genes and 
biological patterns whose DNA methylation levels distinguish populations of different 
ancestry (Africa, Asian and European). This analysis would allow to identify 
mechanism that likely play a role in recent human adaptation.  
We performed a new analysis of the Infinium 450k assay data available online 
(Heyn et al. 2013) in GEO database. We applied the same pipeline used for 
Italian samples in order to identify regions with a functional role considering 
DNA methylation profile of both LCL (lymphoblastoid cell line) and whole 
blood cells in different populations.  We analyzed 288 LCL samples composed 
by 96 African American (AFR), 96 Han Chinese America (EAS) and 96 
American individuals of European ancestry (EUR). After quality check, the 
exclusion of CpG sites located in chromosomes X and Y and the exclusion of 
CpGs sites or probes that include SNPs with MAF>1% (The 1000 Genomes 
Project Consortium 2010) we recovered 440793 out 485577 loci for the analysis. 
The results obtained were validated in whole blood of a small cohort of 
individuals of similar origin (Asian, African and European), to reduce the tissue-
specificity bias. An overview of the entire pipeline of analysis here performed 
considering individuals of European, African and Asian ancestry is reported in 
Figure 12. 
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Figure 12. Overview of the pipeline of analyses 
applied to 3 human populations with different 
ancestry (European, African and Asian) 
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6.3.1. Identification of differentially methylated regions between three 
human populations (AFR, EAS and EUR) 
To identify DMRs between the 3 populations we applied the new analysis 
pipeline described previuously (Bacalini et al. 2015).  
In Class A, we identified  77, 217 and 301 BOPs able to discriminate respectively 
AFR and EU, AFR and EAS, EUR and EAS (q-value <5*10-8). In Class B 15, 43 
and 122 BOPs resulted differentially methylated in AFR and EU, AFR and EAS, 
EUR and EAS respectively (q-value<10-8). 
Methylation values of Class C and Class D probes were compared between 
groups by ANOVA. 53, 161 and 1815 CpG probes out of 106873 probes 
mapping in Class C and 62, 107 and 1559 out of 52979 of probes mapping in 
Class D were differentially methylated between AFR and EU, AFR and EAS, 
EUR and EAS respectively (q-value < 10-8). Number and percentage of 
diferentially methylated BOPs/CpGs are reported in Table 2. 
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AFR vs EUR 77 0.26 43 0.68 53 0.05 62 0.12 
AFR vs EAS 217 0.73 15 0.24 161 0.15 107 0.2 
EUR vs EAS 301 1.01 122 1.92 1815 1.70 1559 2.94 
Table 2. Number and percentage of differentially 
nethylated BOPs for Class A and Class B in the 
pairwise comparisons between populations and 
number and percentage of diferentially 
methylathed CpG sites for Class C and Class D in 
the pairwise comparisons between populations 
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6.3.2. Gene ontology enrichment analysis 
We performed a gene ontology enrichment analysis using the list of Class A 
BOPs differentially methylated between populations. Regarding the genes that 
include AFR-EUR DMR (regions differentially methylated between African-
Americans and Americans of European ancestry) we did not observe an 
enrichment in GO terms with a p-value < 10-3. However, DMRs are located in 
important genes, such as PACS2 that is involved in the communication between 
endoplasmatic reticulum (ER) and mitochondria and it is involved also in 
mechanisms causing cell death, and MAD1L1 one of the human accelerated 
regions (HAR3), i.e. whose regions that changed very little throughout 
mammalian evolution, but then experienced many changes in humans since 
divergence from chimppanzee (Hubisz and Pollard 2014). 
AFR-EAS DMR (regions differentially methylated between African-Americans 
and Han Chinese-Americans) predominantly mapped in genes involved in 
interferon-gamma mediated signalling pathway such as HLA-C, HCK, IRF7, 
HLA-DQB2, HLA-E, HLA-DPB1genes (GO: 0060333, p-value 
nominal=9.7*10-5, FDR q-value=ns), moreover the component of MHC protein 
complex are more represented (GO: 0042611 FDR quvalue=4.23*10-2). It is 
important to note the over representation of the interferon-gamma mediated 
signalling pathway that is crucial for antigen presentation and immune cells 
activation. The classic process that activates this pathway is viral infections but 
interferon gamma is also crucial in inflammatory response and immunoregulation 
(Schroder et al. 2004). EAS-EUR DMR (regions differentially methylated 
between Han Chinese-Americans and Americans of European ancestry) 
predominantly map in genes involved in cell adhesion. The DMR mapped mainly 
in genes involved in homophilic cell adhesion via plasma membrane adhesion 
molecules, such as PCDHA10, CDH4, PCDHA7, PCDHA8, PCDHA6, 
Human Evolutionary Epigenetics | RESULTS AND DISCUSSION - 
POPULATION EPIGENETICS 
44 
 
PCDHA5, PCDHA4, PCDHA3, PCDHA9, PCDHA2, PCDHA1, PCDHB5 
(GO: 0007156, FDR q-value = 5.18*10-3). These proteins regulate process 
including endocytosis, secretion, phagocytosis, cell adhesion and cell migration.  
We then performed a gene ontology enrichment analysis using the list of  Class C 
probes, i.e. all the probes that include CpG sites that map near/in a gene but not 
in islands, shore or shelves. Since the analysis were conducted using a single CpG 
approach, for the gene ontology enrichment analysis we selected all the genes 
that included at least 2 CpGs whose levels of DNA methylation differentiate the 
two populations analyzed. AFR-EAS DMR are located in gene involved in UDP 
glucuronosyltransferase, this enzyme is involved in the process of 
glucoronidation (Tukey and Strassburg 2000), i.e. a classic detoxification process 
characterized by the addiction of glucoronic acid to xenobiotics, process that 
leads to the formation of water-soluble metabolites. This mechanism is not only 
the most important pathway for the elimination of vast majority of drugs but also 
for the removal of toxins, pollutants and fatty acid derivates. The CpGs 
cg07952421 and cg10632656 are located in correspondence of the binding site of 
the transcription factor POLR2A that is responsible for messenger RNA 
synthesis located upstream the UGT2B17.  Regarding the Class C AFR-EUR 
DMR, analysis of enrichment was no possible because only two genes resulted 
differentially methylated in more than one CpGs. The genes are PRDM16 that 
codes for a protein involved in the differentiation of brown adipose tissue (BAT) 
and MLPH that codes for melanophilin a protein found in melanocytes (pigment 
producing cells). EAS-EUR comparison revealed an enrichment of DMRs 
located in genes involved in cellular glucoronidation (as highlighted for AFR-
EUR DMR), developmental growth involved in morphogenesis, inorganic anion 
transport, regulation of membrane potential, flavonoid metabolism, cell adhesion 
and sensory perception of sound. The last process is interesting because it opens 
cultural consideration that should be addressed in the future. It is known in fact 
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the different music perception between Eastern and Western people and the 
Asian advantage for pitch memory (Schellenberg and Trehub 2008), for example 
Asians speak tone languages, where different-pitched vowel sounds have 
different meanings. Some authors suggested that language and also culture 
influence sound and external perception (for an extensive review see (Jandt 2004; 
Jandt 2007). What is interesting is the link between culture and molecular 
mechanisms such as DNA methylation, that here emerged for the first time.  
6.3.3. Identification of an epigenetic profile of Americans of African, 
Asian and European origin 
To identify an epigenetic profile characteristic of each descent (African, Asian 
and Europen) from the list of Class A BOPs we selected a list of DMRs whose 
DNA methylation status was remarkably different in two comparisons on the 
basis of p-values and DNA methylation difference, that has to be higher than 
0.15 between the 2 groups. In other words epigenetic profile of African origin 
includes all the DMR that distinguish both AFR-EUR and AFR-EAS (as shows 
in Figure 13) with a p-value < 5*10-8 (after Benjamini Hochberg correction) and 
with DNA methylation defference higher than 0.15 as previously suggested (Du 
et al. 2010). Figure 13 summarized the idea behind the identification of epigenetic 
profile of African origin (Figure 13A), Asian origin (Figure 13B) and European 
ancestry (Figure 13C) . 
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Figure 13. Strategy for the identification of 
epigenetic profile of individuals of African (A), 
Asian (B), and European origin (C) 
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This analysis showed that 66 DMRs differentiate individuals of African origin 
form from both individual of European and Asian orgin. DMRs identified were 
reported in Table 3. Gene ontology enrichment analysis was  performed and no 
enriched GO terms were found for these genes. 
CHR Genomic Position 
Relation to 
CpG island 
GeneName 
Best CpG in 
the BOP 
1 3559952-3561009 Island WDR8 cg26422465 
1 3559952-3561009 N_Shore WDR8 cg02764188 
1 110230238-110230614 Island GSTM1 cg11680055 
1 59042013-59043295 Island TACSTD2 cg01821018 
1 246414748-246415569 Island SMYD3 cg08887025 
1 38157295-38158586 N_Shore C1orf109 cg06917450 
1 5937157-5937392 Island NPHP4 cg14654471 
1 153662203-153662439 Island NPR1 cg21860360 
1 101004471-101005885 N_Shore GPR88 cg06223162 
1 19970255-19971923 Island NBL1 cg00755546 
2 27664939-27665151 Island KRTCAP3 cg21248554 
2 99771109-99771637 Island LIPT1 cg15544633 
2 74725039-74727038 Island LBX2 cg04255230 
2 37035698-37035918 Island VIT cg06703213 
4 3485963-3486381 Island DOK7 cg15450966 
4 1364146-1364349 N_Shore KIAA1530 cg03698374 
5 150051116-150052107 Island MYOZ3 cg14388237 
5 643427-643669 N_Shelf CEP72 cg15402732 
5 79864842-79866447 Island ANKRD34B cg24834873 
6 30227320-30228255 Island HLA-L cg01655658 
6 33048416-33048814 Island HLA-DPB1 cg00570906 
7 6570453-6571095 N_Shore GRID2IP cg14615128 
7 1950279-1950482 N_Shore MAD1L1 cg16178271 
7 1885033-1885402 N_Shore MAD1L1 cg16658412 
7 75024250-75025212 S_Shelf TRIM73 cg04681579 
7 157937614-157937841 N_Shelf PTPRN2 cg15935227 
7 2054060-2054386 N_Shelf MAD1L1 cg27286614 
7 886803-887535 N_Shelf UNC84A cg10146442 
8 145003589-145004145 Island PLEC1 cg24891660 
8 67976440-67977448 N_Shore COPS5 cg27247252 
9 95526459-95527825 N_Shore BICD2 cg01028796 
9 117160139-117161064 N_Shelf AKNA cg13910813 
10 1252141-1252505 N_Shore ADARB2 cg20205188 
10 13515185-13515427 Island BEND7 cg10309386 
11 614760-616068 N_Shore IRF7 cg16486109 
Human Evolutionary Epigenetics | RESULTS AND DISCUSSION - 
POPULATION EPIGENETICS 
48 
 
11 46389074-46389378 Island DGKZ cg12856521 
11 124615389-124617006 N_Shore NRGN cg26069044 
12 124788559-124788884 N_Shore FAM101A cg19235645 
12 132263617-132263856 Island SFRS8 cg18997918 
14 105830605-105830846 Island PACS2 cg19499452 
14 105944421-105945700 Island CRIP2 cg06285241 
14 33402094-33404079 S_Shelf NPAS3 cg11787167 
15 89920793-89922768 Island LOC254559 cg01317586 
16 604801-605348 N_Shelf SOLH cg26722972 
16 2334108-2334347 Island ABCA3 cg01491428 
16 1493499-1493773 Island CCDC154 cg06352616 
16 85684107-85684491 N_Shore KIAA0182 cg02817932 
16 1358729-1360232 S_Shore UBE2I cg06161540 
16 85684107-85684491 S_Shore KIAA0182 cg26657404 
17 47091037-47091567 Island IGF2BP1 cg20966754 
17 48585385-48586167 Island MYCBPAP cg03168497 
17 47091973-47092211 Island IGF2BP1 cg10950924 
17 78039291-78039547 Island CCDC40 cg07446795 
17 113664-113881 N_Shore RPH3AL cg16767880 
19 14582419-14585098 S_Shore PTGER1 cg03020379 
19 40950025-40950777 Island SERTAD3 cg14150973 
19 49375484-49375928 Island PPP1R15A cg19746536 
19 56915356-56915856 Island ZNF583 cg27129744 
19 51294876-51295098 N_Shore ACPT cg06590444 
19 55889005-55889476 N_Shore TMEM190 cg08806681 
20 61877854-61878071 Island NKAIN4 cg07711085 
20 30639908-30640786 Island HCK cg09796376 
20 4803013-4804146 Island RASSF2 cg14359894 
21 47580492-47582065 Island C21orf56 cg14789911 
21 47601020-47601229 S_Shelf C21orf56 cg10296238 
21 47602431-47602740 S_Shore C21orf56 cg08742575 
Table 3. Genomic regions whose DNA 
methylation level can disttinguish individuals of 
African ancestry (profile). Chromosome, genomic 
position (GRCh37/hg19 Assembly), Relation to 
CpG island, the name of the gene and the CpG 
site that better distinguish the groups inside the 
region considered. 
This analysis shows that 102 DMR differentiate individuals of Asian origin. 
DMRs identified were reported in Table 4. Gene ontology enrichment analysis 
was performed and BOPs mapped in gene involved in homophilic cell adhesion 
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via plasma membrane adhesion molecules (GO: 0007156, FDR q-value=2.47*10-
5) and nervous system development (GO: 0007399, FDR q-value=3.02*10-4). 
CHR Genomic Position 
Relation to 
CpG island 
GeneName 
Best CpG in 
the BOP 
1 110230238-110230614 Island GSTM1 cg11680055 
1 59042013-59043295 Island TACSTD2 cg01821018 
1 246414748-246415569 Island SMYD3 cg08887025 
1 38157295-38158586 N_Shore C1orf109 cg06917450 
1 5937157-5937392 Island NPHP4 cg14654471 
1 153662203-153662439 Island NPR1 cg21860360 
1 101004471-101005885 N_Shore GPR88 cg06223162 
1 3559952-3561009 N_Shore WDR8 cg02764188 
1 19970255-19971923 Island NBL1 cg00755546 
1 26672445-26672650 N_Shore AIM1L cg14517454 
1 205818898-205819191 S_Shore PM20D1 cg24503407 
1 152487978-152488270 N_Shore CRCT1 cg21823605 
1 155246991-155247748 Island HCN3 cg14669863 
2 27664939-27665151 Island KRTCAP3 cg21248554 
2 99771109-99771637 Island LIPT1 cg15544633 
2 74725039-74727038 Island LBX2 cg04255230 
2 37035698-37035918 Island VIT cg06703213 
2 3321063-3321293 S_Shore TSSC1 cg07144255 
2 109744585-109746833 Island SH3RF3 cg03846641 
4 3485963-3486381 Island DOK7 cg15450966 
4 1364146-1364349 N_Shore KIAA1530 cg03698374 
5 643427-643669 N_Shelf CEP72 cg15402732 
5 79864842-79866447 Island ANKRD34B cg24834873 
5 176296541-176296933 N_Shelf UNC5A cg16635016 
5 1226976-1227305 N_Shore SLC6A18 cg26427908 
5 140242073-140243007 Island PCDHA4 cg01042202 
6 30227320-30228255 Island HLA-L cg01655658 
6 33048416-33048814 Island HLA-DPB1 cg00570906 
6 33048416-33048814 S_Shore HLA-DPB1 cg20981163 
6 33048416-33048814 S_Shelf HLA-DPB1 cg15138289 
7 1885033-1885402 N_Shore MAD1L1 cg16658412 
7 75024250-75025212 S_Shelf TRIM73 cg04681579 
7 1950279-1950482 N_Shore MAD1L1 cg16178271 
7 157937614-157937841 N_Shelf PTPRN2 cg15935227 
7 2054060-2054386 N_Shelf MAD1L1 cg27286614 
7 886803-887535 N_Shelf UNC84A cg10146442 
7 6570453-6571095 N_Shore GRID2IP cg14615128 
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7 155088705-155090212 S_Shore INSIG1 cg21341645 
7 57247588-57247927 Island LOC642006 cg02066813 
7 157503469-157504144 Island PTPRN2 cg14168080 
7 157524157-157526741 N_Shore PTPRN2 cg12297440 
8 145003589-145004145 Island PLEC1 cg24891660 
8 67976440-67977448 N_Shore COPS5 cg27247252 
8 144659745-144660635 Island NAPRT1 cg08017634 
8 134308328-134310145 N_Shore NDRG1 cg17129188 
9 95526459-95527825 N_Shore BICD2 cg01028796 
9 117160139-117161064 N_Shelf AKNA cg13910813 
10 1252141-1252505 N_Shore ADARB2 cg20205188 
10 13515185-13515427 Island BEND7 cg10309386 
10 134918755-134918975 S_Shore GPR123 cg23098789 
10 123356616-123358285 N_Shore FGFR2 cg25052156 
10 134911976-134912483 N_Shore GPR123 cg23713909 
10 134925815-134926878 S_Shelf GPR123 cg04553632 
11 614760-616068 N_Shore IRF7 cg16486109 
11 46389074-46389378 Island DGKZ cg12856521 
11 124615389-124617006 N_Shore NRGN cg26069044 
11 289771-290010 Island ATHL1 cg10261205 
11 1410119-1412346 S_Shore BRSK2 cg15465743 
11 129306659-129306882 Island BARX2 cg05471602 
12 132263617-132263856 Island SFRS8 cg18997918 
12 111806559-111807060 S_Shore FAM109A cg10833066 
12 124829153-124829490 N_Shore NCOR2 cg23878260 
13 113635654-113635899 N_Shore MCF2L cg13108304 
13 114783502-114783733 Island RASA3 cg01758122 
14 105944421-105945700 Island CRIP2 cg06285241 
14 105830605-105830846 Island PACS2 cg19499452 
14 33402094-33404079 S_Shelf NPAS3 cg11787167 
15 89920793-89922768 Island LOC254559 cg01317586 
15 63892789-63893911 N_Shelf FBXL22 cg01767116 
15 68521418-68522237 S_Shore CLN6 cg22576950 
16 604801-605348 N_Shelf SOLH cg26722972 
16 1493499-1493773 Island CCDC154 cg06352616 
16 2334108-2334347 Island ABCA3 cg01491428 
16 85684107-85684491 N_Shore KIAA0182 cg02817932 
16 1358729-1360232 S_Shore UBE2I cg06161540 
16 85684107-85684491 S_Shore KIAA0182 cg26657404 
16 711065-711414 N_Shore WDR90 cg16808927 
17 47091037-47091567 Island IGF2BP1 cg20966754 
17 48585385-48586167 Island MYCBPAP cg03168497 
17 47091973-47092211 Island IGF2BP1 cg10950924 
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17 78039291-78039547 Island CCDC40 cg07446795 
17 113664-113881 N_Shore RPH3AL cg16767880 
17 43971410-43975040 S_Shelf MAPT cg24801230 
17 185075-185296 Island RPH3AL cg03226844 
17 76897078-76897298 S_Shelf TIMP2 cg20589078 
19 40950025-40950777 Island SERTAD3 cg14150973 
19 49375484-49375928 Island PPP1R15A cg19746536 
19 14582419-14585098 S_Shore PTGER1 cg03020379 
19 56915356-56915856 Island ZNF583 cg27129744 
19 51294876-51295098 N_Shore ACPT cg06590444 
19 55889005-55889476 N_Shore TMEM190 cg08806681 
19 51128325-51128793 Island SYT3 cg18118147 
19 51051782-51052122 Island LRRC4B cg16212298 
20 30639908-30640786 Island HCK cg09796376 
20 4803013-4804146 Island RASSF2 cg14359894 
20 61877854-61878071 Island NKAIN4 cg07711085 
20 62097193-62098254 Island KCNQ2 cg13782274 
20 61150437-61150646 Island C20orf166 cg15010213 
21 47580492-47582065 Island C21orf56 cg14789911 
21 47601020-47601229 S_Shelf C21orf56 cg10296238 
21 47602431-47602740 S_Shore C21orf56 cg08742575 
22 24384134-24384405 S_Shore GSTT1 cg17005068 
Table 4. Genomic regions whose DNA 
methylation level can disttinguish individuals of 
Asian ancestry (profile). Chromosome, genomic 
position (GRCh37/hg19 Assembly), Relation to 
CpG island, the name of the gene and the CpG 
site that better distinguish the groups inside the 
region considered 
55 DMRs differentiate individuals of European origin. The identified DMR were 
reported in Table 5. Gene ontology enrichment analysis was  performed and 
BOPs mapped in gene involved in cell-cell adhesion (GO: 0098742, FDR q-value 
= 9.56*10-7), homophilic cell adhesion via plasma membrane adhesion molecules 
(GO: 0007156, FDR q-value = 8.36*10-8), nervous system development (GO: 
0007399, FDR q-value = 9.6*10-5) and cranial suture morphogenesis such as 
FGFR2 and INSIG1 genes (GO: 0060363, p-values = 7.7*10-4; FDR q-value = 
ns). 
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CHR Genomic Position Relation 
to CpG 
island 
GeneName Best CpG in 
the BOP 
1 3559952-3561009 Island WDR8 cg26422465 
1 3559952-3561009 N_Shore WDR8 cg02764188 
1 246414748-246415569 Island SMYD3 cg08887025 
1 38157295-38158586 N_Shore C1orf109 cg06917450 
1 26672445-26672650 N_Shore AIM1L cg14517454 
1 205818898-205819191 S_Shore PM20D1 cg24503407 
1 152487978-152488270 N_Shore CRCT1 cg21823605 
1 155246991-155247748 Island HCN3 cg14669863 
2 74725039-74727038 Island LBX2 cg04255230 
2 3321063-3321293 S_Shore TSSC1 cg07144255 
2 109744585-109746833 Island SH3RF3 cg03846641 
4 3485963-3486381 Island DOK7 cg15450966 
5 150051116-150052107 Island MYOZ3 cg14388237 
5 176296541-176296933 N_Shelf UNC5A cg16635016 
5 1226976-1227305 N_Shore SLC6A18 cg26427908 
5 140242073-140243007 Island PCDHA4 cg01042202 
6 33048416-33048814 S_Shore HLA-DPB1 cg20981163 
6 33048416-33048814 S_Shelf HLA-DPB1 cg15138289 
7 6570453-6571095 N_Shore GRID2IP cg14615128 
7 1950279-1950482 N_Shore MAD1L1 cg16178271 
7 155088705-155090212 S_Shore INSIG1 cg21341645 
7 57247588-57247927 Island LOC642006 cg02066813 
7 157503469-157504144 Island PTPRN2 cg14168080 
7 157524157-157526741 N_Shore PTPRN2 cg12297440 
8 144659745-144660635 Island NAPRT1 cg08017634 
8 134308328-134310145 N_Shore NDRG1 cg17129188 
10 134918755-134918975 S_Shore GPR123 cg23098789 
10 123356616-123358285 N_Shore FGFR2 cg25052156 
10 134911976-134912483 N_Shore GPR123 cg23713909 
10 134925815-134926878 S_Shelf GPR123 cg04553632 
11 289771-290010 Island ATHL1 cg10261205 
11 1410119-1412346 S_Shore BRSK2 cg15465743 
11 129306659-129306882 Island BARX2 cg05471602 
12 124788559-124788884 N_Shore FAM101A cg19235645 
12 111806559-111807060 S_Shore FAM109A cg10833066 
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12 124829153-124829490 N_Shore NCOR2 cg23878260 
12 132263617-132263856 Island SFRS8 cg18997918 
13 113635654-113635899 N_Shore MCF2L cg13108304 
13 114783502-114783733 Island RASA3 cg01758122 
14 105830605-105830846 Island PACS2 cg19499452 
15 63892789-63893911 N_Shelf FBXL22 cg01767116 
15 68521418-68522237 S_Shore CLN6 cg22576950 
16 604801-605348 N_Shelf SOLH cg26722972 
16 2334108-2334347 Island ABCA3 cg01491428 
16 711065-711414 N_Shore WDR90 cg16808927 
17 43971410-43975040 S_Shelf MAPT cg24801230 
17 185075-185296 Island RPH3AL cg03226844 
17 76897078-76897298 S_Shelf TIMP2 cg20589078 
19 14582419-14585098 S_Shore PTGER1 cg03020379 
19 51128325-51128793 Island SYT3 cg18118147 
19 51051782-51052122 Island LRRC4B cg16212298 
20 61877854-61878071 Island NKAIN4 cg07711085 
20 62097193-62098254 Island KCNQ2 cg13782274 
20 61150437-61150646 Island C20orf166 cg15010213 
22 24384134-24384405 S_Shore GSTT1 cg17005068 
Table 5. Genomic regions whose DNA 
methylation level can disttinguish individuals of 
European ancestry (profile). Chromosome, 
genomic position (GRCh37/hg19 Assembly), 
Relation to CpG island, the name of the gene and 
the CpG site that better distinguish the groups 
inside the region considered 
6.4. DEEPENING THE NATURAL EPIGENETIC VARIABILITY OF THREE 
CANDIDATE GENES KRTCAP3, MAD1L1 AND BRSK2 
(1) We wondered if the environment is the major force that shaped the DNA 
methylation patterns described or if the ancestry is the main force. (2) Moreover we 
investigated at a candidate gene level the epigenetic variability of individuals coming from 
different countries belonging to the same continent (e.g. individuals from Morocco and 
Nigeria for Africa and individuals from China and Philippines for Asia). (3) Since the 
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Illumina 450k array allows the analysis of  DNA methylation of a part of CpGs in 
the human genome, we investigated the DNA methylation pattern around the most 
significant CpG sites that distinguish the populations in order to assess if population 
variability regards only few CpG sites or also the CpG sites that map in the flanking 
regions. 
To this purpose, DNA methylation of 90 individuals of African, Asian and 
European origins living in Bologna was measured. In particular to investigate the 
DNA methylation variability observable within macro-geographical areas, such as 
Europe, Africa and Asia we selected 30 samples of European origin, 17 
individuals coming from China, 13 from Philippines, 16 from Morocco and 14 
from Nigeria, a Sub-Saharan region. After a meta-analysis conducted between the 
data published by Heyn and colleagues (2013), the data here obtained and the 
results achieved using public available data on whole blood of individuals of 
different populations (i.e. African-Americans, Asian-Americans and Americans of 
European descent), three candidate regions were selected (in KRTCAP3, 
MAD1L1, BRSK2 genes) and DNA methylation analysis was performed. 
Patterns of population genetic structure at the three genes was also analyzed 
considering populations sequenced in the 1000Genomes project (1000Genomes 
Consortium 2010) 
6.4.1. Candidate gene selection  
Considering BOP of Class A identified previously in the three pairwise 
comparisons we selected all the CpGs located in this BOPs (11555 CpG sites, q-
value <10-8 and methylation difference of 0.15 for 2 consecutive CpGs). DNA 
methylation of these 11555 sites was extracted from a public dataset that 
considers DNA methylation from whole blood in individuals of comparable 
origin (GSE36064) . The whole blood dataset here analyzed was composed by 10 
Human Evolutionary Epigenetics | RESULTS AND DISCUSSION - 
POPULATION EPIGENETICS 
55 
 
individuals of African origin, 10 individuals of Asian origin and 10 individual of 
African origin. Absolute pairwise difference between blood DNA methylation of 
the 3 groups were calculated and ANOVA was performed. The most significant 
CpGs (according to p-value and DNA methylation difference) in LCL and whole 
blood dataset that are also identify in the study of Heyn and colleagues were 
selected for further analysis. The CpGs sites are cg21248554 (GRCh37/hg19 
chr2: 27,665,151), cg16658412 (GRCh37/hg19 chr 7:1,883,420) and cg15465743 
(GRCh37/hg19 chr11: 1,413,145) also identified in the populations profiles and 
mapped in KRTCAP3, MAD1L1 and BRSK2 genes, respectively. Using a 
MALDI TOF MS technology (Sequenom Epityper) we measure DNA 
methylation levels of 16 CpGs units nearby cg21248554 (GRCh37/hg19 chr2: 
27,664,896-27,665,359), 13 CpG units nearby cg 16658412 (GRCh37/hg19 chr7: 
1,883,322-1,883,759) and 6 CpGs units nearby cg 15465743 (GRCh37/hg19 
chr11:1,413,109-1,413,442). 
6.4.2. DNA methylation variability between macro-geographic groups 
Considering KRTCAP3 methylation status in individuals of African, European 
and Asian origin, the DNA methylation of the CpGs sites nearby cg21248554 are 
concordant and showed a general hypomethylation of individuals of African 
origins when compared with individuals of European or Asian origin. This 
hypomethylation of African individuals was also observed in the study of Heyn 
and colleagues. ANOVA was performed and CpGs 7.8.9.10, 11, 12, 13.14, 34, 35, 
36 resulted significantly different between groups with a nominal p-value < 0.05. 
The MAD1L1 amplicon showed lower values of DNA methylation for 
individuals of African origins, the results is confirmed also for CpGs site nearby 
the cg16658412. This hypomethylation of African individuals was also observed 
in the study of Heyn and colleagues. ANOVA was performed and CpGs 
1,2,4,6,8,9,10,12,13 showed a nominal p-value < 0.05. DNA methylation of the 
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BRSK2 amplicon showed lower methylation levels for individuals of Asian origin 
than for European and African individuals. This hypomethylation of Asian 
individuals was also observed in the study of Heyn and colleagues. ANOVA was 
performed and all CpG sites showed a significant difference between groups with 
a nominal p-value < 0.01. Average DNA methylation values for the three regions 
analyzed is reported in Figure 14. 
These results confirmed the data published by Heyn and colleagues (2013). 
Differences between populations are reported also in the CpGs flanking the 
CpGs analyzed with a microarray approach (Illumina 450k BeadChip), 
highlighting the potential possibility of a functional importance of the regions 
selected. Obviously more data on gene expression and protein activity are needed 
to draw further conclusions.  
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Figure 14. Average DNA methylation levels of 
KRTCAP3, MAD1L1 and BRSK2 according to 
macro-geographic groups (individuals were 
grouped according to African, European and Asian 
origin) 
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6.4.3. DNA methylation variability within macro-geographic areas 
Recent studies considered DNA methylation differences across macro-
geographic areas (i.e. Africa, Asia and Europe) without considering the high 
genetic, cultural and environmental diversity that is observable within each area. 
Here we selected samples from two different African countries (i.e. Morocco and 
Nigeria) and from two countries of Asia (i.e. China and Philippines). Pairwise t 
test was performed considering DNA methylation levels of the 3 amplicons (i.e. 
KRTCAP3, MAD1L1 and BRSK2). The BRSK2 gene showed differences 
between individuals coming from Morocco and individuals coming from Nigeria 
(pairwise t-test: CpG 6 p-value = 5.2*10-3; CpG 9 p-value = 2.6*10-3; CpG 10 p-
value = 3.1*10-3; CpG 11 p-value = 2.8*10-3). This result demonstrates a high 
level of DNA methylation diversity between individuals belonging to the same 
cntinent (Africa). Moreover it is noteworthy that despite all individuals lived in 
Bologna, DNA methylation levels of Maroccans clustered with Italian 
individuals, whereas DNA methylation values of individuals of Nigerian origin 
clustered with individuals of Asian origins (i.e. China and Philippines) as Figure 
15 showed. This indicates that DNA methylation patterns can strongly vary 
across Africa.  
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Figure 15. Average DNA methylation for the 6 
CpGs analyzed in BRSK2 gene. Black lines indicate 
individuals of African orifin (living in Bologna), 
blue line indicate Italian individuals and ornge lines 
indicate individuals of Asians origin 
Here we suggest two hypothesis to explain this result as regards BRSK2, a gene 
involved in insulin secretion and abundantly expressed in pancreatic islets (Chen 
et al. 2012). (1) A first hypothesis is that according to their population history 
each group has evolved a different strategy to cope with a new environment. The 
European influence (both cultural and in term of genetic admixture) on peolple 
from Morocco is well known and this could be one possible explanation of the 
pattern observed. (2) The second hypothesis - more specultive - is based on 
recent studies that suggest that nutrition transitions are one of the main causes of 
modern epidemic of diabetes, obesity and metabolic syndrome all over the world. 
In particular, sub-Saharan Africa migrants are particularly affected by obesity and 
type 2 diabetes (Agyemang et al. 2009; Hossain, Kawar, and El Nahas 2007), as 
well as Chinese and Philippine populations (Dahly et al. 2013; Popkin and 
Gordon-Larsen 2004). The methylation patterns of this gene could be a possible 
mechanism that contributes to the high susceptibility to these diseases, but more 
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data are needed to support this hypothesis, since we do not have data on the 
prevalence of diabetes in our cohort. 
6.4.4. Population genetic structure at BRSK2, KRTCAP3, and MAD1L1 
genes 
Heyn and colleagues in their study identified a pool of pop-CpGs whose 
methylation level is associated to a certain genotype (meQTL), suggesting a 
genetic influence on DNA methylation levels. Here we investigated patterns of 
population genetic structure at the 3 examinated genes using genome-wide data 
from several human groups included in the 1000Genomes database. Elucidating 
the population genetic structure observable at these genes could be crucial to 
disentangle the role of genetics in driving the differences observed in DNA 
methylation patterns. We considered phase 3 genotypes of 15 populations 
sequenced by 1000Genomes project, i.e 5 of East Asian origin (Han Chinese in 
Bejinh CHB, Japanese in Tokyo - JPT, Southern Han Chinese - CHS, Kinh in 
Ho Chi Minh City - KHV), 5 of European origin( Utah Residents with Northern 
and Western European ancestry - CEU, Toscani in Italy - TSI, Finnish in Finland 
- FIN, British in England and Scotland - GBR, Iberian population in Spain - 
IBS), 5 of African origin (Yoruba in Ibadan, Nigeria - YRI, Luhya in Webuye, 
Kenya - LWK, Gambian in Western Divisions in The Gambia - GWD, Mende in 
Sierra Leone - MSL, Esan in Nigeria - ESN). Data were filtered for allelic state 
(i.e. only biallelic loci were retained), then a pruned subset of SNPs in 
approximate linkage equilibrium with each other was generated (Alexander, 
Novembre, and Lange 2009) and monomorphic loci were excluded. The 
genomic localization and the number of SNPs considered in the analyses are 
listed in Table 6. 
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Gene 
Name 
Genomic localization (GRCh 
37) 
Length 
(bp) 
Number of SNPs after 
filtering 
KRTCAP3 chr2: 27665233-27669348 4848 38 
MAD1L1 chr7:1855429 – 2272878 417449 2975 
BRSK2 chr11: 1411129-1483919 72790 466 
Table 6. Genomic localization and number of 
SNPs onsidered to assess the genetic population 
structure of KRTCAP3, MAD1L1 and BRSK2 
genes. 
Using this data we investigated genetic diversity of the 15 populations considered 
by discriminant analysis of principal components (DAPC) that allows a 
description of homogeneous genetic clusters using few synthetic variables.  
Considering the KRTCAP3 gene, DAPC identified 2 main clusters, one 
including African populations and the second one including both European and 
Asian groups as reported in the scatterplot (Figure 16). SNPs with the highest Fst 
value between populations of African and non-African-origin were rs62131871 
and rs780112 (Fst = 0.22 and 0.35 respectively, estimated according to Nei 1973). 
The genetic structure showed in the scatterplot is in agreement with the 
differences identified via epigenetic analysis, placing individuals of African origin 
apart from European and East Asian populations. On the basis of this data we 
cannot exclude that genetic structure could impact on chromatin conformation 
and therefore on the observed DNA methylation patterns. Moreover we selected 
only three populations whose individuals' ancestry is more similar to individuals 
considered in DNA methylation analysis, i.e. YRI, individuals of Nigerian origin, 
CEU, Utah residents with Northern and Western European ancestry and CHB, 
Han Chinese in Bejing. We calculated Fst values considering SNPs  located in a 
wider genomic region (chr2:27,617,372-27,717,244), to look for those whose 
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frequency is different between individuals of African ancestry (AFR) and 
individuals of non-African ancestry (CEU and CHB) as DNA methylation profile 
suggested. The only SNPs that differentiates these populations are rs1728911, 
rs780110, rs1260327, rs780105, rs780108 (Fst CEU-YRI were 0.20, 0.21, 0.30, 
0.30, 0.31 and Fst YRI-CHB were 0.56, 0.58, 0.70, 0.70, 0.70 respectively). 
Further experiments of genotyping and methylation are needed to  understand 
the role of these SNPs in determining epigenetic structure and levels.  
 
Figure 16. DAPC scatterplot of KRTCAP3 gene 
considering 15 populations of African, Asian and 
European origin. The plot represents individuals as 
dots and the populations as inertia ellipses. 
Eigenvalues and principal component of the 
analysis are displayed. 
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Considering the MAD1L1 gene, DAPC inferred three main clusters, one 
including African populations (YRI, LWK,ESN, MSL, GWD), the second one 
including individuals of European ancestry (GBR, TSI, CEU, FIN, IBS) and the 
third one including East Asian groups (CHB, CHS, JPT, KHV, CDX) as 
reported in the scatterplot in Figure 17. The first component of the analysis 
revealed a clear difference between individuals of African ancestry and 
individuals of non African ancestry (Europeans and Asians) as DNA methylation 
patterns suggests. The scenario is similar to KRTCAP3 in which we cannot 
exclude that genetic structure could have an impact on DNA methylation 
profiles. Experiments of DNA sequencing and bisulphite sequencing of 
candidate regions are needed to disentangle this complicated scenario. Moreover 
we selected only three populations whose individuals' ancestry is more similar to 
individuals considered in DNA methylation analysis, i.e. YRI, individuals of 
Nigerian origin, CEU and CHB. We calculated Fst values considering all SNPs in 
the MAD1L1 gene (chr7: 1,855,426-2,272,683), to look for SNPs whose 
frequency is considerably different between individuals of African ancestry (AFR) 
and individuals of non-African ancestry (CEU and CHB) as DNA methylation 
profile suggested. The only SNPs that differentiates these populations were 
rs73288707, rs55934553, rs6968659, rs3839699 (Fst CEU-YRI were 0.33, 0.30, 
0.35, 0.49 and Fst YRI-CHB were 0.34, 0.35, 0.35, 0.36 respectively). Further 
genotyping and methylation experiments are needed to understand the role of 
these SNPs in determining epigenetic structure.  
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Figure 17. DAPC scatterplot of MAD1L1 gene 
considering 15 populations of African, Asian and 
European origin. The plot represents individuals as 
dots and the populations as inertia ellipses. 
Eigenvalues and principal component of the 
analysis are displayed 
Considering the BRSK2 gene, DAPC suggested the presence of three main 
clusters, one including African populations (YRI, LWK,ESN, MSL, GWD), the 
second one including individuals of European ancestry (GBR, TSI, CEU, FIN, 
IBS) and the third one including East Asian groups (CHB, CHS, JPT, KHV, 
CDX) as reported in the scatterplot (Figure 18). It is interesting to note that 
DNA methylation profiles of BRSK2 amplicon cannot be explained with the 
genetic structure of the region alone. In fact, DNA methylation of individuals of 
Nigerian origin is similar to DNA methylation of individuals of Asian origin, on 
the contrary genotypes frequency of these individuals are very diverse 
considering both PC1 and PC2. We then selected the SNPs with the highest Fst 
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values between populations of European ancestry and population of non-
European ancestry, according to DNA methylation pattenrs identified in Figure 
15. rs12419563, rs61869026, rs61868972, rs34805614, rs4881748 and rs7395567 
were the SNPs with the highest Fst values in the comparison between the two 
groups (EUR vs EAS/AFR). Genotyping of this SNPs in the same samples 
analyzed could be interesting to elucidate the role of genetic variability in 
determining population specific DNA methylation profiling. 
Moreover we selected only three populations (YRI, individuals of Nigerian 
origin, CEU and CHB) and we calculated Fst values of all SNPs located in 
BRSK2 gene (chr11: 1,397,560-1,497,452), in order to identify the SNPs whose 
frequency is considerably different between individuals of European ancestry 
(CEU) and individuals of non-European ancestry (YRI and CHB) as DNA 
methylation profile suggested. The only SNPs that appreacibly differentiate these 
populations are rs61869028 (Fst CEU-YRI =0.27 and Fst CEU-CHB =0.34 and 
Fst YRI-CHB = 0.014). An experiment of genotyping and methylation typization 
should be performed to  understand the role of this SNP in determining 
epigenetic structure.  
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Figure 18. DAPC scatterplot of BRSK2 gene 
considering 15 populations of African, Asian and 
European origin. The plot represents individuals as 
dots and the populations as inertia ellipses. 
Eigenvalues and principal component of the 
analysis are displayed 
In conclusion we showed that the epigenetic structure at the MAD1L1 and 
KRTCAP3 genes could be explained by the genetic variation observed between 
populations. However Heyn and colleagues did not identify meQTL for the 
CpGs located in MAD1L1 and KRTCAP3 even if their data are obtained by 
SNPs microarray that captures only a part of genetic variation present in the 
genome (i.e. 550K or 660K variants). Noteworthy most of the potential SNPs 
involved in the genetic diversity here identified are not present in the Illumina 
550K array. Our data demonstrated that we cannot exclude that the genetic 
context nearby the pop-CpGs can influence the chromatin structure and 
therefore can have an impact on DNA methylation profile. However the main 
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limit of our approach is that, despite  individuals were selected according to their 
ancestry, DNA methylation profiles and genetic background were analyzed in 2 
different cohorts.  
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Chapter 7 
 
RESULTS AND DISCUSSION - AGE-DEPENDENT EPIGENETIC 
VARIABILITY 
The purpose of this chapter is to elucidate the methylation changes that naturally 
occur during aging, focusing the analysis on the identification of potential 
biomarkers useful for the anthropological research. To this aim we firstly 
performed a genome-wide analysis of DNA methylation status in whole blood 
considering individuals of different ages (Section 7.1). We identified some regions 
whose DNA methylation levels correlated with age(ELOVL2, FHL2 and PENK 
genes) and we analyzed their methylation status in teeth, one of the best source 
of DNA for anthropological studies (Section 7.2). 
7.1.DNA METHYLATION LEVEL IN WHOLE BLOOD AS A BIOMARKERS OF AGE 
We wondered what are the changes that occur during physiological aging in whole blood 
to identify potential biomarkers for age-estimation. 
A genome wide DNA methylation analysis (Illumina Infinium 
HumanMethylation450 BeadChip) on whole blood of a small cohort of 64 (32 
mothers and 32 offspring) subjects was performed (Garagnani et al. 2012). The 
age range was 42-83 for the mothers and 9-52 for offsprings. ANOVA analysis 
identified 163 CpG whose DNA methylation levels are associated with age (p-
value < Bonferroni treshold (2.2 x 10-8)). The top 3 significant loci mapped within 
the CpG islands of ELOVL2, FHL2 and PENK genes. We then replicated these 
results in a wider cohort constitues by 494 individuals (245 men and 249 women) 
ranging from 9 to 99 years and 7 cord-blood (3 males and 4 females) (Garagnani 
et al. 2012) . DNA methylation levels of individual CpG sites in ELOVL2, 
FHL2 and PENK CpG islands  was performed by the EpiTYPER assay 
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(Sequenom, San Diego, CA), a MALDI-TOF mass spectrometry-based method, 
starting from DNA extracted from whole blood. The genomic localization of he 
regions analyzed is reported in Figure 19. 
 
Figure 19. Genomic localization of ELOVL2, 
FHL2 and PENK genes considering CpG islands 
and genes (GRCh37/hg19 Assembly) 
Spearman's correlation analysis for the 3 genes showed a strong correlation 
bethween DNA methylation and age. ELOVL2 CpGs unit 11.12.13 showed the 
highest correlation value of 0.95 (Figure 20A). FHL2 showed a correlation value 
of 0.80 for CpG 9.10 (Figure 20B) and CpG 19.20, and PENK of 0.63 (CpG 
23.24) (Figure 20C). ELOVL2 encodes for a transmembrane protein involved in 
the synthesis of polyinsaturated fatty acids (PUFA), but its role in blood cells is 
not completely understood and this is the first study in which ELOVL2 is 
associated with aging. The role that DNA methylation of ELOVL2 played during 
aging is yet unknown but considering that PUFA are involved in processes such 
as modulation of inflammation and maintanance of cell membrane integrity it is 
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possible that ELOVL2 DNA methylation could paly a role in individual 
adptation to physiological changing that occurs during aging. Further studies are 
needed to elucidate the function of DNA hypermethylation during aging, 
however the outstanding results obtained make these three genes a potential 
candidate for forensic applications aimed at identifying proband age. 
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Figure 20. Methylation values of the CpG units 
that better correlate with age in whole blood. DNA 
methylation of CpG 11.12.13.14 for ELOVL2 (A), 
CpG 9.10 for FHL2 (B) and CpG 23.24 for PENK 
(C) 
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7.2. DNA METHYLATION LEVEL IN TEETH AS A BIOMARKERS OF AGE 
We wondered if age-dependent DNA methylation changes of ELOVL2, FHL2 and 
PENK identified in whole blood could be a potential candidate for anthropological 
applications in teeth. 
We analyzed DNA methylation levels of few CpGs located in three genes 
(ELOVL2, FHL2 and PENK) of cementum, dentin and pulp of 21 modern 
teeth of individuals - from 17 to 77 yrs – and we built a model to predict age. 
Tooth is one of the best source of DNA in ancient samples due to both its 
sheltered localization in jawbone and its peculiar structure that provides 
protection from post-mortem decay. Teeth are also less sensitive to 
contamination if compared to bones (Adler et al. 2011; Higgins and Austin 2013; 
Higgins et al. 2013; Pilli et al. 2013). Since DNA methylation is a tissue-specific 
process (Rakyan et al. 2008), DNA has been extracted frome 3 different layers - 
pulp, cementum and dentin  - of 21 teeth from 17 to 77 years to assess DNA 
methylation profile in relation to tissue composition and age.   
7.2.1. DNA methylation and age: single CpGs analysis 
We calculated Pearson's correlation between age and methylation levels for each 
CpGs unit in the 3 tissues analyzed (cementum, dentin and pulp). Correlation 
coefficients were also calculated using DNA methylation values of 12 whole 
teeth. Figure 21 shows, through a gradient of colors, the correlation values for 
each district for the 3 genes; the red asterisks indicate CpGs sites whose DNA 
methyation levels significantly correlate with age (nominal p value< 0.01). In all 
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cases, these sites showed a positive correlation and tended to be hypermethylated 
with advancing age with the exception of PENK CpG 21.22 and PENK CpG 3. 
 
Figure 21. Levelplot for correlation values of DNA 
methylation and age. Pearson's correlation 
coefficient were calculated for each CpG unit in 
ELOVL2, FHL2 and PENK considering the 3 
different tissues (cementum, dentin and pulp) and 
the DNA extracted from the whole tooth. Positive 
correlations are indicated with blue colors while 
the inverse correlation is indicated with yellow 
colors. The red asterisks indicate CpGs that 
strongly correlate with age (nominal p-value<0.01) 
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7.2.2. DNA methylation and age: multivariate linear regression model 
After a detailed analysis of DNA methylation of the single CpGs, a multiple 
linear regression was used to predict age from DNA of teeth. A multiple 
regression model can be used to predict the age by simply plugging the beta 
values of the selected CpGs into the formula Age=b0 + b1CpG1 + b2CpG2 +... + 
bNCpGN as other authors suggested (Hannum et al. 2013; Horvath 2013). For 
each district (pulp, dentin and cementum) a multiple linear regression model was 
calculated considering the CpGs units that are strongly correlated with age for 
the 3 genes. In the pulp a multiple linear regression model was built considering 
13 CpGs units and the median of the absolute difference between Age and 
methAge (age calculated o n the basis of DNA methylation level) was 2.25 
(Figura 22A). In the dentin a multiple linear regression model was built 
considering 5 CpGs units and the median of the absolute difference between Age 
and methAge was 7.07 (Figura 22B). In the cementum a multiple linear 
regression model was built considering 13 CpGs units and the median of the 
absolute difference between Age and methAge was 2.45 (Figura 22C).  
However the best way to predict age is to consider DNA methylation values of 
the best correlating tissues (cementum and pulp). At this purpose DNA 
methylation values of 8 CpGs units were included in a new model to predict age 
from cementum and pulp. The median of the absolute difference between Age 
and methAge was 1.20 for this model. However in this case it is possible to 
predict age only if it is possible to collect and to separate cementum and pulp 
from a single tooth.  
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Figura 22. Multiple linear regression model for 
DNA extracted from dental pulp (A), dentin (B) 
and cementum (C). The scatter plots report Age 
against Age calculated according to the multiple 
linear regression model (methAge) on the basis of 
the formula reported on the left part of the figure. 
The gray dashed line indicates the bisector, to 
indicate the perfect concordance between 
estimated age and the real age. The regression line 
is plotted in blue and CI 95% is indicated with a 
gray shadow. Median, minimum and maximum of 
the absolute difference between Age and methAge 
as well as multiple r square and the number of 
individuals considered in the model are reported. 
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Figure 23. Multiple linear regression model 
considering DNA methylation of both cementum 
and pulp. The scatter plots report Age against Age 
calculated according to the multiple linear 
regression model (methAge). The gray dashed line 
indicates the bisector, to indicate the perfect 
concordance between estimated age and the real 
age. The regression line is plotted in blue and CI 
95% is indicated with a gray shadow. Median, 
minimum and maximum of the absolute difference 
between Age and methAge as well as multiple r 
square and the number of individuals considered in 
the model are reported. 
 These data demonstrated that the pulp is the area with the highest correlation 
with age, but alternatively also the cementum could be used to predict age with 
high accuracy. The methylation status of DNA extracted from dentin did not 
show strongly correlation with age. This could be due to the composition of this 
layer. Recent studies showed that dentin can be subdivided in primary dentin, 
formed during tooth development, secondary dentin, secreted throughout the 
life, and tertiary dentin, also called “reparative dentin”, that is secreted in 
response to external damage (Goldberg and Smith 2004; Saygin, Giannobile, and 
Somerman 2000). The inter-individual variability of the tertiary dentin that 
changes according to external stimuli could be responsible for the observed low 
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correlation with age, even if further experiments are needed to test this 
hypothesis. 
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Chapter 8 
 
CONCLUSIONS 
Epigenetic variability is a new and important mechanism for the study of 
microevolution, because it creates phenotypic diversity both within an individual 
and within population without genetic variation (Richards 2008). This 
mechanism constitutes an important reservoir for rapid adaptation in response to 
internal and external stimuli. This thesis explored how DNA methylation changes 
may influence human adaptive processes. Secondly this thesis paves the way for 
the application of DNA methylation for the study of hystorical remains.  
This thesis demonstrated that DNA methylation contributes to natural human 
variation in Italy and that individuals from Italian peninsula are characterized by 
different epigenetic pathways. This is the first study that addressed the variability 
across Italy, to date only a recent study investigated the DNA methylation profile 
in Italy, focusing on Italian migrations (Campanella et al. 2014). Here we depicted 
the natural variations that occur in DNA methylation profiles considering 
individuals who born and lived in different areas of Italy. Italy is a very diverse 
country in term of culture, traditions, history and genetics (Boattini et al. 2013; 
Sarno et al. 2014) and for this reason it constitutes a good model to investigate 
epigenetics variations. We used a new pipeline of analysis in order to highlight the 
regions with a potential functional role. We reasoned that an oscillation of DNA 
methylation levels of single CpGs could be less important than the variations of 
many CpGs in functional elements (such as islands, shore or shelves).  
The comparisons between DNA methylation patterns of individuals from North 
and Centre of Italy with individuals from South of Italy revealed an enrichment 
of DMRs (differentially methylated region) located in genes involved in nitrogen 
compund transport and nitrogen compund metabolic process. Reactive nitrogen 
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has been extensively studied and it is object of research for environmental issues. 
In fact human intervention has dramatically altered the aquatic and terrestrial 
ecosystems, as nitrogen oxides (NOx), that are by-products of fossil fuel 
combustion, have a big impact on them. Moreover gases containing nitrogen can 
also affect human respiratory health. It is estimated that the major sources of 
nitrogen compounds are linked to agriculture and  to the ever-growing human 
population that leads to the increasing of sewage and industrial wastes (Galloway 
et al. 1995; Galloway et al. 2008; UNEP, United Nations Environment 
Programme 2007). The link between DNA methylation and pollutants is 
extensively described in literature (see review Breton and Marutani 2014) and 
even if these results constitute only a preliminar investigation, it is interesting to 
note that they reflect a different distribution of industries and of agricultural 
history typical of the Italian peninsula. It is well known that the North of Italy is 
characterized by a large amount of industries if compared to the south that is 
more dedicated to agricultural practices. 
Considering all genes that included a DMRs, resulting from the pairwise 
comparison between individuals from North, South and Centre of Italy, we 
observed an enrichment of genes involved in pathogens response. This is a very 
interesting point also discussed in recent papers (Bierne, Hamon, and Cossart 
2012) as pathogens exert a very strong influence on human genetic/epigenetic 
variation and some authors suggested that local pathogens diversity constitutes 
the main selective pressure through human evolution (Fumagalli et al. 2011). We 
can hypothesize that epigenetic variation could constitute a further level of 
variability important to counteract pathogens impact. A recent study published 
by Marr and colleagues (Marr et al. 2014) elucidated the possible role of DNA 
methylation in pathogens response and they demonstrated that intracellular 
parasite can alter host cell DNA methylation patterns resulting in altered gene 
expression possibly to establish diseases. Other studies identified Helicobacter 
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pylori-associated DNA hypermethylation in gastric mucosa at specific genes, such 
as E-cadherine gene CDH1 (Chan et al. 2003) and DNA repair genes, 
MLH1(Yao et al. 2006). Moreover it is also known by in-vitro studies that 
bacteria affect genes involved in cell proliferation. An example is uropathogenic 
Escherichia Coli that, in uroepithelial cells, can induce down-regulation of 
CDKN2A (a cell cycle inhibitor). This is supposed to increase cell proliferation 
and pathogens persistence (Tolg et al. 2011). However, the exact mechanism by 
which DNA methylation contributes to pathogens response remains unclear and 
we do not have enough data to understand whether DNA methylation variability 
constitutes a way to adapt to pathogens infection (in order to maintain the 
survival of the organism) or if DNA methylation variability is a way for the 
pathogens to maintain their survival.  
 
Considering also DNA methylation of individuals of European, Asian and 
African ancestry we observed an enrichment of DMRs located in genes involved 
in immune response. The p-values are in general lower if compared to those 
from the Italian study, this is likely due to the very significant variations in genetic 
and cultural background of the populations considered. The DMRs comparison 
between individuals of African ancestry and individuals of Asian ancestry showed 
an enrichment of genes involved in interferon gamma mediated signalling 
pathway and in the component of MHC protein. It also showed an increase in 
genes involved in UDP glucoronosyltransferase, that are enzymes involved in 
glucoronidation, foundamental for detoxification processes. These results 
confirmed the data of a previous study by Heyn and colleagues (Heyn et al. 
2013). They suggested that selection pressure not only shapes the genetic code, 
but also DNA methylation profiles, as confirmed also by our pipeline.  
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Moreover, we observed that DMRs are located in genes involved in cell stability, 
such as genes of the cell adhesion, cell comunication and cell growth. For 
example, PACS2 gene (AFR-EUR DMRs) is involved in cell communication 
between endoplasmatic reticulum and mitochondria and in mechanisms of cell 
death, MAD1L1 gene is a component of the mitotic spindle-assembly 
checkpoint associated with chromosomal stability. It is also a well known gene 
since it is located in one of the fastest-evolving regions of the human genome 
(HAR3) and one of the reason for the rapid increase of substitution rate in the 
human lineage seems to be the big advantage leaded by accumulation of 
mutations in this gene. In fact it is likely that the mutations of the human lineage 
lead to the reduction of the error rate during cell division. A dysfunction of this 
gene is linked to tumorigenesis of various types of human cancer (Tsukasaki et al. 
2001) and DNA hypermethylation of the promoter of this gene is linked to cell 
cycle dysregulation and progression of the ovarian cancer. This data constitutes 
an important link between genes important for human evolution and genes 
involved in modern diseases. DNA methylation is the mechanism that could 
contribute to the evolution of disease vulnerability as other authors suggested 
(Zeng et al. 2012).  
Moreover these pathways remarked the importance of microenvironment. In 
fact not only external environment could constitute a selective force that acts on 
the organism, but also microenvironment could constitute a selective pressures 
on cells fitness. This theory is particularly important in tumorigenesis (Anderson 
et al. 2006) but could be applied also in physiological states were some clones of 
cells, with a common epigenetic profile, could be more apt to cope with the 
microenvironment (microenvironment here refers to the sum of mediators, 
molecules, compound, proteins of the extracellular matrix, hormones, chemicals, 
signalling molecules as well as physical interaction). 
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Noteworthy, we can observe that gene enrichment analysis considering macro-
geographic groups (AFR, EAS and EUR) highlighted some pathways that 
emerged also in the study of Voight and colleagues (2006). The authors reported 
p-values for enrichment of GO Categories among genes showing evidence for 
partial sweeps. Here we noted some pathways also reported to be differentially 
methylated between populations included in our study, such as MHC-I mediated  
immunity. This supports the model of Klironomos (Klironomos, Berg, and 
Collins 2013) in which early adaptation via epigenetic mutations is a reduction of 
selective constrains on genetic variables while selection pressure acts on the 
epigenetic variables. Thus, it could be that the selective advantage of the favored 
allele is weakened because of epigenetic variability can generate a further level of 
phenotypic variation, reducing the strength of selection on genetic varints 
(Klironomos, Berg, and Collins 2013; Schmitz et al. 2011).    
Regarding the DNA methylation analysis of KRTCAP3 (keratinocyte associated 
protein 3), MAD1L1 gene (component of the mitotic spindle-assembly 
checkpoint), and BRSK2 gene (Serine/threonine-protein kinase that plays a key 
role in polarization of neurons and axonogenesis, cell cycle progress and insulin 
secretion), we demonstrated that the differences between populations regard the 
entire amplicon and not only one CpG sites. Moreover, by comparing Americans 
and Italian individuals of different ancestry, we observed that the DNA 
methylation patterns are also similar, indicating that ancestry shapes DNA 
methylation profiles. Noteworthy, DNA methylation patterns of BRSK2 gene 
have shown significant differences considering individuals coming from the same 
macro-geographic area (Maroccans and Nigerians). In particular, the discriminant 
analysis of principal components shows that individuals from Morocco grouped 
with Italians while individuals from Nigeria clustered with Asians. This analysis 
have not been addressed in the study of Heyn and colleagues (2013) because 
there are no available data regarding the origin of African Americans individuals. 
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As described in Chapter 6, the more plausible assumption considers the history 
of Morocco and the European influence exerted on this country. This influence 
might lead to similar patterns of DNA methylation between individuals from 
Italy and individuals from Morocco. Analyzing the genetic diversity of these 
regions (considering 1000Genomes data) we identified a population genetic 
structure that for KRTCAP3 and MAD1L1 could  reflect the DNA methylation 
differences. For BRSK2 the genetic structure seems to be different. In fact in the 
Italian cohort, individuals from Nigeria and from Asia share similar values of 
DNA methylation, while the genetic structure clearly showed three main clusters 
with Asian population, African individuals and European individuals. 
This thesis explored also the relationship between DNA methylation patterns 
and age both in blood and in human teeth, one of the most used specimens for 
anthropological studies. In particular, we focused on biomarkers of age to 
identify genes whose DNA methylation levels could be strongly correlated with 
individual age. This is particular interesting for forensic anthropology to achive 
age estimation from blood. ELOVL2, FHL2 and PENK genes, considered in 
this study, constitute a good model for the use in forensics and for the age 
estimation on blood traces. This striking correlation with age was also observed 
in DNA from modern teeth. In particular cementum and dental pulp were the 
two area where DNA methylation values showed an high correlation with age. 
DNA methylation of 8 CpGs of two genes (ELOVL2 and FHL2) could be used 
to predict age with the highest accuracy when both dental pulp and cementum 
are available. Indeed, median absolute difference between age estimated from 
DNA methylation and chronological age was 1.20 years and the r2 of the linear 
model was 0.97. Despite the models were constructed with a modest number of 
individuals (N=21), these data indicated that DNA methylation from cementum 
and pulp are the best way to predict age from teeth and could be applied 
extensively for the estimation of the age. Future studies are needed to test DNA 
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methylation from historical samples but it seems to be very promising since a 
recent study showed how DNA methylation could be used to estimate age of a 
4000-yr-old Paleo-Eskimo (Pedersen et al. 2014).  
In conclusion the data presented constitute a comprehensive view of natural 
DNA methylation variations across the Italian peninsula and also at 
macroeographical level, considering continental differences. The genes and the 
pathways here reported constitute potential mechanisms for human adaptation in 
different conditions and demonstrated the major forces that are shaping DNA 
methylation profiles both at a micro- and macro-geographical level. 
  
Human Evolutionary Epigenetics | APPENDIX A 
85 
 
APPENDIX A 
Most relevant publications during the Ph.D course 
1: Bacalini MG, Boattini A, Gentilini D, Giampieri E, Pirazzini C, Giuliani C,  
Fontanesi E, Remondini D, Capri M, Del Rio A, Luiselli D, Vitale G, Mari D, 
Castellani G, Di Blasio AM, Salvioli S, Franceschi C and Garagnani P. A meta-
analysis on age-associated changes in blood DNA methylation: results from an original analysis 
pipeline for Infinium 450k data. Aging (Albany  NY). Jan 2015, Advance online 
publications 
2: Giuliani C, Bacalini MG, Sazzini M, Pirazzini C, Franceschi C, Garagnani P, 
Luiselli D. The epigenetic side of human adaptation: hypotheses, evidences and theories. Ann 
Hum Biol. 2015 Jan;42(1):1-9. PubMed PMID: 25413580. 
3: Bacalini MG, Friso S, Olivieri F, Pirazzini C, Giuliani C, Capri M, Santoro A, 
Franceschi C, Garagnani P. Present and future of anti-ageing epigenetic diets. Mech 
Ageing Dev. 2014 Mar-Apr;136-137:101-15. Review. PubMed PMID: 24388875. 
4: Garagnani P, Bacalini MG, Pirazzini C, Gori D, Giuliani C, Mari D, Di Blasio 
AM, Gentilini D, Vitale G, Collino S, Rezzi S, Castellani G, Capri M, Salvioli S, 
Franceschi C. Methylation of ELOVL2 gene as a new epigenetic marker of age. Aging 
Cell. 2012 Dec;11(6):1132-4. PubMed PMID: 23061750. 
5: Pirazzini C*, Giuliani C*, Bacalini MG, Boattini A, Capri M, Fontanesi E, 
Marasco E, Mantovani V, Pierini M, Pini E, Luiselli D, Franceschi C, Garagnani 
P. Space/population and time/age in DNA methylation variability in humans: a study on 
IGF2/H19 locus in different Italian populations and in mono- and di-zygotic twins of different 
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During my PhD programme I have deepened some methodological and theoric 
issues, such as the study of mitochondrial genomes and in particular of mtDNA 
heteroplasmy. From a methodological point of view I have deepened the libraries 
preparation for sequencing a 853 bp segment of mtDNA by  ultra-deep 
sequencing. The aim here was to detect heteroplasmies in blood under a 
threshold of 2%, reaching an average coverage of 49334-fold per position. As 
follows I will list publications that better synthetized the mitochondrial questions 
that I explored in this three years of my PhD programme. 
1: Giuliani C, Barbieri C, Li M, Bucci L, Monti D, Passarino G, Luiselli D, 
Franceschi C, Stoneking M, Garagnani P. Transmission from centenarians to their 
offspring of mtDNA heteroplasmy revealed by ultra-deep sequencing. Aging (Albany NY). 
2014 Jun;6(6):454-67. PubMed PMID: 25013208 
2: Sevini F, Giuliani C, Vianello D, Giampieri E, Santoro A, Biondi F, 
Garagnani P, Passarino G, Luiselli D, Capri M, Franceschi C, Salvioli S. mtDNA 
mutations in human aging and longevity: controversies and new perspectives opened by high-
throughput technologies. Exp Gerontol. 2014 Aug;56:234-44. Review. PubMed 
PMID: 24709341. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
In the last two years the Infinium HumanMethylation-
450 BeadChip (Infinium  450k)  [1]  has  been  largely 
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used to investigate age-associated changes in DNA 
methylation profile of the human genome [2–9]. The 
Infinium 450k contains 485577 probes, 64% of them 
mapping to CpG islands and CpG islands surrounding 
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regions (shores and shelves), while the remaining 
mapping to dispersed CpG sites in the genome [10]. The 
array is highly informative, as it covers 96% of the CpG 
islands of the genome and 99% of RefSeq genes.  
 
Using the Infinium 450k, researchers have identified 
several CpG sites that either get hypermethylated or 
hypomethylated during aging in different tissues [11], 
and a subset of these CpG sites has been successfully 
combined in predictors of chronological age [12,13].  
 
Although defining a list of CpG sites whose methylation 
status is age-dependent is an essential step in aging 
research, the real challenge is to identify biologically 
relevant DNA methylation changes and their relative 
contribution to the aging process.  
 
The difficult task of extracting relevant information 
from microarray data can be made easier if the number 
of microarray features is reduced on the basis of a 
biologically meaningful criterion. In this way the top 
ranking groups of features are more likely to be 
functionally linked to the phenotype under study than 
the single features. For expression microarrays this task 
has been successfully addressed by grouping genes that 
share common biological functions [14], but this 
approach is less suitable for methylation microarrays, as 
the relationship between DNA methylation and 
biological function is complex. An alternative solution 
is to adopt a region-centric approach in which the 
methylation value not of the single CpG probes, but of a 
group of adjacent CpG probes is considered. This 
approach is particularly interesting as changes in DNA 
methylation, especially in the CpG islands, usually 
involve groups of adjacent CpG sites whose 
methylation levels are correlated, thus potentially 
affecting chromatin structure. On the contrary the 
biological relevance of alterations at individual CpGs, 
although potentially interesting at specific genomic 
regions, is less characterized [15].  
 
At present, different region-centric approaches have 
been proposed. Illumina Methylation Analyzer (IMA) 
defines for each gene 11 region categories (TSS1500, 
TSS200, 5’ UTR, 1st EXON, GENE BODY, 3’ UTR, 
ILSAND, NSHORE, SSHORE, NSHELF, SSHELF) 
and calculates their mean or median methylation values, 
which are then compared between the samples under 
analysis [16]. As an alternative approach, Numerical 
Identification of Methylation Biomarker Lists (NIMBL) 
reports the number of differentially methylated probes 
within the different annotated regions of each gene [15]. 
A more sophisticated approach is based on the “bump 
hunting” method developed for the analysis of CHARM 
data [17], but its applicability to Infinium 450k data is 
weakened by the lower density of analysed CpG sites in 
comparison to CHARM array.  
 
The main point is that the Infinium 450k probes are not 
evenly distributed across the genome, but they are 
enriched in specific regions while others are 
underrepresented. To deal with this issue, a methodology 
in which differentially methylated regions (DMRs) are 
defined as regions in which at least two contiguous 
probes within 1-kb distance have a significant differential 
statistic was recently proposed [18] and used in a meta-
analysis to identify age associated DMRs. A tool for 
DMRs identification at a region level was implemented 
also in the RnBeads package, where regions were defined 
based on the microarray annotation and ranked based on 
3 criteria (mean of the differences between average 
methylation levels of the probes in a region in the two 
groups under investigation, mean of quotients and a 
combined p-value calculated from the single p-values of 
the probes in the region). 
 
Here we implemented an alternative pipeline for the 
analysis of Infinium 450k data that is based on a careful 
description of CpG probes distribution within the array. 
The proposed methodology: 1) classifies CpG probes 
based on their genomic localization 2) defines groups of 
adjacent CpG probes based on their density in the 
region 3) depending on the previous classifications, 
applies a single-probe or a region centric analysis which 
considers the concomitant variation of a group of 
adjacent CpG probes.  
 
As a proof of principle, we used our approach to 
conduct a meta-analysis on 3 independent datasets in 
which the Infinium 450k was used to investigate age-
associated variations in blood DNA methylation 
profiles. From this meta-analysis, we extracted a short 
list of genes that potentially have a biologically relevant 
role in the aging process. 
 
RESULTS 
 
Grouping Infinium 450k probes in biologically 
meaningful clusters 
 
The method we propose focuses on grouping CpG 
probes into clusters, hereafter referred as “blocks of 
probes” (BOPs). CpG probes were grouped taking into 
consideration not only their contiguity in DNA 
sequence, but also their genomic localization, which 
represents a critical aspect for data interpretation [19]. 
Using Illumina probe annotation, we first divided the 
probes included in the array in four classes (Fig. 1A; see 
Materials and Methods section): i) Class A, including 
probes  in  CpG  islands  and  CpG  islands-surrounding  
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sequences (shores and shelves) that map in genic 
regions; ii) Class B, including probes in CpG islands 
and CpG islands-surrounding regions (shores and 
shelves) which do not map in genic regions; iii) Class 
C, including probes in genic regions which are not CpG 
rich; iv) Class D, including probes in non-genic regions 
which are not CpG rich. These four classes have 
different epigenetic functions, as their methylation 
status can affect gene function and chromatin structure 
in different ways [20]. Class A, B, C and D included 
247394, 62071, 118206 and 57906 CpG probes 
respectively. 
 
Then, we defined BOPs as follows (Fig. 1B): for probes 
mapping in CpG islands and in CpG islands 
surrounding regions (Class A and Class B), we grouped 
the CpG probes localized in the same island, in the 
same shore or in the same shelf; for probes mapping in 
not CpG rich genic regions (Class C), we grouped the 
CpG probes mapping to the same gene. Class D probes 
were not grouped because they were highly interspersed 
across the genome.  
 
Class A, B and C included 77202, 34448 and 20273 
BOPs respectively (Fig. 2). Class A BOPs mapped 
mainly to CpG islands and shores, but CpG islands 
BOPs were definitely richer in CpG probes (Fig. 2A, 
left panel). Class B BOPs mapped to shelves with 
higher frequency than Class A BOPs, but also in this 
case CpG probes mapped mostly to CpG islands (Fig. 
2A, middle panel). As expected Class C BOPs 
contained a very high number  of  CpG  probes,  with  a  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
median of 13 and a maximum of 506 (Fig. 2A, right 
panel).  
 
A region-centric approach is meaningful only if CpG 
probes are sufficiently close along the DNA sequence 
under investigation. Indeed, experimental evidences 
indicate that DNA methylation of nearby CpG sites is 
correlated within a tract of 250-500 bp [21]. We 
therefore calculated the mean distance between the 
probes in each BOP for Class A, Class B and Class C 
probes (Fig. 2B). Probes in BOPs belonging to Class A 
and Class B were generally close, with a mean distance 
of 183.5 and 259.4 bp respectively (Fig. 2B, left and 
middle panels) and a mode of 73 and 130 bp 
respectively (Fig. 2C, left and middle panels). In both 
the cases, as expected, mean distance was lower in 
islands than in shores and shelves. On the contrary, 
BOPs belonging to Class C included probes that were 
scattered across the length of gene sequences and, on 
average, that were too distant to be analysed together 
(mean distance 10230 bp, mode 1935 bp; Fig. 2B and 
2C, right panels).  
 
DMR identification by multivariate analysis of 
variance (MANOVA)  
 
Based on the previous observations we propose an 
analysis pipeline for Infinium 450k “customized” on the 
characteristics of the different classes of probes (Fig. 
3A). BOPs belonging to Class A and Class B are suitable 
for a region-centric analysis, while for Class C and Class 
D probes a single-probe analysis is more advisable.  
 
Figure 1.  Infinium 450k probes classification and BOPs definition.  (A) The 485577 probes  included  in  the
Illumina HumanMethylation450 BeadChip were divided  in 4 classes   on the basis of their genomic  localization. (B)
Graphic representation of how probes were grouped in BOPs. Probes mapping in the island and in the surrounding
regions of the same CpG island were grouped in 5 functional units: probes in the N‐Shelf of the island, probes in the
N‐Shore of the island, probes in the island, probes in the S‐Shore of the island, probes in the S‐Shelf of the island.
Probes mapping in gene bodies were grouped on the basis of the gene in which they are located.  
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For the region-centric analysis we propose the use of 
multivariate analysis of variance (MANOVA) to test for 
general changes in methylation of a genomic region. 
However, as described above, Class A and Class B 
BOPs contain a largely variable number of CpGs, 
spanning from 1 to 75 for Class A BOPs and from 1 to 
41 for Class B BOPs. We considered BOPs containing 1 
or 2 CpG probes not informative enough for a region-
centric approach but more suitable for a single-probe 
approach. On the contrary, the remaining BOPs (32356 
BOPs including 192465 probes in Class A; 7253 BOPs 
including 31077 probes in Class B) are analysed by  ap- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
plying a sliding-window MANOVA (Fig. 3B). Indeed, 
the non-homogeneous distribution in BOP probe 
content could lead to overrepresentation of short BOPs 
among the top significant BOPs, because when the 
number of probes in a BOPs is high, it is likely that only 
a subgroup of them is differentially methylated in the 
phenotype under study (see the example reported in Fig. 
3C). In the sliding window approach we calculated 
MANOVA for each subgroup of 3 consecutive CpG 
within the same BOP and we kept the lowest p-value 
among those calculated, actually normalizing the 
analysis for the varying number of probes per BOP.  
Figure 2. Characteristics of the BOPs belonging to different probe classes. (A) Numbers of BOPs and CpG probes in Class
A, Class B and Class C. For Class A and Class B, subdivision in CpG islands, N‐Shores, S‐Shores, N‐Shelves and S‐Shelves is reported.
In the lower part of the tables, descriptive statistics for the distribution of number of probes/BOP in the 3 Classes are reported.
(B) Descriptive statistics for the distribution of mean bp distance between probes /BOP in the 3 Classes are reported.(C) Density
distributions (upper panel) and frequency histograms (lower panels) of the mean bp distance between the probes/BOP. 
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We implemented the proposed pipeline in R software 
environment. Starting from a table containing the beta-
values of interest (1 row per CpG site, 1 column per 
individual), the script annotates the probes and divides 
them in Class A, Class B, Class B and Class D. Class A 
and Class B probes are grouped in BOPs and BOPs 
containing 3 or more probes are analysed by the region-
approach (MANOVA on sliding windows of 3 CpG 
probes within the same BOP). The remaining CpG 
probes are analysed by ANOVA. Both categorical and 
continuous covariates can be used. A list of significant 
CpG probes is outputted from the single-probe analysis.  
For the region-centric approach, a list of BOPs ranked 
by nominal or FDR-corrected p-values and, if present, 
associated genes, is provided as output. Then, authors 
can choose to select significant BOPs containing at least 
2 adjacent CpG sites for which the DNA methylation 
difference between the considered groups (in the case of 
a categorical variable) or two selected ranges of values 
of the continuous variable is higher than a set threshold.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Significant BOPs can be ranked according to this 
criterion allowing authors to identify “bubbles” of 
different methylation between the conditions under 
study, which are likely to be biologically meaningful. 
The pipeline provides as outputs several useful plots, 
including schematic diagrams in which the 
chromosomal position of the probes within the selected 
BOPs is plotted against the methylation level of each 
probe (see the examples reported in Fig. 6 and in 
Supplementary Fig. 1). These plots provide a easy-to-
interpret visualization of relevant results, that in one 
shot gives information about probes density within the 
region and about the changes in DNA methylation 
between the groups under study. 
 
Identification of age-associated DMR through the 
region-centric approach 
 
We validated our pipeline on three independent age-
related Infinium 450k experiments performed on whole 
Figure 3. Proposed analytical pipeline for Infinium 450k data. (A) Workflow for the use of single‐probe or region‐
centric approaches on Infinium 450k data. (B) Graphical representation of the sliding window MANOVA used to normalize
for BOPs  lengths.  CpG  probes  are  represented  as  circles.  The CpG  probes  considered  in  each  round  of MANOVA  are
highlighted in yellow. (C) Example of methylation values of CpG probes within a BOP. The BOP includes 22 CpG probes, 5
of which define a “bubble” of differential methylation between Group A and Group B. The p‐value derived from MANOVA
on  this  BOP  is  2.70*10e‐11.  We  hypothesized  to  have  a  shorter  BOP  including  only  the  5  CpG  probes  differentially
methylated  between  Group  A  and  Group  B,  plus  a  probe  on  both  the  sites  whose  methylation  level  is  comparable
between the two samples. In this case, although the extent of the bubble of differentially methylation is the same of the
longer BOP, the p‐value derived from MANOVA is lower, equal to 8.64*10e‐14. This simple example shows that if we do
not normalize for the length of the BOP, short BOPs tend to rank at higher positions than long BOPs. 
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blood. The first dataset (referred hereafter as D1) 
includes data from 656 subjects ranging from 19 to 101 
years (average 64 ± 15 years) [3]. The second dataset 
(referred hereafter as D2) includes data from 38 subjects, 
19 newborns and 19 nonagenarians [2]. The third 
dataset (referred hereafter as D3) includes data from 58 
subjects ranging from 9 to 83 years (average 44 ± 18 
years) [4].  
 
In each dataset, probes containing missing values in at 
least one sample and probes on X and Y chromosome 
were removed. Age-associated DMR were identified in 
D1 and D3 using the age as a continuous variable and in 
D2 the group (newborns or nonagenarians) as a 
categorical variable. Ethnicity (Caucasian-European or 
Hispanic-Mexican) was used as covariate in the D1 
analysis. As the relative proportions of the different 
types of blood cells can vary significantly with age, we 
inferred blood cell counts from methylation data and 
use them as covariates in the analysis. 
 
Here we present results only for the region-centric 
analysis performed on Class A BOPs containing at least 
3 CpG probes. MANOVA results were corrected for 
multiple comparisons through Benjamini-Hochberg 
False Discovery Rate correction; 0.05 was used as 
significant threshold for q-values. Based on these 
criteria 21083, 517 and 2736 BOPs were identified as 
age-associated DMRs in D1, D2 and D3 respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The considerably lower number of BOPs identified in 
D2 is ascribable to the effect of blood cell types 
correction, as cord blood and whole blood significantly 
differ for this parameter. 
 
To validate our approach, we compared the results of 
the region-centric approach with the results of a single-
probe approach by analysis of variance (ANOVA). As 
shown in Figure 4, the number of significant CpG 
probes per BOP tended to be higher in the top ranking 
BOPs identified by the region-centric analysis. In most 
the cases, significant CpG probes within the same BOP 
concordantly moved towards hypermethylation or 
hypomethylation in younger compared to older subjects. 
Notably a small number of the selected BOPs in the 
three datasets included slightly differentially methylated 
CpG probes that did not reach the significance threshold 
by themselves, but whose concomitant variation with 
adjacent probes within the same BOP resulted 
significant when analysed by a multivariate approach. 
These results indicate that our approach was successful 
in identifying chromosomal regions, rather than single 
CpG sites, whose methylation status is affected by 
aging. 
 
To confirm that our region-centric approach reduces 
spurious results and is more likely to identify 
biologically relevant regions, we compared the results 
from the three datasets. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Number of significant CpG probes per significant BOP. For each dataset, the boxplot reports
the –log10(q‐value) of each significant Class A BOP  (MANOVA analysis) against  the number of significant CpG
probes (q‐value < 0.05, ANOVA analysis) included in each BOP. 
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First, we compared the DMRs identified in Hannum et 
al. and in Heyn et al. with those identified by our 
approach. Hannum et al. used a multivariate linear 
model approach based on the Elastic Net algorithm and 
identified a nucleus of 89 CpG probes whose 
methylation is associated to age, while Heyn et al 
selected 3205 age-associated CpG probes that resulted 
significant after ANOVA test (q-value < 0.01) and that 
showed a difference in average beta-values between 
newborns and nonagenarians greater than 0.20. We 
considered only the CpG probes belonging to Class A 
probes, that is 45 and 800 probes in D1 and D2 
respectively, and we matched them with the 
corresponding BOPs. In this way, we achieved a list of 
34 and 472 BOPs identified by Hannum et al. and by 
Heyn et al.. Only one BOP was shared by the two lists 
(Fig 5A, left panel). On the contrary, when we 
considered the first 34 and the first 472 BOPs identified 
by our approach respectively in D1 and D2, we 
observed an overlap of 15 BOPs (Fig 5A, right panel).  
 
Secondly, we considered a progressively increasing 
number of significant BOPs (region-centric analysis) 
and CpG probes (single-probe analysis) and we 
calculated the number of  common  DMRs  between  the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
three datasets. As shown in Figure 5B, the extent of 
overlap was higher for the region- centric approach 
compared to the single-probe approach.  
 
Finally, we provided a short list of genomic regions 
whose methylation levels vary according to age in D1, 
D2 and D3 (Table 1). We considered the overlap 
between the first 500 ranked BOPs identified by our 
region-centric approach in the 3 datasets, resulting in 42 
BOPs (44 genes, because some BOPs mapped to 
multiple genes which share the same CpG island). 11 
and 2 of the selected BOPs included at least one CpG 
probe that was provided also in Hannum’s and Heyn’s 
results respectively. Moreover, 4 of the selected BOPs 
contained at least one CpG probe that was included also 
in Horvath’s epigenetic clock. Two genes (HOXC4 and 
SST) were included in the GenAge database as related 
to aging in model systems and/or humans [22]. To have 
a general view of age-associated changes of the selected 
BOPs, we joined their beta-values from D1, D2 and D3 
and we divided samples in 10 age ranges from 0 to 100 
years. The plots reported in Fig 6 and in Supplementary 
Figure 1 confirm that the 42 genomic regions encounter 
a systematic hypermethylation (20 BOPs) or hypo-
methylation (22 BOPs) with age. 
Figure 5. The region‐centric approach increases the common findings between the
3 datasets. (A) Intersection between the results provided by Hannum et al. and Heyn et al.
(left panel) and between the results of the region‐centric approach on the two datasets. (B)
Intersection between a progressively increasing number of top ranking features (BOPs for the
region‐centric analysis, CpG probes for the single‐probe analysis) in the three datasets.  
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Figure 6. Examples of DNA methylation profiles of  selected age‐associated BOPs.  6  of  the  42
selected BOPs are reported as an example. Mean methylation values in 10 age classes are reported for each
CpG probe within the selected BOPs. For each BOP, beta‐values from D1, D2 and D3 were joined together. 
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Table 1. Candidate age‐associated genomic regions 
 
Gene Name Description BOP 
H
an
nu
m
 
H
ey
n 
H
or
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th
 
ABCC4 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 chr13:95953337-95954211*N_Shore    
ABHD14A abhydrolase domain containing 14A chr3:52008943-52009339*N_Shore X  X
ABHD14B abhydrolase domain containing 14B chr3:52008943-52009339*N_Shore X  X
AKAP8L A kinase (PRKA) anchor protein 8-like chr19:15529290-15529902*S_Shore    
ALDOA aldolase A, fructose-bisphosphate chr16:30076310-30077872*N_Shore    
AMER3 APC membrane recruitment protein 3 chr2:131513363-131514183*Island X   
ATP13A2 ATPase type 13A2 chr1:17337829-17338590*S_Shore X   
AXL AXL receptor tyrosine kinase chr19:41769215-41769417*N_Shore X   
CACNA1G calcium channel, voltage-dependent, T type, alpha 1G subunit chr17:48636103-48639279*Island    
COL1A1 collagen, type I, alpha 1 chr17:48276877-48279008*N_Shore    
CPEB1 cytoplasmic polyadenylation element binding protein 1 chr15:83315116-83317541*Island  X  
CSNK1D casein kinase 1, delta chr17:80231019-80231820*S_Shore   X
EDARADD EDAR-associated death domain chr1:236558459-236559336*N_Shore X  X
EIF1 eukaryotic translation initiation factor 1 chr17:39844833-39845950*N_Shore X   
ELOVL2 ELOVL fatty acid elongase 2 chr6:11043913-11045206*Island X   
FHL2 four and a half LIM domains 2 chr2:106014878-106015884*Island X X  
GIT1 G protein-coupled receptor kinase interacting ArfGAP 1 chr17:27918161-27918398*N_Shore    
GLRA1 glycine receptor, alpha 1 chr5:151304226-151304824*Island    
GPR78 G protein-coupled receptor 78 chr4:8582036-8583364*Island    
GRIN2C glutamate receptor, ionotropic, N-methyl D-aspartate 2C chr17:72848166-72848901*Island    
GUSB glucuronidase, beta chr7:65446771-65447340*S_Shore    
HNRNPUL1 heterogeneous nuclear ribonucleoprotein U-like 1 chr19:41769215-41769417*N_Shore X   
HOXC4 homeobox C4 chr12:54447744-54448091*S_Shore X   
IRX5 iroquois homeobox 5 chr16:54962422-54967805*Island    
LAG3 lymphocyte-activation gene 3 chr12:6882855-6883184*N_Shore   X
MLXIPL MLX interacting protein-like chr7:73037528-73038957*Island    
NENF neudesin neurotrophic factor chr1:212606105-212606844*N_Shore    
NFIA nuclear factor I/A chr1:61548753-61549564*N_Shore    
OTUD7A OTU deubiquitinase 7A chr15:31775540-31776988*Island X   
PI4KB phosphatidylinositol 4-kinase, catalytic, beta chr1:151300522-151300724*N_Shore    
PRLHR prolactin releasing hormone receptor chr10:120353692-120355821*Island    
PRRT4 proline-rich transmembrane protein 4 chr7:127990926-127992616*Island    
PTGDS prostaglandin D2 synthase 21kDa (brain) chr9:139872237-139873143*N_Shore    
PXN paxillin chr12:120702976-120703541*S_Shore    
RCSD1 RCSD domain containing 1 chr1:167599464-167599839*N_Shore    
SLC12A5 solute carrier family 12 (potassium/chloride transporter), member 5 chr20:44657463-44659243*Island    
SLC25A22 solute carrier family 25 (mitochondrial carrier: glutamate), member 22 chr11:797640-798544*N_Shore    
SOX1 SRY (sex determining region Y)-box 1 chr13:112720564-112723582*Island    
SST somatostatin chr3:187387914-187388176*N_Shore X   
TFAP2B transcription factor AP-2 beta (activating enhancer binding protein 2 beta) chr6:50787286-50788091*Island    
VARS2 valyl-tRNA synthetase 2, mitochondrial chr6:30881533-30882296*S_Shore    
ZAR1 zygote arrest 1 chr4:48492117-48493589*Island    
ZEB2 zinc finger E-box binding homeobox 2 chr2:145281736-145282269*N_Shelf    
ZYG11A zyg-11 family member A, cell cycle regulator chr1:53308294-53309262*Island    
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DISCUSSION 
 
In this paper we present an original pipeline for the 
analysis of Infinium 450k data, in which different 
genomic regions are analyzed either by a single-probe 
or a region-centric approach depending on their context 
and probe content/density.  
 
The Infinium 450k is currently the most used 
technology for EWAS studies. The reasons for the 
success of this microarray are to be found in its 
affordability and simplicity, in addition to a reasonable 
informativeness on genome-wide DNA methylation 
profiles. Alternative techniques such as sequencing of 
immunoprecipitated methylated DNA (MeDIP-seq) or 
of bisulfite-treated genomic DNA (BS-seq) provide a 
more comprehensive picture of DNA methylome [23] 
but, despite the recent introduction of pipelines for their 
automatization and analysis [24–27], are still more 
laborious and expensive. 
 
A recent comprehensive review has collected the 
bioinformatic tools developed to specifically analyze 
Infinium 450k data [27]. Apart from methods to 
normalize data and adjust them for technical bias, several 
algorithms to identify differentially methylated regions 
(DMRs) between groups of interest have been developed. 
A growing body of literature suggests to analyze 
Infinium 450k data by a region-centric approach, with 
several advantages respect to single-probe analysis 
[15,18]. First of all, it better resembles the biological 
basis of the process, as concordant changes in a group of 
adjacent CpG sites are more likely to affect the 
phenotype compared to alterations of single CpG sites. 
Moreover, a region-centric approach simplifies the 
identification of genomic regions of interest as provides a 
shorter list of ranked results and is less prone to provide 
spurious results due for example to the presence of SNPs 
in the probes included in the array [18].  
 
Here we reasoned that the statistical analysis of the 
Infinium 450k microarray should take into account the 
specific architecture of the microarray. Indeed, we 
clearly showed that different genomic regions present 
different level of coverage in terms of probes 
distribution. We grouped probes in blocks (BOPs) based 
on microarray annotations and verified that only in CpG 
islands and in the surrounding regions (shores and 
shelves) the mean distance between probes in a BOP 
was within 500 bp, a range in which the methylation 
values of CpG sites are usually correlated [21]. On the 
contrary, the density of probes mapping in not CpG-rich 
regions (not CpG-rich promoters, gene bodies, 
intergenic regions) was strikingly lower. This means 
that different regions of the array are more suitable to a 
single-probe or a region-centric analysis. Noteworthy, 
the proposed probes classification does not have only a 
mere methodological value, but it has important 
biological implications. First of all, the region-centric 
approach is selectively applied to short regions (most 
CpG islands are within 3000 bp, while shores and 
shelves are by definition 2000 bp long), in which the 
methylation level of CpG probes is more likely to be 
correlated. Moreover, a growing body of evidences 
indicates that the function of DNA methylation greatly 
varies with genomic context [28]. This means for 
example that methylation of CpG islands, of shores or 
of gene bodies can differently affect gene expression 
and that it can be differently affected by the condition 
under study. Also, the methylation status of non-genic 
regions can have important consequences, for example 
by influencing chromatin architecture and stability, and 
it is likely that the effect of methylation at non-genic 
CpG islands or at open-sea CpG sites can be different. 
Analyzing separately these regions that have different 
functional meaning can therefore facilitate the 
identification of informative variations in methylation 
profiles in the model under consideration. Moreover, 
this approach provides shorter ranked lists of results that 
can be more easily examined by the researcher. 
 
We used multivariate ANOVA (MANOVA) to test for 
general changes in methylation in the region-centric 
analysis. This approach has been previously adopted for 
the analysis of methylation data [29,30] as it allows to 
explore simultaneously the relationship between several 
dependent variables (in our case, 3 adjacent CpG probes 
within a BOP) and the independent variables under 
study. Notably, most of the other algorithms for DMRs 
identification is not based on a multivariate approach, 
but combines the results from univariate analyses on 
adjacent CpG probes [27]. As shown in the meta-
analysis, MANOVA can identify not only regions in 
which multiple adjacent probes are significantly 
different between the samples, but also regions in which 
there are concomitant little variations of adjacent 
probes, none of which would reach the significance 
threshold by itself in a univariate test. This could be 
particularly valuable when small differences exist 
between the samples under study.  
 
Overall the strength of our approach is that not only 
microarray features are grouped in biologically 
meaningful groups, but also that the ranking criterion is 
based on a multivariate approach. Additionally, 
significant BOPs can be ranked also on the basis of the 
“bubble” of differential methylation, defined as at least 
two adjacent probes whose mean methylation in the 
groups under investigation differs of at least a minimum 
value. As a confirm of the validity of the approach we 
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demonstrated that, when considering the top ranking 
BOPs, our method increased the number of common 
genes identified in all three studies compared to a 
single-probe analysis, indicating that it is likely to 
provide a more informative overview of biologically 
relevant results. 
 
The analysis pipeline we propose is implemented in R 
software environment and is therefore freely available. 
Researchers just need to define the analysis parameters, 
such as the covariates to be used in the 
ANOVA/MANOVA, the FDR correction method, the 
significance threshold and the minimum difference 
between mean methylation values between the groups 
under investigation. 
 
We used our analysis pipeline to perform a meta-
analysis on 3 Infinium 450k datasets that investigated 
age-associated changes in DNA methylation. The 3 
datasets are considerably different in terms of both 
samples number and age range. Nevertheless, we were 
able to identify a core of genomic regions whose 
methylation profiles systematically vary with aging, 
from newborns to nonagenarians. To our knowledge, 
this is the first report describing a relatively large 
number of genomic regions with such characteristics. 
Only a subset of these genes was identified by Hannum 
et al. and by Heyn et al. or was included in Horvath’s 
epigenetic clock. Inferring how the methylation of these 
regions can contribute to the aging process is out of the 
scope of this paper, although the life-long variations in 
DNA methylation that we described are suggestive of a 
profound link between development and aging [31]. 
Many genes showed marked differences between cord 
blood and the other age ranges. Although these 
differences could in principle be ascribed to differences 
in blood cells composition, it is tempting to suggest that 
during the first phases of growth a profound epigenetic 
remodeling occurs. It is interesting to note that 2 genes 
from our list (SST and HOXC4) are enclosed as age-
related genes in the GenAge database [22]. Moreover, a 
Pubmed search using the query “gene name AND aging 
[title/abstract]” gave some interesting hints, as the 
expression of CACNA1G, COL1A1, LAG3, PTGDS and 
ZEB2 genes resulted modulated by age in several models 
[32–38]. COL1A1 and PTGDS emerged from the same 
study [32] in which hippocampal gene expression in 
senescent female mice was assessed after long-term 
exercise. The observation that age-dependent expression 
of the above mentioned genes was detected in tissues 
other than blood prompts further studies to evaluate 
general rearrangements in epigenetic landscapes of 
different cell types. Finally, the methylation status of 
ELOVL2, FHL2 and EDARADD genomic regions was 
previously described as associated to aging [4,39]. 
Collectively the above observations indicate that this 
short list of genes, selected by means of an analytical 
pipeline that is tailored on the architecture of the 
microarray and that is more likely to provide 
biologically relevant findings, can be used as the basis 
for deeper investigations to shed light on the molecular 
basis of the aging process. 
 
METHODS 
 
Datasets. D1 and D2 are publicly available at NCBI 
Gene  Expression  Omnibus   (GEO)   (http://www.ncbi. 
nlm.nih.gov/geo/) under accession numbers GSE40279 
and GSE30870 respectively. D3 includes 32 mother–
offspring couples and is part of a larger datasets 
submitted to GEO with accession number GSE52588. 
 
Estimation of cell counts. Abundance measures of 
blood cell types were estimated using the appropriate 
option of the DNA Methylation Age Calculator, freely 
available at https://dnamage.genetics.ucla.edu/ [12], 
which is in part based on a previously published 
algorithm [40]. As suggested by authors, methylation 
measures were corrected for “CD8.naive” (Naive CD8 
T cells), “CD8pCD28nCD45RAn” (memory and 
effector T cells), “PlasmaBlast” (plasmablasts), CD4 T 
cells, monocytes, granulocytes and natural killer cells. 
 
BOPs definition and DMR identification. The 
analytical pipeline is implemented as an R script freely 
available at https://immunologyomics.unibo.it/labkey/-
450K_pipeline.url. For ease of use, the pipeline is split 
in 3 step: 1) Definition of Classes and BOPs; 2) DMRs 
identification 3) FDR correction, selection of 
significant DMRs/probes, sorting of probes and plots. 
Step 2 and step 3 are separately provided for Class A 
BOPs containing 3 or more probes, Class A BOPs 
containing 1 or 2 probes, Class B BOPs containing 3 
or more probes, Class B BOPs containing 1 or 2 
probes , Class C probes and Class D probes. Detailed 
explanations of input and output files are provided. A 
general description of the 3 analytical steps is provided 
below: 
 
Step 1: Probes containing missing values  and probes 
with a detection p-value greater than 0.05 in more than 
75% samples were removed, together with those 
localized on sexual chromosomes. Probes that 
contained SNPs were annotated as previously 
described [21]. For probes classification and BOPs 
definition, the RELATION_TO_UCSC_CPG_ISLAND 
and the UCSC_REFGEN_NAME columns in the 
Illumina Infinium 450k annotation were used to subset 
the array probes in four classes and to group probes in 
BOPs.  
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Step 2: DMRs identification is based on MANOVA and 
ANOVA functions from the R package car. For sliding 
windows MANOVA, the function is applied on sliding 
windows of 3 consecutive CpGs within the same BOP. 
For each BOP, the lowest p-value among those 
calculated for the different sliding windows is kept. 
Both MANOVA and ANOVA analysis support the use 
of both categorical and continuous covariates. Parallel 
processing can be used if the computational 
environment supports it. 
 
Step 3: The analytic pipeline allows to correct 
MANOVA/ANOVA p-values for multiple testing using 
the correction methods implemented in the R package 
multtest. BOPs/probes can be selected on the basis of a 
significance threshold on either nominal or FDR-
corrected p-values. In the case of BOP analysis, BOPs 
can be ranked on the basis of a user-defined minimum 
mean methylation difference between adjacent CpG 
probes. MDS plots, heatmap plots and line plots are 
generated as outputs. 
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Abstract
Context: Epigenetics represents a still unexplored research field in the understanding of micro-
and macro-evolutionary mechanisms, as epigenetic changes create phenotypic diversity within
both individuals and populations.
Objective: The purpose of this review is to dissect the landscape of studies focused on DNA
methylation, one of the most described epigenetic mechanisms, emphasizing the aspects that
could be relevant in human adaptations.
Methods: Theories and results here considered were collected from the most recent papers
published.
Results: The matter of DNA methylation inheritance is here described as well as the recent
evolutionary theories regarding the role of DNA methylation—and epigenetics in a broader
sense—in human evolution. The complex relation between (1) DNA methylation and genetic
variability and (2) DNA methylation and the environmental stimuli crucial in shaping genetic
and phenotypic variability through the human lineage—such as diet, climate and pathogens
exposure—are described. Papers about population epigenetics are also illustrated due to their
high relevance in this context.
Conclusion: Genetic, epigenetic and phenotypic variations of the species, together with cultural
ones, are considerably shaped by a vast range of environmental stimuli, thus representing the
foundation of all human bio-cultural adaptations.
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Introduction
It has long been accepted that natural selection favours the
fittest organism, suggesting that individuals who acquired
favourable adaptations to their environment will be positively
selected during evolution. In this framework, genetic variation
and especially polymorphisms able to influence phenotypic
traits become fundamental as potential ‘‘substrates’’ on which
environmental (and/or, in the case of H. sapiens, cultural)
selective pressures could act and through which natural
selection shapes diversity patterns of populations and species.
However, genetics appears to not be the only domain able
to describe processes underlying the adaptive events that
occurred in the evolutionary histories of organisms. For
instance, epigenetics represents a relatively new and still
unexplored research field that promises to contribute to a
deeper understanding of micro- and macro-evolutionary
mechanisms, according to the capability of epigenetic changes
to create phenotypic diversity within both individuals and
populations, with or without the occurrence of genetic
variation (Richards, 2008).
In particular, this review will focus on the dissection of the
landscape of studies focused on DNA methylation, one of the
most described epigenetic mechanisms, emphasizing the
aspects that could be relevant for a deeper understanding of
processes involved in human adaptations. The complex
relation between changes in DNA methylation and in DNA
sequence, as well as the environmental stimuli able to produce
variability in methylation patterns will be, thus, described.
Regarding environmental factors, we will especially focus on
those that have played a crucial role in shaping genetic and
phenotypic variability through the human lineage, such as
diet, climate and pathogens exposure.
For this purpose, in the following section we will review
the most informative studies that have exploited an epigen-
etics approach to the study of human phenotypic traits, in the
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attempt to shed new light on the recent evolutionary history of
our species.
DNA methylation overview
DNA methylation is a molecular mechanism entailing the
covalent addition of a methyl group in the fifth carbon of the
cytosine pyrimidine ring (m5C) that, in mammals, is usually
located within a CpG dinucleotide. In the human genome, the
density of these CpGs is non-random and they also appear to
be under-represented with respect to what is expected
according to such genomic complexity.
This imbalance is due to the high rate of mutation of m5C
to thymine (i.e. deamination) that likely led to a reduction of
CpG dinucleotides in mammalian genomes over the course of
evolution (Razin & Riggs, 1980). Regions with a higher CpGs
content than the genomic average (i.e. ‘‘CpG islands’’) are
supposed to be 29 000 throughout the human genome,
although this estimate could vary according to CpG island
definition and 60% of them co-localize with gene promoters.
The DNA methylation status of these CpG islands is subjected
to dynamic changes during development and cell differenti-
ation and is known to affect gene expression levels
(Antequera, 2003; Lander et al., 2001). In particular, it
could have different effects according to the position of the
involved CpGs. For instance, methylation of CpG islands at
transcription start sites (TSSs) is usually associated with
inactivation of gene expression by interfering with transcrip-
tion factors or, indirectly, by recruiting chromatin modifica-
tion enzymes. On the contrary, CpGs located in gene bodies
might even stimulate transcription and influence splicing
mechanisms. Many methylated CpGs are also found in
repeated sequences, most of which are derived from trans-
posable elements, suggesting that they could play a funda-
mental role in genome stability, acting as suppressors of
transposable elements expression (Jones, 2012).
In general, vertebrate promoters can be divided into two
classes—low CpGs (LCG) and high CpGs (HCG)—just
according to their CpGs content. Most of LCG are methylated
and are associated to tissue-specific genes, while HCG are
usually hypo-methylated and are related to broadly expressed
genes. One possible evolutionary reason for such bimodal
distribution is that broadly expressed genes have selectively
avoided DNA methylation because their consequent inacti-
vation would have been deleterious (Elango & Yi, 2008).
Transgenerational inheritance of DNA
methylation patterns
The establishment of DNA methylation patterns is a complex
and dynamic process, strictly connected with the development
of the organism and influenced by genetic and environmental
factors.
Soon after fertilization, the genome of the zygote encoun-
ters a global DNA de-methylation event, which is necessary to
erase the epigenetic patterns characteristic of the gametes and
to guarantee the zygote totipotency (Feng et al., 2010; Surani
et al., 2007). However, a consistent proportion of the genome
is protected from DNA de-methylation and retains its
methylation marks. This is the case of imprinted genes
(i.e. genes that are expressed only from the maternal or the
paternal allele), whose methylation state is established during
gametes differentiation. Moreover, during the development,
activity of de novo DNA methyltransferases 3a and 3b
(Dnmt3a/b) is critical to introduce tissue-specific epigenetic
marks and to ensure cell differentiation (Chen et al., 2003;
Okano et al., 1999). In adult individuals, the methylation
status of most CpGs is maintained across cell divisions
through the activity of Dnmt1, allowing stable tissue-specific
gene expression without changes in DNA sequence. However,
the epigenome retains a certain level of plasticity and can be
modified by several environmental factors (e.g. diet, climate,
stress, exposure to environmental compounds or pathogens)
or by physiological (e.g. ageing) or pathological (e.g. cancer)
conditions (Bacalini et al., 2014).
For many years, it was believed that phenotypic effects of
epigenetic modifications concerned only the individual
exposed to related environmental stimuli. However, several
recent evidence indicates that some of the changes in DNA
methylation induced by environmental stimuli can be also be
transmitted to generations derived from the exposed individ-
ual (Daxinger & Whitelaw, 2012; Franklin & Mansuy, 2010;
Heard & Martienssen, 2014; Skinner et al., 2010). Inheritance
of the methylation status of a DNA sequence (defined as
epiallele) is well-described in plants (Becker & Weigel, 2012;
Schmitz et al., 2011), while its occurrence in mammals is
sustained by a minor body of evidences (Dolinoy et al., 2007;
Rakyan et al., 2002, 2003). When dealing with this issue, it is
important to distinguish between its inter-generational and
transgenerational effects (Heard & Martienssen, 2014). Inter-
generational effects are observed when an individual inherits
a DNA methylation-driven phenotype because it is indirectly
exposed to a triggering environmental force, for instance
through in utero exposure of the offspring and of its
developing gametes. On the contrary, transgenerational
effects occur when epialleles are maintained in generations
that were never exposed to a given triggering environmental
stimulus (Morgan et al., 1999; Rakyan et al., 2003). This
implies that DNA methylation signatures are inherited
through the gametes and escape the erasure that occurs not
only in the zygote (see above), but also during germline
maturation (Popp et al., 2010). Although the extent and the
frequency of this epigenetic inheritance in mammals are still
not clear, it has major implications from an evolutionary
perspective, as it represents a potentially adaptive mechanism
directly modulated by the environment and on which natural
selection can act. Moreover, a recent study (Turner, 2011)
suggests that epigenetic changes could persist over genera-
tions in two ways: (i) through the epigenetic inheritance
described above; and (ii) through the persistence of a long-
term stimulus that forces a certain epigenetic profile during
generations, leading to a consequent genetic change that is
able to exert the same phenotypic effect. In this latter case, the
acquired phenotype becomes heritable in a sequence-depend-
ent manner.
Evolutionary relevance of DNA methylation
Some studies investigated the role that epigenetic variations
might have played in human evolutionary history and,
accordingly, several theories have been proposed. Certainly,
2 C. Giuliani et al. Ann Hum Biol, 2015; 42(1): 1–9
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the fact that DNA methylation constitutes a source of
phenotypic variability, together with recent evidence showing
that some epigenetic changes can escape transgenerational
erasure mechanisms, suggests that these modifications have
the potential to influence micro-evolutionary processes.
In a recent study, Shea et al. (2011) listed two different
epigenetic mechanisms that could have shaped human evo-
lution by producing, respectively, selection-based and detec-
tion-based effects. The first mechanism is similar to that
through which natural selection acts on genes; that is, a
specific epigenetic pattern is maintained across generations
and is inherited by the offspring from the parents. The second
mechanism is instead based on an ‘‘environment detection’’
process, for which parents experience a particular environ-
ment and transmit an epigenetic pattern apt to cope with it.
According to this view, Gluckman et al. (2005) described a
set of theories, known as ‘‘predictive adaptive responses’’,
based on the hypothesis that conditions experienced in utero
may confer advantages in a later phase of life.
It is important to note that it is not known to what extent
epigenetic variants are transmitted per se or arise via de novo
mutations at each generation (Rando & Verstrepen, 2007).
However, Jablonka & Lamb (2005) argued that, since DNA
methylation can alter gene expression, and consequently
phenotypes, epialleles can be subjected to natural selection, as
though alleles at genetic loci. Moreover, Shea et al. (2011)
considered a third channel of information linked to somatic
cells identity and related to the fact that cells belonging to a
given tissue carry information about which specific cell type
to become. The authors argued that in multi-cellular organ-
isms information conflicts could arise since a single locus is
not able to carry different information (i.e. about cell
differentiation and about selection- or detection-based effects
of specific epigenetic profiles). The only way to avoid this
problem seems to entail the existence of different loci that
carry different types of information. For example, regarding
the DNA methylation mechanism, some specific CpG sites
are involved in somatic differentiation and they could not be
involved also in mechanisms producing selection-based
effects at the same time. Obviously, these processes depend
on how much the epigenetic marks have been erased.
Another study (Klironomos et al., 2013) hypothesizes that
variants beneficial in a population could be of genetic and
epigenetic origin and that both of them contribute to increased
fitness of individuals. However, CpG sites are characterized
by a higher mutation rate than single standard nucleotide loci
and this means that adaptation achieved through changes in
DNA methylation could be lost more rapidly than that
achieved via genetic mutations. The authors thus argue that
only a high strength of selection could determine the fixation
of a given epiallele. In other words, under very strong
selective pressures the use of epigenetic mechanisms to
encode new and potential adaptive phenotypes could be
advantageous with respect to the use of genetic ones. They
also argued that, once a phenotype has been produced by
DNA methylation changes, the related genetic variation is not
under selection and vice versa. In this way, they hypothesized
that populations that have to face a new environment could
‘‘buy time’’ by using DNA methylation changes to cope with
environmental cues, until a new potentially adaptive genetic
mutation arises (Figure 1).
Regarding these theories, it is important to cite the study of
Feinberg & Irizarry (2010) that proposes a new idea for the role
that epigenetic mechanisms could have played in human
evolution. In fact, they suggest that some genetic variants may
exert an effect on the variability of a certain trait without
altering the mean phenotype. According to the authors’
hypothesis, propensity to stochastically vary is mediated
epigenetically and populations carrying genetic variants
associated to this higher propensity to variability might have
an advantage (or a disadvantage) in changing environments.
DNA methylation changes affected
by genetic variation
In the last years, many studies (Bell et al., 2011; Smith et al.,
2014) addressed the association between sequence variants
(e.g. single nucleotide polymorphisms, SNPs) and DNA
methylation patterns at specific CpGs. In fact, some of them
identified DNA methylation quantitative trait loci (meQTLs)
as genetic variants associated to DNA methylation at CpG
sites (Smith et al., 2014). Moreover, methylation patterns
seem to be not only linked to SNPs, but also to DNA
composition in terms of local nucleotide sequence content.
A recent study (Bock et al., 2006) assigned a degree of
‘‘methylation propensity’’ for each CpG island calculated on
the basis of the DNA sequence itself. Accordingly, the authors
argue that, in normal tissues, DNA composition of CpG
islands could be used to predict with high accuracy their
methylation status, excluding those differentially methylated
in a tissue-specific manner (i.e. 5% of CpG islands in the
genome) (Song et al., 2005).
Nevertheless, in order to effectively distinguish the
contributions of genetic and environmental factors in the
Figure 1. Epigenetic changes as a medium-
term way for a population to adapt to
environmental stimuli. The type of adaptation
can change according to intensity and per-
sistence of a certain environmental stimulus.
DOI: 10.3109/03014460.2014.961960 The epigenetic side of human adaptation 3
A
nn
 H
um
 B
io
l D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
D
r R
ac
he
l D
ee
ve
y 
on
 1
2/
15
/1
4
Fo
r p
er
so
na
l u
se
 o
nl
y.
examined traits, studies on twins continue to constitute a
unique model. In general, patterns of DNA methylation in
monozygotic twins (MZ) are found to be more concordant
than those observed in dizygotic twins or unrelated pairs,
indicating a genetic influence on DNA methylation profiles
(Fraga et al., 2005). Moreover, this genome-wide study
carried out by Fraga et al. (2005) reveals that epigenetic
modifications in MZ twins pairs arise also during ageing. The
authors suggest that differences in internal and external
factors (e.g. smoking habits, lifestyle, diet, etc.), as well as a
sort of ‘‘epigenetic drift’’, could be the main causes of
differences in DNA methylation profiles that occurred within
genetic identical backgrounds, as subsequently confirmed by
candidate-genes studies (Pirazzini et al., 2012). Data from
studies on twins perfectly pointed out that DNA methylation
differences between individuals could not be entirely under-
stood considering only their genetic backgrounds.
Accordingly, many studies and theories are being focused
on the effects of the environment on DNA methylation
patterns. Moreover, it should be kept in mind that, with
environmental stimuli being equal, DNA methylation patterns
can also be affected by physiological processes, such as
ageing (Hannum et al., 2013). Methylation profiles of the
ELOVL2, FHL2, and PENK genes represent only some
examples of how DNA methylation can change during ageing,
despite the genetic inter-individual variability (Garagnani
et al., 2012). Nevertheless, reviewing all of them is not the
purpose of this article, which is instead aimed at describing
the relationship between epigenetic modifications, especially
DNA methylation ones, and the main environmental stimuli
(i.e. diet, climate and pathogens exposure) that have played a
crucial role in shaping the genetic variability of our species
throughout its evolutionary history. As concerns this issue, the
most informative studies are those that have succeeded in
exploiting a population epigenetics approach and we have
reviewed these in the following section.
DNA methylation changes due to
environmental stimuli
Diet in the periconceptional period and in adulthood
As previously mentioned, DNA methylation changes that
could be inherited could also be modified by a wide range of
environmental stimuli, whose effects directly depend on the
duration of the stimulus and on the genetic background of
the individual subject to it. It is well known that, from one
generation to the next one, methylation status is generally
re-set. However, some CpG regions of the genome represent
an exception, being not modified and allowing transmission
of epigenetic information from one generation to another.
Furthermore, it was observed that methylation status in the
periconceptional period is very sensitive to external stimuli,
such as the diet of the mother and her exposure to toxins
(Barnes & Ozanne, 2011; Laker et al., 2013). In fact, recent
studies carried out on animal models have shown that the diet
of the mother can modulate the epigenome of the zygote,
sometimes leading also to increased disease susceptibility in
adulthood. The most well known studies on humans in this
field take into consideration individuals born from mothers
who have experienced famine in 1945 during the Dutch
hunger winter (Heijmans et al., 2008; Tobi et al., 2009). The
authors found that periconceptional exposure to famine is
associated with the lower DNA methylation level observed
decades later at IGF2 and at other candidate genes (imprinted
and non-imprinted). Accordingly, they argued that hypo-
methylation in adulthood could be related to deficiency in
methyl donors (e.g. methionine) in early life phases, but they
also did not exclude the possible effects of low temperatures
and stress to which the mothers were subject to. This study
supports the idea that transient environmental stimuli can be
recorded as DNA methylation information also in humans.
These findings indeed confirm results obtained with rodents
that already highlighted changes in nutrition associated with
epigenetic instability (mainly due to transposable elements)
during early development (Waterland & Jirtle, 2003).
However, recent studies showed that not only nutritional
habits of the mother can influence DNA methylation patterns
of the newborn, but that also folate levels of the father may
contribute to healthy pregnancy outcomes (Lambrot et al.,
2013). Interestingly, the vast majority of studies focus on in
utero exposition to stress and environmental stimuli (Langley-
Evans, 2014), while investigation of epigenetic plasticity in
adulthood is less addressed. In fact, only recently the role of
diet in DNA methylation changes of adult individuals, and
also during ageing, is acquiring increasing relevance (Bacalini
et al., 2014). Moreover, whereas DNA methylation data on
murine models are abundant, limited data are still available
for humans. For instance, an interesting study by Scoccianti
et al. (2011) demonstrated that DNA profiles of some
candidate genes change according to 4-week diet intervention.
In fact, this study investigated the effects of three dietary
regimens on DNA methylation patterns in white blood cells of
heavy smokers. One of the tested diets was balanced in fruits
and vegetables, another one was enriched in flavonoids and
isothiocyanates, particularly cruciferous vegetables, and the
third one was supplemented with flavonoids, such as green tea
and soy products. The authors demonstrated that an isocaloric
diet (balanced in fruits and vegetables) may succeed in
stabilizing global epigenetic patterns (estimated by measuring
DNA methylation of LINE1 (Yang et al. 2004)), but has no
impact at specific genes selected; however, no changes in
DNA methylation profiles were observed after a short-term
dietary intervention.
A more recent study (Jacobsen et al., 2012) reports for the
first time that a short-time high fat overfeeding diet alters
DNA methylation profiles at the genome-wide level in human
skeletal muscles. The authors also showed that changes were
reversed, at least partially, after a washout period of 8 weeks.
As mentioned above, the periconceptional period is a critical
window in which certain stimuli (e.g. exposure to toxins) can
promote epigenetic transgenerational inheritance of complex
diseases. For instance, a recent study demonstrates that
exposure to the insecticide dichlorodiphenyltrichloroethane
(DDT) can affect DNA methylation patterns across gener-
ations (Skinner et al., 2010). The authors demonstrated that
peculiar methylation profiles are observed not only in F0, F1
and F2, but also in the F3 generation. This is a fundamental
point suggesting that F3 generation profiles are likely due to a
transgenerational germline-mediated mechanism. Moreover,
another study shows that pregnant agouti mothers fed with
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bisphenol A (BPA) generate offspring characterized by
hypomethylation of the agouti gene that is associated with a
more unhealthy outcome (i.e. more incidence of obesity and
diabetes) (Dolinoy et al., 2007). This study also demonstrates
that a maternal nutrient supplementation of methyl-rich foods
can neutralize the negative effects of BPA exposure (Dolinoy
et al., 2007).
Furthermore, not only diet, but also physical activity
represents another factor that is able to modify DNA
methylation status in adulthood. A recent genome-wide
study considered DNA methylation profiles of more than
450 000 CpG sites in adipose tissues of healthy individuals,
showing that DNA methylation plasticity and modulation is
observable, excluding changes in cellular composition, after 6
months of physical activity in 17 975 CpG sites (Ro¨nn et al.,
2013). These differentially methylated sites include also
obesity- and type 2 diabetes-associated genes, such as
TCF7L2 and KCNQ1. Moreover, obtained results indicated
that the vast majority of variability is located in non-CpG
islands regions, supporting other evidence that demonstrated
how CpG islands shores (i.e. regions flanking CpG islands)
have higher probability to vary than CpG islands (Irizarry
et al., 2009).
Pathogens load
Anatomically modern humans spread out of sub-Saharan
Africa 70 000 years ago, beginning to progressively settle
in the other continents (Henn et al., 2012). During this
colonization process, different human populations had to face
completely new and different environmental challenges,
which strongly contributed to shape their genome by trigger-
ing several adaptive events. Interestingly, it has been proposed
that one of the predominant drivers of these local adaptations
was the pathogens load (Fumagalli et al., 2011). In particular,
selective pressures imposed on the human genome by
helminthes infections seem to be stronger than those related
to viral and bacterial ones. The authors also suggest that the
genome of helminthes presents an evolutionary rate similar to
the human one, making the establishment of effective co-
evolutionary processes possible. The same mechanism
appears to be not plausible in the case of virus, according
to the faster evolving rates with respect to that of our species.
However, what role epigenetic variability has in this
scenario is still far from being depicted. What is known is that
DNA methylation profiles can vary when cells are infected by
viruses or parasites. A study by Ja¨hner & Jaenisch (1985)
firstly demonstrated that DNA methylation patterns change
after the integration of viral DNA into host cells. This
mechanism is associated with the transcriptional silencing
that contributes to viral latency. Moreover, some studies
linked epigenetic modifications to hepatitis B infection in the
liver, stressing a strong interplay between pathogens and the
host cell epigenome (Okamoto et al., 2014; Park et al., 2013;
Vivekanandan et al., 2010). A recent study indeed considered
epigenome-wide data from three human populations with
different ancestry (i.e. African-Americans, Asian-Americans
and Americans of European origins), succeeding in identify-
ing a core of 439 CpG sites according to which it is possible
to distinguish the examined populations (Heyn et al., 2013).
It is interesting to note that these data suggest the possibility
that pathogens characterizing different environments could
leave different and stable signatures in the methylome of the
host. In fact, many gene promoters whose DNA methylation
profile differs in the three populations turned out to be
associated with immune responses and enriched for tran-
scription factors involved in reactions to viral (i.e. hepatitis B)
and bacterial (i.e. Shigellosis) infections. Moreover, the
authors suggest that DNA methylation could represent a
link between the genotype (i.e. risk alleles associated to
increased susceptibility to infection) and the phenotype (i.e.
the infection incidence). Accordingly, the hypothesis that
selective pressures related to the pathogen landscape are able
to shape both the human genome and its methylation profiles
appears to be highly plausible.
Climatic and environmental conditions
Local adaptations driven by climate-related selective pres-
sures (e.g. UV radiation, humidity, thermal stresses, etc.) have
also been proposed as evolutionary events able to strongly
influence differential patterns of genetic variation among
human populations (Hancock et al., 2011). For instance, as
regards adaptive responses to thermal stresses, different
strategies and levels of adaptation can be described, ranging
from cultural adaptations, through which humans create
artificial and regulated microclimates, to plasticity of physio-
logical mechanisms and, finally, to genetic adaptation
(Sazzini et al., 2014). All these responses represent comple-
mentary strategies that have allowed some human populations
to cope with highly challenging climate conditions.
The type of the adopted adaptive strategy and its success
strictly depend on the duration of the environmental stimulus.
For instance, physiological modifications are optimal short-
term adaptive mechanisms, resulting instead in potentially
deleterious long-term ones due to the possibility of causing
damage to the organism. One clear example is that of
adaptation to high altitude (Xing et al., 2008), in which
physiological changes, such as increased heart rate, may be
decisive for short-term survival, but finally can cause severe
tissue and organ damage. Interestingly, epigenetics mechan-
isms could represent ‘‘medium-term’’ strategies to cope with
a demanding environmental condition, such as high altitude
hypoxia. Unfortunately, epigenetics studies focused on these
issues suffer from a lack of human data. A single very elegant
study has until now assessed differences in genome-wide
levels of DNA methylation between high- and low-altitude
populations, by analysing high- and low-altitude blood
samples from Amhara (i.e. an Ethiopian ethnic group that is
supposed to have lived at 2500 m for at least 5000 years) and
high- and low-altitude saliva samples from Oromo (i.e. an
Ethiopian ethnic group that have moved to high altitude in
1500 AD (Alkorta-Aranburu et al., 2012; Quirin, 1992).
Interestingly, no methylation differences between low- and
high-altitude Amhara individuals were observed, while sig-
nificant differences were found in Oromo for genes involved
in defense from pathogens and in response to hypoxia
(i.e. VEGF, MT1G, APOBEC3G). The authors suggest that
Oromo, moving to high altitude more recently, are still
adapting to this new environmental condition by means of
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epigenetic variations. This also reflects the fact that more
time is needed to adapt genetically to a new environment (as
in the case of high-altitude Amhara) and that DNA methy-
lation could represent an effective medium-term response to
environmental changes (Figure 1).
Despite these promising findings, further experiments are
needed to take into account tissue specificity, since this study
focuses on different tissues in the two examined populations.
Nevertheless, epigenetics, and in particular DNA methylation,
seems to play a key role in hypoxic response and, in general,
hypoxia responsive pathways are epigenetically activated in
order to promote tissue survival (Watson et al., 2010).
Moreover, it has also been demonstrated that, in a cellular
model of hypoxia (i.e. prostate cancer), cells are able to adapt
to the lack of oxygen by changing their epigenetic profile,
especially their DNA methylation and histone acetylation
status (Watson et al., 2009).
In the past, similarity between the environment where the
human foetus develops and high altitude hypoxia was
proposed, suggesting that the foetus is perfectly adapted to a
low oxygen pressure and that chemoreceptor sensitivity
increases in the neonatal period (Eastman, 1954; Martin
et al., 2010). However, mechanisms and involvement of
epigenetic processes in the regulation of hypoxic sensing are
still not completely understood. Only a recent paper published
by Nanduri et al. (2012) focused on the epigenetic regulation
of hypoxic sensing. In particular, it reported DNA hyper-
methylation of the Sod2 gene and consequent disruption of
redox homeostasis by oxidative stress in neonatal rats exposed
to intermittent hypoxia. Since hypoxic sensitivity is strongly
connected to elevated oxidative stress, the authors described a
possible mechanism by which Sod2 hypermethylation leads to
a decreased expression of the gene. However, by treating
neonatal rats with an inhibitor of DNA methylation, they
observed a reduction of hypersensitivity of the carotid body
and of adrenal chromaffin cells to hypoxia. The effects of
hypoxia on DNA methylation patterns are also explored by
another study that demonstrated how hypoxia alters the
epigenetic profile of cultured human placental trophoblasts
(Yuen et al., 2013) and how epigenetic processes may
contribute to the maintenance of a hypoxia-adapted status
by interacting with the hypoxia-induced transcription factor
(HIF) (Watson et al., 2010).
Regarding climatic changes, UV radiation is another
environmental force that has considerably shaped human
genetic diversity (Jablonski & Chaplin, 2000), but so far only
a few studies have investigated DNA methylation changes
after UV exposure. Accordingly, some hypotheses regarding
the pathways linking UV-induced DNA damage and DNA
hypomethylation have been proposed. In fact, UVB muta-
genesis in skin cells is characterized by C (cytosine) to T
(thymidine) transition and 5-methylcytosine is found to have
higher energy adsorption in the UVB range than C, so that
this propensity to adsorb UVB can lead to a high probability
to lose 5 mC rather than unmethylated C (Lee & Pfeifer,
2003). A recent study explored DNA methylation profiles of
more than 27 000 CpG sites under chronic sun exposure and
compared DNA methylation of the outer forearm (i.e. the sun-
exposed area) with the inner arm (i.e. the sun-protected area),
also separating dermis and epidermis from the two districts.
Interestingly, 14 CpG sites showed a beta value decreased by
0.2 or more in the sun exposed area of the epidermis. In
particular, the authors revealed demethylation for the CpGs
immediately distal to the one previously detected, concluding
that these results demonstrated the demethylation of sun-
exposed epidermis samples at the KRT75 (keratin 75)
promoter region (Gro¨nniger et al., 2010). Moreover, the
authors suggest that the observed DNA methylation variabil-
ity is not linked with an altered expression of DNMT genes.
After a deep bisulphite sequencing of the KRT75 gene, the
authors do not detect evidence of genetic mutations, thus not
confirming previous hypotheses of UV-induced mutations
preferentially at 5 mC, at least for the analysed genomic
region.
The population epigenetics approach
Phenotypic plasticity is one of the main conceptual bases of
population epigenetic studies, since epigenetic information
allows a single genotype to assume multiple epigenotypes,
thus enabling the expression of different phenotypes. This is
particularly emphasized in plants, some of the organisms that
are most obligated to do their best with environmental
conditions from which they are not able to get away. Different
studies, listed below, highlight the link between membership
to a specific ethnic group and DNA methylation patterns, but
few of them actually take into account individuals’ genetic
ancestry, environmental characteristics of the place where
they live, or the main demographic and historical events that
have occurred in the examined geographical areas.
For instance, Terry et al. (2008) observed differences in
DNA methylation according to ethnicity among women that
live in the same city and were drawn from a birth cohort
followed until midlife, with American people of African
ancestry appearing more likely to have lower levels of DNA
methylation than American individuals of European or Latin
American origins (Terry et al., 2008).
Das et al. (2006) instead evaluated methylation patterns in
prostate cancer and benign prostatic hyperplasia tissue
samples using methylation-specific PCR (MS-PCR), showing
that methylation of the TMS1/ASC gene was more prevalent in
cases than controls in patients of European ancestry. On the
contrary, no differences between disease and healthy subjects
were observed for people of African origins (OR¼ 1.1,
p¼ 0.91). A more recent study further hypothesized that
differences in DNA methylation of specific CpG dinucleo-
tides between severe heroin addicts under methadone main-
tenance treatment and control subjects partially depend on
ethnicity. DNA methylation analysis of the m-opioid receptor
gene (OPRM1) promoter region was performed on American
individuals with African ancestry and Latin American origins
and these were compared with a similar cohort of subjects of
European ancestry. However, ethnicity was assessed accord-
ing to the ethnic/cultural background of the subjects and of
their parents, grandparents and great-grandparents, without a
specific investigation of their actual genetic ancestry compo-
nents (Nielsen et al., 2010).
Two highly innovative studies, in terms of adopted
technologies and approaches, were recently carried out by
two different research groups. A first one highlighted
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significant differences in global genomic DNA methylation of
peripheral blood cells by ethnicity, suggesting that this
individuals’ information should be accurately considered in
every methylation study (Zhang et al., 2011). The second one
instead tried to assess the impact of population SNPs diversity
patterns at the genome-wide level on DNA methylation
profiles (Liu et al., 2010). For this purpose, around 200
samples of different self-reported ethnicity were analysed for
1M SNPs and for methylation status at 27 000 CpGs
distributed across the whole genome. The authors argued
that a significant correlation between genetic and epigenetic
population structure exists and they suggest that it is mediated
via complex multiple gene interactions.
In line with these findings, Fraser at al. (2012) argue that
genetic or environmental interactions likely affect most
mSNPs, that is most SNPs identified by evaluating significant
correlations between genotypes and methylation levels. To
compare DNA methylation profiles between human popula-
tions, they utilized lymphoblastoid cell lines (LCLs) from the
Hap Map project. In particular, they examined 30 family trios
(i.e. mother/father/offspring) of Northern European ancestry
(CEU) and 30 trios of Yoruban ancestry (YRI). These
samples were characterized for DNA methylation with a 27 k
CpGs array, showing that 21.4% of CpG sites differ between
the studied populations, even if only 3.9% of these sites
actually differ by an average of over 10% of methylation level.
Heritability estimates also differ between populations, sug-
gesting extensive divergence in the genetic control of DNA
methylation. In the authors’ opinion, most of these differences
could be attributed to two main factors. One type of
divergence that may affect DNA methylation levels is a
difference in the CEU/YRI allele frequencies at genetic
variants able to influence methylation (e.g. genetic variants
can explain over half of the population methylation-specifi-
city observed). On the other hand, a variant that is present in
both populations, but affects DNA methylation only in one of
them, can be explained uniquely by complex genetic inter-
actions. These interactions could also involve environmental
variables, for instance the quantity of available methyl donors,
or epistasis with other variants.
A more recent population epigenetics study produced
epigenome-wide data for three populations with different
ethnicity: Americans of African ancestry, Americans of Asian
ancestry and Americans of European origins (Heyn et al.,
2013). It succeeded in identifying a core of 439 CpG sites
(pop-CpGs), by which it is possible to distinguish the
examined populations, pointing out that this pattern is
associated with CpGs that regulate gene expression and that
many pop-CpGs are located within or nearby transcription
binding sites for NFKB, a transcription factor involved in the
immune defense. Accordingly, the authors proposed that local
selective pressures, such as a specific pathogens landscape,
could shape epigenetic variation in genes involved in immune
or xenobiotic responses. Moreover, this study demonstrated
that two thirds of hypervariable CpG sites were associated
with the individuals’ genetic background, suggesting that part
of population-specific DNA methylation patterns could be
linked to genetic differences between populations and that
genetic background drives and modulates DNA methylation
variability. However, DNA methylation changes could be
divided in genotypic-dependent and genotypic-independent
ones, with one third of CpG sites that vary according to
ethnicity being not linked with genetic variance, thus
suggesting that epigenetic variation can also occur independ-
ently to genetic background (Heyn et al., 2013).
Conclusions
According to available data, it appears clear that genetic,
epigenetic and phenotypic variations of our species, together
with cultural ones, are considerably shaped by a vast range of
environmental stimuli, thus representing the foundation of all
human bio-cultural adaptations (Figure 2).
In this article, we have especially reviewed the most recent
studies that provide robust evidence pointing to epigenetic
changes, and in particular DNA methylation, as suitable
Figure 2. Type of human adaptation.
Epigenetics could be considered a reversible
way to adapt to new stressors at an individual
level as well as at a population level. In the
figure different strategies of adaptation to
environmental stimuli are listed according to
the time in which they arise. Epigenetics,
genetics and cultural changes are shaped by a
wide range of environmental stimuli, thus
representing the foundation of all human bio-
cultural adaptations.
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medium-term evolutionary mechanisms enabling humans to
adapt in response to environmental stresses. Although an
increasing number of studies are being devoted to explore this
issue, the epigenetic contribution to human adaptations is far
from being completely understood. For this purpose, we
believe that more studies, based on more accurate sampling
strategies and deeper investigation of examined individuals’
genetic ancestry components according to well-established
Anthropological Genetics approaches, are needed to reliably
dissect to what extent DNA methylation contributes to human
phenotypic variability. It is also essential to note that all these
issues are substantially complicated by the fact that DNA
methylation is a tissue-specific process and that, therefore, a
certain epitype could be associated to a specific phenotype in
a tightly tissue-specific manner. Despite these problematic
aspects, studies aimed at describing the distribution of
epitypes across worldwide human populations actually repre-
sent the most suitable approach to characterize and explore
the inter-play between genotype and epitype in shaping
human phenotypic variation.
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1. Introduction
Epigenetic modiﬁcations are, by deﬁnition, heritable but
reversible changes in chromatin structure and gene function. This
means that, although epigenetic signatures are transmitted across
cellular divisions and – in some cases – also transgenerationally,
they can be modiﬁed by a wide range of environmental cues,
whose effect is in turn dependent on the genetic background of the
organism. Epigenetic changes are pivotal in the establishment of
developmental patterns in the early life stages, but they appear
also to be both triggers and consequences of the phenotypic
alterations that characterize ageing. In the past decades a great
effort has been placed in order to identify the epigenetic
landscapes of ageing and age-related diseases and to interpret
them in the framework of ageing theories. From these studies a
complex scenario emerges, in which a general relaxation in the
mechanisms controlling epigenetic modiﬁcations coexists with
systemic changes at speciﬁc loci, suggesting that an epigenetic
program originating during development contributes at least in
part to the ageing process (deMagalha˜es, 2012). Given their tissue-
speciﬁcity, epigenetic modiﬁcations could be also able to provide
consistent hints regarding the ‘‘mosaic of ageing’’ theory (Cevenini
et al., 2008), which states that different tissues/organs age at
different rates and differently contribute to the ageing of thewhole
organism. In addition, the identiﬁcation of age-related epigenetic
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changes has two important practical consequences. On one side,
epigenetic signatures have emerged as potential biomarkers of
biological age. On the other side, the malleability of epigenetic
modiﬁcations has prompted the search for interventions that,
acting on epigenetic regulators, could delay or even revert the aged
phenotype (Johnson et al., 2012; Rando and Chang, 2012;
Vaiserman and Pasyukova, 2012).
A growing number of studies suggest nutrition as one of most
promising anti-ageing interventions (Choi and Friso, 2010; Ford
et al., 2011; Ribaricˇ, 2012). Indeed, speciﬁc diet components have
proved to directly regulate the activity of enzymes that catalyze
epigenetic modiﬁcations and diet habits can alter the establish-
ment and themaintenance of epigenetic patterns bymodifying the
intracellular metabolic state or the cellular microenvironment
itself.
In this paper we will review the epigenetic changes that occur
with ageing and we will provide examples of how nutritional
interventions in adulthood, such as that scheduled in the European
project NU-AGE (see Box 1), could revert these changes and
positively impact the ageing process. Among the broad number of
epigenetic modiﬁcations, we will speciﬁcally focus on DNA
methylation, as its role in ageing has been extensively investigated
and its responsiveness to nutritional stimuli is the object of several
studies. The impact of diet on other age-associated epigenetic
modiﬁcations, including histone modiﬁcation, has been deeply
reviewed elsewhere (Choi and Friso, 2010; Cosentino and
Mostoslavsky, 2013; Huidobro et al., 2013; Li et al., 2011a,b;
Martin et al., 2013). Here we will discuss the role of DNA
methylation changes during ageing and how DNA methylation
patterns can be modiﬁed by caloric restriction and by diets
enriched in bioactive food components. In this framework we will
report current knowledge regarding the contribution of DNA
methylation and other epigenetic factors, such as microRNA, to
inﬂammaging, a low-grade systemic inﬂammation that charac-
terizes the aged phenotype, and their modulation by epigenetic
diets. Finally we will discuss how age-related diseases can beneﬁt
from nutritional interventions that target epigenetic mechanisms,
using cardiovascular disease as example.
2. DNA methylation patterns in human ageing
2.1. DNA methylation
DNA methylation is a covalent modiﬁcation consisting in the
addition of a methyl group to the carbon 5 of a cytosine residue,
which usually lies at the 50 of a guanine residue (CpG dinucleotide).
The distribution of CpG dinucleotides in the genome is not random,
as they are relatively depleted from the bulk of the genome and
enriched at the promoters of around 50% of genes (CpG islands).
Recently, the evolutionary dynamics that subtend to the origin and
maintenance of CpG islands have been modelled (Cohen et al.,
2011). The methylation status of CpG dinucleotides is strictly
associated to the regulation of chromatin conformation. CpG
islands are usually unmethylated, promoting an open chromatin
structure suitable for transcription, and their methylation status is
dynamically regulated during development. On the contrary,
methylated CpG dinucleotides promote a closed chromatin
conformation and are more frequent in the bulk of the genome,
in particular in repetitive and intergenic sequences, where they
play a central role in maintaining genomic stability and in
suppressing spurious transcription.
2.2. Age-associate changes in global DNA methylation
Global DNA methylation level of mammalian genomes
decreases with age (Fig. 1, locus A). This observation was ﬁrstly
established more than three decades ago (Vanyushin et al., 1973,
1970) and was then conﬁrmed in multiple species and tissues,
including brain, liver, small intestine mucosa, heart, spleen and
blood cells (Drinkwater et al., 1989; Fuke et al., 2004; Golbus et al.,
1990; Richardson, 2003; Wilson and Jones, 1983; Wilson et al.,
1987). Age-dependent global hypomethylation reﬂects the de-
crease in methylation of repetitive tandem and interspersed
elements, which are highly enriched in CpG dinucleotides
(Jintaridth and Mutirangura, 2010; Rodriguez et al., 2008).
Longitudinalmodels have been exploited to assess intra-individual
changes in global DNA methylation over time (Bjornsson et al.,
2008; Bollati et al., 2009), while the genetic cues that affect the
maintenance of epigenetic patterns during ageing have been
investigated using family-based cohorts (Bjornsson et al., 2008). A
recent study considered the relationship between global DNA
methylation and frailty, a common clinical syndrome in the elderly
(Bellizzi et al., 2012). Interestingly, the authors showed that global
DNA methylation levels were lower in 65–85-year-old frail
individuals compared to prefrail and nonfrail subjects, suggesting
that the relaxation in the epigenetic control of the genome could be
associated with the age-associated functional decline.
2.3. Age-associated changes in DNA methylation at gene promoters
Age-dependent DNA methylation changes have been exten-
sively assessed not only at a global level, but also at speciﬁc
genomic loci. This has allowed the identiﬁcation of age-associated
differentially methylation regions (aDMR) in multiple human
tissues. In contrast to global hypomethylation, the trend for gene-
associated CpG islands is towards the increase of DNAmethylation
during ageing (Fig. 1, locus B), strictly resembling what happens in
cancer (Gilbert, 2009). The list of promoters whose DNA
methylation changes upon ageing is continuously increasing
(Table 1), prompted by the advancements in technologies to
measure sequence-speciﬁc DNA methylation (Ndlovu et al., 2011).
Currently, candidate gene approaches are generally performed
using the Qiagen PyroMark and Sequenom EpiTYPER platforms,
that allow high throughput, highly quantitative analysis of 50–500
nt sequences at single base resolution. On the other side, the most
Box 1. The challenge of the European project NU-AGE.
As it has been reported in the previous paragraphs, there is a
growing amount of data indicating that a series of nutrients,
bioactive dietary components and changes in diet habits could
modulate the epigenetic pattern impinging upon a series of
organs, systems and vital functions that as a whole determine
the health status of people at all the stages of life and particu-
larly in elderly. Nevertheless, there is a lack of knowledge
regarding the effects of the whole diet on the health status,
as the great majority of the past studies have dealt with the
effects of a single or few nutrients. New remarkable insights
regarding that relationship between nutrition, epigeneticmod-
ifications and ageing can be provided by the European project
NU-AGE (FP7, n8 266486; www.nu-age.eu). The rationale
and the design of the project are deeply described in the paper
by Santoro et al. (2014). Briefly, the NU-AGE project will study
in a comprehensive and integrated way the effect of a modi-
fied/fortified Mediterranean diet (described by Berendsen
et al., 2013), specifically designed according to the nutritional
needs of people over 65 years of age, on a series of cellular and
molecular pathways including epigenetics.
NU-AGE will offer an extraordinary opportunity to elucidate
the modulatory role of nutrition on DNA methylation patterns
during ageing, considering also the genetic variability (poly-
morphisms) of some pivotal genes involved in the diet/meta-
bolic response.
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used techniques for genome-wide analysis of DNA methylation
include methylated DNA immunoprecipitation coupled with next-
generation DNA sequencing (MeDIP-seq) and methylation micro-
arrays from Illumina (including GoldenGate assay, the Inﬁnium
HumanMethylation27 BeadChip and the higher density Inﬁnium
HumanMethylation450 BeadChip), while the use whole-genome
bisulﬁte sequencing is less popular due to computational
challenges and high costs. Genome-wide approaches have been
adopted in a number of age-focused studies, drastically increasing
our knowledge of the epigenetic mechanisms of ageing (Table 2).
The ﬁrst studies of this kind conﬁrmed that age-associated
methylation pattern is dependent on genomic context, with a
propensity towards hypermethylation of CpG-island loci and
towards hypomethylation of non-island CpGs (Christensen et al.,
2009). aDMR in whole blood, sorted CD14+ monocytes and sorted
CD4+ T-preferentially occur at bivalent chromatin domains
(Rakyan et al., 2010), i.e. developmental gene promoters that in
stem cells show both marks of active and inactive chromatin and
that are often hypermethylated in cancer. These observations are
consistent with the idea that ageing and cancer share common
defects in cell differentiation and development pathways and
account for the higher prevalence of cancer in the elder population.
Interestingly, bivalent chromatin domains were recently identiﬁed
as preferential sites of age-associated hypermethylation also in the
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Fig. 1.Age-associated changes inDNAmethylation patterns. The ﬁgure reports themethylation pattern of 3 genomic loci, indicated as A, B and C, in 4 cells from the same tissue
in a young (left) and in an old (right) subject. In each DNA molecule, a CpG site can be unmethylated (white circle) or methylated (black circle); for clarity, the methylation
proﬁle of only one of the two homologous chromosomes is reported. In the bottom of the ﬁgure, the DNA methylation levels measured by current approaches are reported.
Note that, as the current methods to analyze DNA methylation do not have single-cell resolution, they provide an estimate of the mean methylation level of each site in the
cellular population. Repetitive elements (locus A) tend to become unmethylated during ageing, leading to a decrease in the global DNAmethylation levels of the genome. The
CpG islands at the promoter of some genes (locus B) are hypermethylated in elderly respect to young subjects as a consequence of an ‘‘ageing program’’ or of age-associated
environmental cues. Finally, the maintenance of the methylation patterns at some genomic loci (locus C) is impaired in the elderly, leading to increased cell-to-cell
heterogeneity in DNA methylation proﬁles. As a consequence, the methylation levels measured by current approaches tends towards 50%.
Table 1
Gene-speciﬁc epigenetic changes associated with ageing.
Gene Tissue Methylation change with ageing References
ER Human colon Hypermethylation Issa et al. (1994)
IGF2 Human colon Hypermethylation Issa et al. (1996)
SFRP1 Human colon Hypermethylation Wallace et al. (2010)
MYOD1, N33 Human colon Hypermethylation Ahuja et al. (1998)
Lox, p16INK4a, RUNX3, TIG1 Gastric mucosa Hypermethylation So et al. (2006)
c-fos Liver Hypermethylation Choi et al. (1996)
GCR, iNOS, TLR2 Whole blood Hypomethylation Madrigano et al. (2012)
IFNg, F3, CRAT, OGG Whole blood Hypermethylation Madrigano et al. (2012)
EDARADD, TOM1L1, NPTX2 Saliva Hypermethylation Bocklandt et al. (2011) and Hannum et al. (2013)
ELOVL2 Whole blood, breast, kidney, lung Hypermethylation Garagnani et al. (2012) and Hannum et al. (2013)
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human brain (Numata et al., 2012;Watson et al., 2012), suggesting
a process common to multiple tissue types.
Two studies compared DNA methylation patterns of centenar-
ians and young subjects (Gentilini et al., 2012; Heyn et al., 2012)
and conﬁrmed that methylome encounters drastic changes during
ageing. Interestingly, both studies highlighted that age associated
DNA hypermethylation preferentially occurs at gene promoters
involved in the regulation of developmental patterns. An increas-
ing interest is directed towards the identiﬁcation of epigenetic
biomarkers that could predict the rate of ageing of an individual
and possibly discern between chronological and biological age of
the subject. Bocklandt and coworkers demonstrated that methyl-
ation of the promoters of EDARADD, TOM1L1 and NPTX2 genes
linearly changeswith age in saliva and that it can be used to predict
age (Bocklandt et al., 2011). Garagnani et al. (2012) analyzedwhole
blood DNAmethylation in 64 subjects from 0 to 99 years using the
Inﬁnium HumanMethylation450 BeadChip and identiﬁed the
promoters of 3 genes, ELOVL2, FHL2 and PENK, whose DNA
methylation strongly correlates with age. Validation in a larger
cohort of 500 subjects aged 0–99 conﬁrmed a very high correlation
with age for the 3 loci and showed that ELOVL2 methylation
progressively increases from 0% in newborns to almost 100% in
nonagenarians. This result is unlikely to be ascribed to the
alterations in blood cellular composition that occur with ageing,
but it is probablymore linked to epigeneticmodiﬁcations that arise
in progenitor stem cells, as previously suggested (Rakyan et al.,
2010). ELOVL2 was included in a quantitative model of ageing
based on Inﬁnium HumanMethylation450 BeadChip results on
whole blood samples from 656 subjects from 19 to 101 years old
(Hannum et al., 2013). This model demonstrated high accuracy in
predicting individual’s age and accounted for relevant factors in
ageing, such as gender and genetic variants. Moreover, the authors
reported that the model was successful in predicting chronological
age also in tissues other thanwhole blood, including breast, kidney
and lung.
This last observation prompts further considerations regarding
the role of epigenetic modiﬁcations in tissue homeostasis and
ageing. Indeed, ageing is a multi-factorial process in which, as
conceptualized by the ‘‘mosaic of ageing’’ theory, different organs
and tissues age at different rate and differently contribute to
systemic ageing process (Cevenini et al., 2008). In this framework,
although the identiﬁcation of epigenetic changes that are
consistent across different tissues (Christensen et al., 2009;
Hannum et al., 2013; Koch and Wagner, 2011) can shed light on
the general chromatin remodelling that occurs with ageing, equal
emphasis should be placed in the discovery of tissue-speciﬁc
epigenetic alterations. Consistently with these considerations,
Hannum and colleagues reported that the entity of variation of the
CpG sites included in the model differed among tissues, suggesting
that epigenetic variations can reﬂect different ageing rates/
mechanisms of different tissues (Hannum et al., 2013). In addition,
when quantitative models of ageing were built independently for
each available tissue, most of the markers were different,
conﬁrming tissue-speciﬁc patterns of epigenetic changes. Notably,
ELOVL2was included in each tissue-speciﬁcmodel, suggesting that
its methylation is uniformly affected by ageing in different tissues
and thus highlighting its potential role as biomarker at the
organism level.
2.4. Triggers and consequences of DNA methylation changes during
ageing
In the previous paragraphwe have reported several examples of
age-associated changeswhich are systemic, that is they involve the
same genomic region in a proportion of the cellular population
large enough to be experimentally detectable (Gravina and Vijg,
2010). Some of the systemic changes arise in response to ageing-
associated environmental factors, while others are interpreted as
part of an ‘‘ageing program’’ which is part of a development (De
Magalha˜es, 2012). Independently of the causes of these systemic
changes, current knowledge suggests that global and locus-speciﬁc
DNA methylation levels are promising markers of human ageing
(Johnson, 2006) that can describe the inter-individual variability in
functional decline and vulnerability to diseases in the elderly
(Bellizzi et al., 2012; Horvath, 2013).
Together with systemic changes, the epigenome is also
subjected to stochastic changes, i.e. random variations in the
epigenetic patterns that have been called epimutations (Holliday,
1987; for an exhaustive review, see Gravina and Vijg, 2010). During
ageing a relaxation of the mechanisms that maintain the
epigenetic patterns occurs, leading to increased cell-to-cell
heterogeneity in both gene expression (Bahar et al., 2006) and
epigenetic markers (Fig. 1, locus C) (Bennett-Baker et al., 2003; Fu
et al., 2008). Epimutations can contribute to the age-associated
Table 2
Genome-wide studies on DNA methylation changes during ageing.
Technique Samples References
GoldenGate assay 217 non-pathological human tissues from 10 anatomic sites Christensen et al. (2009)
Inﬁnium HumanMethylation27 BeadChip Whole blood from 93 different healthy females (31 twin pairs and 31 singletons) ranging
from 49 to 75 years of age; sorted CD14+monocytes and CD4+ T-cells from 25 subjects (20
females and 5 males) ranging from 20 to 69 years old
Rakyan et al. (2010)
Inﬁnium HumanMethylation27 BeadChip Skin biopsies from 20 females and 10 males ranging from 18 to 72 years old Gronniger et al. (2010)
Inﬁnium HumanMethylation27 BeadChip Whole blood from 261 females ranging from 50 to 85 years old Teschendorff et al. (2010)
Inﬁnium HumanMethylation27 BeadChip Saliva from 34 male identical twin pairs ranging from 21 to 55 years old Bocklandt et al. (2011)
Inﬁnium HumanMethylation27 BeadChip CD34+ HPCs from umbilical cord blood and whole blood from 35 years old donors. Bocker et al. (2011)
Inﬁnium HumanMethylation27 BeadChip Human prefrontal cortex from 108 subjects ranging from 0 to 83 years old Numata et al. (2012)
Inﬁnium HumanMethylation27 BeadChip Whole blood from 21 female centenarians, their 21 female offspring, 21 offspring of both
non-long-lived parents and 21 young women
Gentilini et al. (2012)
Inﬁnium HumanMethylation27 BeadChip Normal breast tissue from 38 individuals ranging from 19 to 75 years old Fackler et al. (2011),
Johnson et al. (2013)
and Zhuang et al. (2012)
Whole-genome bisulﬁte sequencing CD4+ T-cells from 1 male newborn and 1 male centenarian Heyn et al. (2012)
Inﬁnium HumanMethylation450 BeadChip CD4+ T-cells from 19 newborns and 19 nonagenarians Heyn et al. (2012)
Inﬁnium HumanMethylation450 BeadChip Whole blood from 32 mother–offspring couples ranging from 9 to 83 years old Garagnani et al. (2012)
Inﬁnium HumanMethylation450 BeadChip Whole blood from 656 subjects ranging from 19 to 101 years old Hannum et al. (2013)
Inﬁnium HumanMethylation450 BeadChip Peripheral blood leukocytes from 421 individuals ranging from 14 to 94 years old Johansson et al. (2013)
Inﬁnium HumanMethylation450 BeadChip Whole blood from 965 subjects ranging from 50 to 75 years old Florath et al. (2013)
Whole-genome bisulﬁte sequencing Primary human epidermis samples from 5 young (18–24 years old) and 5 old (70–75
years old) subjects
Raddatz et al. (2013)
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epigenetic drift, which consists in the progressive divergence of the
epigenetic patterns between individuals with time. In a seminal
paper, Fraga and colleagues showed that the methylomes of young
twin couples are more similar than those of elderly couples (Fraga
et al., 2005). Based on these observations, several studies have
analyzed the age-associated divergence in DNA methylation
patterns between twins (Heijmans et al., 2007; Pirazzini et al.,
2012; Talens et al., 2012) and have shown that (i) some genomic
loci are epigenetically more stable than others; (ii) the ability to
maintain DNA methylation patterns differs among different
individuals and it is genetically determined, as suggested also
by longitudinal family-based models (Bjornsson et al., 2008).
Regarding this epigenetic drift, it is difﬁcult to discern the relative
contributes of environmental-driven and stochastic changes in
DNA methylation, but recent experiments using laboratory
animals, whose environmental conditions can be strictly moni-
tored, have shown that chromatin entropy increases with age,
while chromatin homogeneity decreases, pointing for a key role of
epimutations in the ageing process (Pantic et al., 2012).
Age-associated changes in DNA methylation are triggered, at
least in part, by alterations in the expression/activity of DNA
methyltransferases (DNMTs). Indeed, several authors reported that
a decrease in Dnmt1 and Dnmt3a expression occurs with ageing,
while the levels of Dnmt3b follow the opposite trend (Casillas et al.,
2003; Liu et al., 2009; Lopatina et al., 2002). Accordingly, while
Dnmt1 knock-down promotes age-related phenotypes (Liu et al.,
2011; Ray et al., 2006), the rescue of Dnmt3a2 levels restores
cognitive function in aged mice (Oliveira et al., 2012). Beside
DNMTs expression, many other mechanisms can affect the
maintenance of DNA methylation during ageing. For example,
other epigenetic modiﬁcations and proteins involved in the DNA
damage response can modulate the access of DNMTs to target
sequences and affect the methylation status of CpG dinucleotides
(Ciccarone et al., 2012; Guastaﬁerro et al., 2008; Jin and Robertson,
2013).
Future researches should address not only the causes of DNA
methylation changes during ageing, but also their consequences.
While the contribution of DNA methylation changes at promoters
should be evaluated on the basis of the function of the speciﬁc
gene, the global hypomethylation of the genome could exert
ageing-effects by promoting genomic instability and activation of
transposable elements (Alexeeff et al., 2013; Barbot et al., 2002; De
Cecco et al., 2013).
3. Epigenetic mechanisms in anti-ageing nutritional
interventions
Epigenetic patterns are set during gametogenesis, fertilization
and in utero development and they are particularly responsive to
environmental factors in these periods. Accordingly, a number of
studies both on murine and human models have highlighted the
epigenetic consequences of nutritional interventions during
preconceptional and in utero periods and their transgenerational
heritability. These studies have been deeply reviewed in recent
manuscripts (Barnes and Ozanne, 2011; Gabory et al., 2011;
Lillycrop and Burdge, 2012) and will not be reported here. On the
contrary, we will speciﬁcally focus on the epigenetic plasticity in
the adulthood, reporting available evidences that diet interven-
tions can alter epigenetic patterns later in life and positively affect
ageing and lifespan. The example of honeybees is a proof of
principle of this deep relationship between after birth diet,
epigenetics and ageing, as female larve develop in short-living
workers or in long-living queens according to DNA methylation
modiﬁcations induced by the type of feeding (i.e. beebread or royal
jelly) (Kucharski et al., 2008). Examples of diet-mediated changes
in epigenetic modiﬁcations have been reported also in humans.
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Fig. 2. Nutritional interventions, including caloric/dietary restriction, nutrients involved in one-carbon metabolism and bioactive food components, can modify DNA
methylation and/or other epigenetic modiﬁcations, that in turn can affect DNA methylation patterns.
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The extent of age-related variations in leukocytes global DNA
methylationwas associatedwith the daily intake of carbohydrates,
lipids, vitamin B6 and magnesium (Gomes et al., 2012). A recent
study considered the effect of a diet rich in vegetables and plant oil
containing polyunsaturated fatty acids on the methylation of
MLH1, a gene involved in mismatch repair and in maintenance of
genomic integrity (Switzeny et al., 2012). The intervention resulted
in signiﬁcant increase in MHL1 CpG methylation that was not
associated to variations in its expression but that probably
reﬂected a decrease in reactive oxygen species (ROS) and in the
demethylating effects of DNA damage related enzymes.
In the following paragraphs we will summarize the effects of
dietary restriction and different bioactive compounds on DNA
methylation changes during ageing (Fig. 2).
3.1. Caloric and dietary restriction
Although the notion that limited food intake can positively
affect health and ageing has deep roots in history, the ﬁrst scientiﬁc
demonstration that reducing food intake signiﬁcantly increases
rodents life span dates back to 1935 (McCay et al., 1989). Since
then, a number of dietary modiﬁcations have been experimented.
Caloric restriction (CR) consists in the reduction of caloric intake,
typically by the 20–40% respect to the ad libitum intake of the
species, without leading to malnutrition and deﬁciency in
micronutrients. CR is distinct from dietary restriction (DR), in
which one or more macronutrients is reduced or removed without
affecting the total caloric intake, and from regular fasting such as
alternate-day fasting (ADF) (Trepanowski and Bloomer, 2010).
The effects of these dietary modiﬁcations on health and
longevity have been investigated in many species, from yeast to
primates, leading to exciting but sometimes controversial results
(Speakman and Mitchell, 2011). For example CR has proven to
extend lifespan in many animal models and to effectively protect
against age-related diseases such as diabetes and cancer in murine
models. However, some evidences indicate that these outcomes
are not universal, and that factors such as genetic background (Liao
et al., 2010) and initial basal metabolic rate (Brzek et al., 2012) can
affect this phenomenon. The results from two long-term studies on
the effects of CR in non-human primates have been recently
published (Colman et al., 2009; Mattison et al., 2012). Both studies
reported health beneﬁts such as reduction of the incidence of
diabetes and of cancer in calorie restricted rhesusmonkeys respect
to controls, but were discordant on the effects of CR on life span
extension. These apparently conﬂicting results probably arise from
the design of the two studies that differ for the diet composition of
both caloric restricted and control monkeys. Data on the effects of
CR on humanmodels are also available. For example, a randomized
clinical study on non-obese, sedentary humans, demonstrated that
a 20% reduction in calorie intake for 12 months decreases visceral
fat mass, improves insulin sensitivity, increases plasma adipo-
nectin concentration, reduces circulating inﬂammatory markers,
decreases plasma triiodothyronine levels, and reverses some of the
age-related deterioration in cardiac diastolic function (Fontana
et al., 2010a; Stein et al., 2012; Weiss et al., 2008). Ongoing studies
on human subjects who voluntarily follow a caloric restricted diet
will contribute to clarify not only the potential anti-ageing effects
of CR (Mercken et al., 2013), but also its contribution to the
slowdown of age-associated diseases onset (Stein et al., 2012).
The molecular mechanisms by which CR exerts its beneﬁcial
effects are poorly understood, but two nutrient-sensing signalling
networks, the insulin/IGF (insulin-like growth factor) and the
mTOR (mammalian target of rapamycin) pathways, seem to
respond to CR in the control of cell growth and ageing pathways
(Speakman and Mitchell, 2011). In addition, some authors have
suggested the involvement of Sirtuins, a group of NAD-dependent
histone acetylase, but their role in linking CR to longevity is, at least
in mammals, still controversial (Baur et al., 2010; Fontana et al.,
2010b). It is worth to note that both mTOR (Grummt and Voit,
2010; Murayama et al., 2008) and Sirt-1 (Salminen and Kaarnir-
anta, 2009) link the cellular energy condition with the epigenetic
status of ribosomal DNA, which in turn plays a role in longevity in
model organisms (Larson et al., 2012).
Paradoxically, the possibility that CR could exert anti-ageing
effects by reversing epigenetic alterations during ageing and age-
related diseases has been relatively poorly investigated (Li et al.,
2011b; Vaquero and Reinberg, 2009). In this sense, it is relevant the
recent study by Ions et al. (2012) who analyzed available public
databases and reported a signiﬁcant overlap between the genes
differentially expressed in response to CR and those whose
methylation varies during ageing. Two independent studies
reported that CR increases methylation levels of MYC in mice
liver (Miyamura et al., 1993) and of HRAS in pancreatic acinar cells
(Hass et al., 1993), reverting the trend towards age-associated
hypomethylation of the two oncogenes. More recently, CR was
shown to counteract the increase in Dnmt3a expression in the
hippocampal dentate gyrus that is observed in aged mice
(Chouliaras et al., 2011) and to prevent the age-related changes
in DNA methylation levels (Chouliaras et al., 2012). In an in vitro
model of CR, glucose restriction increased Dnmt1 activity and
induced hypermethylation of a E2F-1 binding site in the promoter
of the CDKN2A gene, down-regulating its expression and extending
cell lifespan (Li et al., 2010a,b). As the tumor suppressor p16
accumulates during senescence, its decreased expression could
contribute to CR-mediated longevity in vivo. The same group
reported that p16 reduction upon glucose restriction was
ascribable to the combined effect of DNA methylation and Sirt-1
mediated histone deacetylation, supporting a link between these
two chromatin modiﬁcations (Li et al., 2011b). In line with these
evidences, manipulation of Sirt-1 levels by overexpression or
silencing of the gene in Caco-2 cells altered the methylation of six
genes whose expression is responsive to CR (Ions et al., 2012).
Epigenetic data on the effects of CR in humans are limited. In a
cohort of overweight/obese postmenopausal women before and
after a reduced energy intake intervention over 6 months,
epigenomic analysis in subcutaneous adipose tissue showed
signiﬁcant hypermethylation of three loci (chromosomes 1p36,
4q21, and 5q13) in responders to the treatment (Bouchard et al.,
2010). In a similar study, two CpG sites in the ATP10A and in the
WT1 genes were hypermethylated in peripheral blood mononu-
clear cells (PBMCs) in overweight/obese men after 8 weeks dietary
intervention (Milagro et al., 2011). As obesity is a major risk factor
for age-related diseases, these studies can shed light on the
mechanisms by which CR can potentially exert its anti-ageing
effects.
As CR is not a feasible nutritional intervention in the general
population, researchers have looked for mimetics of CR that do not
imply food restriction (Ribaricˇ, 2012). Protein restriction, and in
particular methionine restriction, seems to be an effective
alternative to CR in lifespan extension (Miller et al., 2005).
Methionine is the precursor of S-adenosylmethionine (AdoMet) in
one-carbon metabolism (see below), but the outcomes of its
restriction on DNA methylation have been considered only in few
studies. For example, 7 weeks 40% methionine restriction induced
DNA hypomethylation in rat heart (Sanchez-Roman et al., 2011)
but not in rat liver (Sanchez-Roman et al., 2012), suggesting a
tissue-speciﬁc effect. Two other potential CR mimetics are
rapamycin, a bacterial macrolide with antifungal and immuno-
suppressant activities inhibiting mTOR, and resveratrol, a poly-
phenol (see below) enriched in the skins of red grapes that can
activate Sirt-1 (Barger et al., 2008). However, also in this case the
epigenetic mechanisms by which they can exert an anti-ageing
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effect have not been assessed yet. These compounds, together with
other bioactive food components such as green tea extracts (see
below), are being tested by the Interventions Testing Program, a
multi-institutional program promoted by the National Institute of
Ageing that aims at identify treatments with an anti-ageing effect
in mice.
3.2. Nutrients involved in one-carbon metabolism
The one-carbonmetabolism is a complex biochemical pathway,
also known as the homocysteine cycle (Fig. 1). One of the
intermediates of this metabolism is AdoMet, which represents the
unique methyl donor in all the DNMTs-mediated DNA methyl-
transferase reactions in eukaryotes. Various nutrients can regulate
the one-carbon metabolism, acting both as sources of methyl
donors (for example methionine, choline, betaine and serine) and
as co-enzymes (for example vitamins B2, B6, B12 and folate) (Kim
et al., 2009). Although the role of these nutrients in physiological
and pathological processes has not been completely studied, many
evidences support that they can affect DNA methylation changes
during ageing.
With the term ‘‘folate’’ we indicate a group of water-soluble B
vitamins, also known as B9, that carry amethyl groupwhich can be
used for the AdoMet synthesis. As folate and its derivates directly
affect reproductive success and survival early in life, natural
selection has worked to protect folate levels and preserve the
integrity of folate metabolism. Humans cannot synthesize folate,
which therefore has to be supplied through the diet. Folate-rich
foods include dark green leafy vegetables, asparagus, broccoli,
strawberries, liver, organ meats and legumes. In addition, folate
can be supplemented with diet and fortiﬁed foods in the form of
the synthetic molecule folic acid. Many studies have addressed the
relationship between DNA methylation and folate intake during
pregnancy (Ciappio et al., 2011; Kim et al., 2009) and cancer
(Stefanska et al., 2012),while the effects of folate administration on
ageing are less well characterized. Age associated decrease of DNA
methylation in mouse colon was reduced by folate administration,
which induced also CDKN2A hypermethylation (Keyes et al., 2007).
These results are in agreement with those recently achieved by Li
and colleagues (Li et al., 2010a,b). In this study, T lymphocytes from
healthy subjects aged 22–81 were cultured in a folate-depleted
medium. T cells from 50 years or older donors showed
hypomethylation of genes that are activated during ageing, such
as KIR and CD70 genes, suggesting a synergic effect between age-
associatedDNAmethylation changes and folate levels. A number of
studies conﬁrm that a folate-poor diet is associated to global DNA
hypomethylation and to an increased risk for chronic diseases
(Axume et al., 2007; Pufulete et al., 2005; Rampersaud et al., 2000;
Shelnutt et al., 2004). On the other side, folate supplementation
increased global DNA methylation levels in rectal mucosa of a
subset of patients with colonic adenomas (Cravo et al., 1998b) and
reduced microsatellite instability in the mucosa of ulcerative
colitis patients (Cravo et al., 1998a). The effect of folic acid
administration on site speciﬁc DNA methylation was analyzed in
1000 colorectal mucosa biopsies (Wallace et al., 2010). In this
study estrogen receptor gene a (ESR1) and SFRP1 methylation
levels, that increase with age and may predispose to colorectal
cancer, were positively correlated with folate levels in red blood
cells, posing safety concerns regarding folic acid administration in
healthy adults.
Beside folate, other intermediates of one-carbon metabolism
can affect DNAmethylation and ageing. Vitamin B12 (cobalamin) is
a water-soluble vitamin that acts as co-enzyme of methionine
synthase. Low vitamin B12 concentration reduces methionine
synthase activity and prevent folate metabolism, resulting in
a decrease in AdoMet concentration and therefore in DNA
methylation. Vitamin B-rich foods include eggs, cheese, beef,
lamb, seafood and milk. Deﬁciencies in vitamin B12 can lead to
elevated DNA damage and altered DNA methylation (Blount et al.,
1997; Lindahl andWood, 1999) and to an increase of homocysteine
level, a risk factor for cardiovascular disease in particular for the
elderly (Krishna et al., 2013; Van Dijk et al., 2013).
It should be noted that DNAmethylation responses to B vitamin
levels may depend on various factors, including genetic back-
ground (Axume et al., 2007; Friso et al., 2002; Shelnutt et al., 2004),
extent and duration of the depletion/supplementation and the
tissues under investigation. For example, Hubner et al. recently
reported that one-year vitamin B supplementation did not affect
AdoMet plasma levels and long interspersed element-1 (LINE-1)
methylation levels in blood cells (Hu¨bner et al., 2013).
3.3. Bioactive food components
Polyphenols constitute a heterogeneous group of natural
substances, chemically formed by several phenolic rings, which
are particularly known for their positive effects on human health
and are enriched in many plant foods. The intake of polyphenols in
the human diet varies greatly depending on the type, the quantity,
the quality of vegetables consumed and the chosen cooking
method that can reduce considerably the polyphenolic content of
the food. Polyphenols can exploit a wide range of activities,
including antioxidant, antiatherogenic, anticarcinogenic and anti-
nﬂammatory effects. Their antioxidant properties are recognized
worldwide: polyphenols may protect cell constituents against
oxidative damage and, therefore, limit the risk of degenerative
diseases associated to oxidative damage that can be related to both
normal cellular metabolism and stressful events, such as radiation,
smoke, pollutants, UV rays, emotional and physical stress,
chemical additives, viral and bacterial attacks. Numerous studies
have shown that, when added to the diet, polyphenols limit the
development of cancers (Darvesh and Bishayee, 2013; Gokbulut
et al., 2013; Gollucke et al., 2013; Tabrez et al., 2013),
cardiovascular diseases (Khurana et al., 2013; Li and Fo¨rstermann,
2012), neurodegenerative diseases (Cimini et al., 2013), diabetes
(De Bock et al., 2013; Patel et al., 2012), obesity (Siriwardhana et al.,
2013; Tian et al., 2013) and osteoporosis (Oka et al., 2012; Sacco
et al., 2013).
Regarding the effects of polyphenols on DNA methylation,
studies have been focused on different pathologies, including
cancer (Vanden Berghe, 2012). Several mechanisms by which
polyphenols concur to cancer inhibition have been reported. These
mechanisms include the reduction of hypermethylation status that
characterizes genes such as CDKN2A and RARB. Polyphenols may
act both directly through physical interactionwithDnmt1 catalytic
site and indirectly by the reduction of intracellular concentration
of AdoMet, that in turn reduces Dnmt1 activity (Fang et al., 2007; Li
and Tollefsbol, 2010).
Lee et al. (2005) evaluated the effects of several tea catechins
and bioﬂavonoids on DNAmethylation, ﬁnding that each of the tea
polyphenols considered [catechin, epicatechin, and ()-epigallo-
catechin-3-O-gallate (EGCG)] and bioﬂavonoids (quercetin, ﬁsetin,
and myricetin) inhibited Dnmt1-mediated DNA methylation in a
concentration-dependent manner. Many other authors observed
the inhibition of DNMTs activity as a consequence of different
polyphenols diet supplementation (Fu and Kurzrock, 2010; King-
Batoon et al., 2008; Meeran et al., 2010), with tea polyphenols and
genistein showing the strongest inhibitory effect.
EGCG is a polyphenolic catechin found in green tea with
antioxidant properties that can induce epigenetic changes by
inhibiting enzymes involved in DNAmethylation and bymodifying
histone acetylation (Nandakumar et al., 2011; Pandey et al., 2010).
Wong et al. reported that the diet EGCG intake could inhibit
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DNMTs activity and could induce Foxp3 and IL-10 expression in
CD4(+) Jurkat T cells at physiologically relevant concentrations in
vitro, showing a role in controlling the development and function
of regulatory T cells (Treg). Furthermore, authors found that mice
treated with EGCG in vivo had a signiﬁcant increase in Treg
frequencies, suggesting, on the whole, that EGCG can induce Foxp3
expression and increase Treg frequency through an epigenetic-
based mechanism (Wong et al., 2011). Qin et al. conducted a
study on 34 healthy premenopausal women consuming iso-
ﬂavones for one menstrual cycle to test if soy isoﬂavones have
dose-related estrogenic and methylation effects, ﬁnding that
this kind of polyphenols caused signiﬁcant changes in the
methylation levels of two cancer related genes (RARB and
CCND2) in the breast, according to the circulating levels of
genistein (Qin et al., 2009).
Although the data collected until now are encouraging, future
studies should speciﬁcally consider the effects of polyphenols on
DNA methylation in an anti-ageing perspective.
4. MicroRNAs and ageing: the inﬂamma-miRs
During ageing a low-grade systemic inﬂammation character-
ized by elevation of circulating acute-phase proteins and proin-
ﬂammatory cytokines (mainly IL-6 and TNF-a) occurs, a condition
that we have previously designated inﬂammaging (Franceschi,
2007; Franceschi et al., 2000). Such inﬂammatory imbalance is
associated to frailty and the development and progression of age-
related conditions that include cardiovascular disease (CVD), type
2 diabetes mellitus (T2DM), neurodegenerative diseases, sarcope-
nia and cancer (Cevenini et al., 2013; Franceschi, 2007; Vasto et al.,
2007).
The role of DNA methylation in inﬂammaging has not been
disentangled yet, but some evidences point for an association
between age-related global DNA hypomethylation and increased
expression of a number of inﬂammatory markers (Agrawal et al.,
2010; Alexeeff et al., 2013; Baccarelli et al., 2010b). Beside DNA
methylation, researchers have examined the function of other
epigenetic modiﬁcations in the establishment of the inﬂammaged
phenotype, focusing in particular on microRNAs (miRs).
MiRs are a broad class of small, non-coding RNAs that exert a
powerful gene regulatory role, acting both as repressor as well as
activators, mainly at a post-transcriptional level (Breving and
Esquela-Kerscher, 2010).
The primary transcripts of miRs (pri-miRs) are transcribed by
RNA polymerase II–III in the nucleus. Pri-miRs are processed by the
Drosha/DGCR8 enzyme complex into 70 base pair precursor and
then transported into the cytoplasm, where RNase III enzymes,
Dicer and Loquacious, process them into about 22-nucleotide miR
duplexes with guide and passenger strands. The guide strand
functions as amaturemiR and is incorporated into an RNA-induced
silencing complex (RISC), containing an Argonaute (Ago) protein.
MiRs guides RISC to recognize target sequences located mainly in
the 30UTR of mRNAs, which lead to the inhibition of translation or
degradation of mRNA (Bartel, 2009). Since the speciﬁcity of miR
targeting is mediated only by 6–11 nucleotides, a single miR can
target hundreds of mRNAs (Inukai and Slack, 2013; Park and Kim,
2013). MiRs have been reported to act through autocrine and/or
paracrinemechanisms (Kumarswamy et al., 2011; Raitoharju et al.,
2011). In addition, circulatingmiRs can act as hormones, eliciting a
systemic response (Wahlgren et al., 2012). Recent studies show
that transfer of nucleic acids, including miRs, can be an important
means of intercellular communication, occurring both by direct
cell-cell contact, for instance via gap junctions, or by cell-contact-
independent mechanisms, including release of microvesicles into
surrounding tissue (Collino et al., 2010; Hosoda et al., 2011) or the
blood stream. Plasma exosomes can deliver exogenous short
interfering RNA, including miRs to monocytes and lymphocytes
(Wahlgren et al., 2012).
Even if a single miR can target hundreds of mRNAs, groups of
miRs can induce regulation of speciﬁc biological processes by
acting in a co-ordinated manner on pathways of functionally
related genes (Cloonan et al., 2011). Thus, miRs have recently been
indicated as regulators of a number of cellular processes such as
apoptosis, differentiation, cell cycle, and immune functions, and
their expression can be altered by a wide spectrum of environ-
mental factors including drugs, virus and bacterial pathogens,
cigarette smoking, alcohol, sleep, exercise, stress, radiation and
nutrition.
It is worth stressing that exceptionally long survival requires
dynamic preservation of optimal levels of physiological variables,
and that the mean levels of many biomarkers of ageing are not
stable, but change in the course of life (Spazzafumo et al., 2013).
Thus, a peculiar modulation of miRs expression might contribute
to efﬁcient homeostasis in human ageing (Grillari and Grillari-
Voglauer, 2010; Inukai and Slack, 2013). Recently we discussed the
pleiotropic effects exerting of some miRs on pathways related to
inﬂammation, senescence, and carcinogenesis (Olivieri et al.,
2013a). A number of miRs have been reported to play a role in
modulating cellular senescence and inﬂammatory responses (SA-
miRs and inﬂamma-miRs, respectively). Given the interest elicited
by this new area of research, more and more miRs involved in the
modulation of inﬂammation and senescence are expected to be
identiﬁed in the near future. A clear link between miRs and
longevity has been demonstrated in C. elegans, suggesting that
miRs could have relevant role also in regulation of human lifespan
and ageing process (Iba´n˜ez-Ventoso and Driscoll, 2009). However,
only few studies have compared the miRs expression proﬁle in
tissues and blood of old and young organisms of different species
(Table 3). Interestingly, differences in the circulating miRs have
been found in a variety of age-associated diseases. The origin of
circulating miRs is not completely deﬁned, but senescent cells
emerge as a possible source of such secreted miRs, suggesting that
these miRs might contribute to the functional decline observed
during ageing (Weilner et al., 2012). Overall the results of these
studies supported the hypothesis that achievement of extreme
longevity probably requires a special gene expression regulation
involving inﬂamma-miRs (ElSharawy et al., 2012; Gombar et al.,
2012; Olivieri et al., 2012a; Serna et al., 2012). The prototype of
inﬂamma-miRs are miR-155, miR-21, miR-146a and miR-126
(Olivieri et al., 2013b, 2012b; Quinn and O’Neill, 2011). Under
physiological conditions, transcription of the inﬂamma-miRs is
maintained at basal levels; however, as soon as the pro-
inﬂammatory signalling are promoted, their expression is strongly
co-induced through a mechanism that is mainly NF-kB-dependent
(Boldin and Baltimore, 2012; Olivieri et al., 2013b). Although the
importance of inﬂamma-miRs in the regulation of the innate
immune response and the acquisition of senescence-associated
secretory phenotype during cellular senescence is clearly demon-
strated, the molecular mechanism of their action turned out to be
much more complex than initially thought (Olivieri et al., 2012a;
Grillari and Grillari-Voglauer, 2010).
5. Epigenetic diets and inﬂammaging
A growing number of evidences support the role of diet in slow
down and at least in part revert inﬂammaging (Proietti et al., 2009).
As diet is known to inﬂuence the expression ofmiRs, nutrientswith
antioxidant and anti-inﬂammatory effects were investigated to
verify their ability to modulate the expression of speciﬁc miRs,
among which inﬂamma-miRs. A potential role of miR-126 in the
anti-inﬂammatory properties of polyphenols from red wine
was observed in human colon myoﬁbroblasts cells (CCD-18Co)
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(Angel-Morales et al., 2012). MiR-126 targets NF-kB signalling
(Olivieri et al., 2013b) and mRNA levels of adhesion molecules,
such as Icam-1, Vcam-1, and Pecam-1.
The anti-inﬂammatory properties of the ﬂavonol quercetin have
been intensively investigated using in vitro cell systems and are to a
great extent reﬂected by changes in the expression of inﬂammatory
markers (Boesch-Saadatmandi et al., 2012). Quercetin protected
CCD-18Comyoﬁbroblasts against ROS in part by increasing activity
of antioxidant enzymes and in part by inducing an up-regulation of
miR-146a, known as a negative regulator of pro-inﬂammatory NF-
kB activation, thus protecting CCD-18Co from inﬂammation
(Noratto et al., 2011). Moreover, hepatic miR-122 and miR-125b
concentrations, previously involved in inﬂammation (miR-125b)
and lipid metabolism (miR-122), were increased by dietary
quercetin supplementation, suggesting that miRs modulation can
contribute to the gene-regulatory activity of quercetin in vivo
(Boesch-Saadatmandi et al., 2012). Resveratrol and quercetin in
combination are able to decrease the generation of ROS in colon
cancer cells decreasing in turn oncogenic miR-27a expression (Del
Follo-Martinez et al., 2013).
Interestingly, the stimulation of speciﬁc signalling pathways
can occur in the cross-talk between probiotic bacteria and gut
epithelium cells, which can help to explain the adjuvant properties
of probiotic lactobacilli (Vizoso Pinto et al., 2009). Strain speciﬁc
properties of probiotics in providing supportive health effects in
the immune system and the gastrointestinal tract have been
widely investigated in vivo and in vitro, suggesting that speciﬁc
strains could even modify the immune response at post-
transcriptional level by modifying miRs expression in dendritic
cells (DCs) (Giahi et al., 2012). Probiotic strains can affect toll like
receptor 4 (TLR4) expression in a down-regulatory direction,
reducing in turns inﬂammation level. Inactivated strains of
Lactobacillus rhamnosus GG (LGG) in human DCs can induce a
signiﬁcant down-regulation of miR-146a expression and a
concomitant up-regulation of miR-155 in DCs, which is consistent
with the down-regulation of p38MAPK (Giahi et al., 2012). It was
reported that these two seemingly co-induced regulatory RNAs,
miR-146a and miR-155, dramatically differ in their induction
behaviour under different stimuli strengths and act non-redun-
dantly through functional specialization.
Inconclusion, inﬂamma-miRsseemtobemodulatedbynutrients,
highlighting the potential role of probiotic intervention in reducing
the pro-inﬂammatory status associated with human ageing.
6. A notable example: cardiovascular disease
In the developed countries most of the elderly are affected by
age-related chronic diseases, which share an inﬂammatory
background. These pathologies share features of accelerated
ageing, which from an epigenetic point of view consist in global
hypomethylation and site-speciﬁc hypermethylation of the
genome as discussed above. The ongoing epigenetic characteriza-
tion of age-related diseases has two important consequences: (1)
allows the identiﬁcation of epigenetic markers of biological age
that can be used to early detect the pathologies; (2) provides an
interventional target. Indeed, most of the age-related diseases are
multi-factorial pathologies in which environmental lifestyle, and
in particular nutritional habits, plays a pivotal role. Based on these
considerations, it is clear that the anti-ageing dietary interventions
provide a powerful tool to counteract or slowdown the age-related
diseases onset. In this paragraph, we discuss cardiovascular
diseases as a notable example.
Recent studies reported the function of epigenetic mechanisms
in CVDs (Baccarelli et al., 2010a; Handy et al., 2011; Turunen et al.,
2009; Udali et al., 2013). Epigeneticmodiﬁcation can regulate gene
expression of key pathways related to coronary artery disease
development in human and animalmodels (Baccarelli et al., 2010a;
Creemers et al., 2012; Hiltunen et al., 2002a,b; Laukkanen et al.,
1999) or speciﬁcally affect the expression of genes involved in its
major thrombotic complication, myocardial infarction (Friso et al.,
2012; Handy et al., 2011). Changes in both genome and site-
speciﬁc DNA methylation have been described in CVD (Friso et al.,
2012, 2008) although their speciﬁc function is still to be largely
investigated (Baccarelli et al., 2010a).
Hiltunen et al. (2002b) described the ﬁrst report of a global
hypomethylation, in advanced atherosclerotic lesions in humans
as well asmouse and rabbit models. However, whether global DNA
hypomethylation has a causal role or is it a consequence of
atherogenesis is not yet known. Global DNA hypomethylation was
described also in atherosclerosis-prone APOE/ mice compared
to C57BL/6 controls at early disease stages leading to the
hypothesis that aberrant DNA methylation may precede the onset
of disease even of several years, as described for cancer disease
(Ehrlich, 2006; Lund et al., 2004).
Some studies analyzed the levels of global DNA methylation in
association with plasma concentrations of homocysteine (Hcy), a
biomarker for vascular disease (Handy et al., 2011). Castro et al.
(2003) described a signiﬁcant decrease in DNA global methylation
in white blood cells DNA of patients with vascular disease and
higher Hcy, compared to a control group. The higher plasma Hcy
paralleled with increased concentrations of S-adenosylhomocys-
teine (AdoHcy) (Castro et al., 2003), the intracellular precursor of
Hcy with a well-known function as a strong inhibitor of DNMTs (Yi
et al., 2000). Considering that both Hcy (Girelli et al., 1998; Jacques
et al., 1996) and DNA methylation are dependent on folate
concentrations through a gene-nutrient interaction model
Table 3
Main miRs associated with organismal ageing.
MiRs Organism Tissue References
miR-20a, miR-106a, miR-126, miR-155 Humans Whole blood ElSharawy et al. (2012)
miR-21 Humans Plasma Olivieri et al. (2012b)
miR-126 Humans Plasma Our unpublished data
miR-21 Humans PBMCs Serna et al. (2012)
miR-21 Humans B lymphocytes Gombar et al. (2012)
45 miRs Male mice Serum Dhahbi et al. (2013)
miR-34a Mice Plasma, PBMCs, brain Li et al. (2011a)
93 miRs Mice Brains Inukai et al. (2012)
miR-34a, miR-93, miR-214, miR-669c, miR-709 Mice Liver Smith-Vikos and Slack (2012)
miR-22, miR-101a, miR-720, miR-721 Mice Brain Smith-Vikos and Slack (2012)
miR-7, miR-468, miR-542, miR-698, miR-124a, miR-181a,
miR-221, miR-382, miR-434, miR-455
Mice Skeletal muscle Smith-Vikos and Slack (2012)
65 miRs, including miR-21 Mice Heart Zhang et al. (2012)
let-7 miR cluster Mice Heart Cao et al. (2012)
miR-34 Drosophila Brain Liu et al. (2012)
miR-124 Different species Different tissues Dallaire et al. (2012)
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(Friso et al., 2013, 2002) it seems of high interest to explore
whether nutritional regulation within one-carbon metabolism
may modify the risk of CVD through DNA methylation. A recent
observation reported that a nutrient-gene interaction within
folate metabolism, not only affect the levels of global DNA
methylation but also the risk of cancer disease through this
epigenetic phenomenon (Friso et al., 2013). Whether this ﬁnding
may also apply to CVD is still to be evaluated. Using a surrogate
marker for global DNA methylation, LINE-1 methylation was
evaluated as a possible marker for cardiovascular risk (Baccarelli
et al., 2010c). Different results have been reported, however,
when global methylation in peripheral blood leukocytes was
evaluated by measuring Alu and juxtacentromeric Satellite 2
repetitive elements (Kim et al., 2010) whose methylation highly
correlate with global methylation of DNA (Weisenberger et al.,
2005). The precise reason of the inconsistencies observed in
those studies may be found in either the different study design
but also in the techniques utilized for measuring DNA
methylation, namely bisulﬁte treatment-based methods (Bac-
carelli et al., 2010c; Kim et al., 2010), restriction enzyme
digestion (Castro et al., 2003; Lund et al., 2004; Yi et al., 2000) or
HPLC-based methods (Hiltunen et al., 2002b) which may indeed
account for the results variability.
Several studies reported the role of methylation at speciﬁc
gene-sites in CVD. One of the ﬁrst report refers to the epigenetic
regulation through methylation of the estrogen receptors a (ESR1)
and b (ESR2) genes whose functions have been largely described
for CVD (Mendelsohn and Karas, 1999). Post and colleagues
observed higher methylation levels of ESR1 promoter region in
human coronary atherosclerotic plaques compared to normal
vascular tissues (Post et al., 1999). The ESR2 methylation at
promoter region was also described in human atherosclerotic
lesions where the increase in DNA methylation correlated with
decreased ESR2 expression (Kim et al., 2007).
Gene-speciﬁc DNA methylation in human atherosclerotic
lesions was also studied by analyzing the gene coding for 15-
lipoxygenase (ALOX15), a lipid peroxidating enzyme strongly
expressed in atherosclerotic plaque (Hiltunen et al., 2002b). Using
a bisulﬁte-sequencing approach a hypomethylation in CpG
promoter region sequences was observed that possibly account
for the increased ALOX15 gene expression.
The role of methylation in CVD was also studied at coagulation
factor 7 gene (F7) promoter site considering that factor VII plasma
concentrations are a strong risk factor for coronary artery disease.
F7 promoter was evaluated in the DNA extracted from PBMCs of
patients affected by coronary artery disease (CAD) compared to
CAD-free subjects where F7 promoter hypomethylation correlated
with higher plasma concentrations of FVIIa and higher risk for CAD,
therefore highlighting a possible role for methylation at F7
promoter site and CAD risk (Friso et al., 2012).
Regarding the inter-relationships among nutritional factors,
DNAmethylation and CVD risk, van Straten and colleagues recently
showed that a low protein diet inﬂuences adult lipid metabolism
through DNAmethylation by altering, among several differentially
methylated genes, liver X-receptor alpha (NR1H3) (Van Straten
et al., 2010). This gene is involved in the control of cholesterol and
fatty acid metabolism and it is hypothesized to contribute to the
risk of CVD.
A very interesting model is that proposed by Lillycrop and
colleagues who showed, using a rodent model, that a protein
restricted diet induces a lower promoter methylation status in
glucocorticoid receptor (NR3C1) and peroxisomal proliferator-
activated receptor a (PPARA): both genes are related to cardiovas-
cular disease also in humans by being involved in the regulation of
blood pressure and in the lipid and carbohydrate homeostasis,
respectively (Lillycrop et al., 2008, 2005).
A growing interest is emerging for the role of miRs and CVD
mostly due to the hypothesis of being potentially useful
biomarkers of disease development or progression (Bauersachs
and Thum, 2011). In this view, miRs have been largely explored in
both plasma and serum of stable CAD patients mostly to evaluate
whether miRs usually expressed in endothelial cells (miR-126,
miR-17, miR-92a), in smooth muscle cells (miR-145) or in
inﬂammatory response-associated cells (miR-155) may also serve
as possible CVD markers (Fichtlscherer et al., 2010). However,
whether speciﬁc miRs plasma levels will be useful markers of
disease diagnosis or complication in the near future is not clearly
known. Moreover, it is still to be explored whether miRs proﬁles
may be modiﬁable by environmental or nutritional factors as
occurring to other epigenetic features of DNA. The latter issue is of
great importance considering that bymodulating the environment
or nutritional setting it could be possible to modify disease risk or
adverse progression.
7. Conclusions
Unravelling the molecular basis of successful ageing is a
challenging but exciting goal of current research. Epigenetics is
gaining a central position in this scenario, as it provides at the same
time mechanistic insights into the ageing process and scientiﬁc
basis for interventional strategies. A growing number of studies
demonstrate that age-associated epigenetic variations can be
positively affected by physical exercise, lifestyle habits and diet.
However, it should be kept in mind that we are still at the
beginning of such studies, and thatmuch has to be done in order to
disentangle the complex relationship between epigenetics, nutri-
tion and ageing. For example, the tissue (or even cellular)
speciﬁcity of age-associated epigenetic changes and their func-
tional contribution to ageing deserve deeper investigation,
together with the molecular mechanisms by which dietary habits
and food components affect the epigenetic patterns. Among all
tissues, adipose tissue appears to be critical for the tight
connections between over-nutrition and inﬂammatory status,
being a paradigmatic example of the powerful effects of the
underlying epigenetic changes (see the paper by Zamboni et al.,
2013, in this special issue). In addition, the stability of the
epigenetic modiﬁcations induced by nutritional interventions
should be evaluated over time. Finally, although the use of murine
models is a valuable tool in these studies, the availability of
opportune studies on humans, such as those provided by the
European Project NU-AGE (see Box 1), appears unavoidable to
make in the next future epigenetic diets a valid interventional
approach for successful ageing.
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Summary
The discovery of biomarkers able to predict biological age of
individuals is a crucial goal in aging research. Recently, research-
ers’ attention has turn toward epigenetic markers of aging. Using
the Illumina Infinium HumanMethylation450 BeadChip on whole
blood DNA from a small cohort of 64 subjects of different ages,
we identified 3 regions, the CpG islands of ELOVL2, FHL2, and
PENK genes, whose methylation level strongly correlates with
age. These results were confirmed by the Sequenom’s EpiTYPER
assay on a larger cohort of 501 subjects from 9 to 99 years,
including 7 cord blood samples. Among the 3 genes, ELOVL2
shows a progressive increase in methylation that begins since the
very first stage of life (Spearman’s correlation coefficient = 0.92)
and appears to be a very promising biomarker of aging.
Key words: aging; biomarker; DNA methylation; ELOVL2;
FHL2; PENK.
Aging is a complex process characterized by a global decline in
physiological functions and is associated with an increased risk for
several diseases. A great effort is made to find reliable biomarkers of
aging and epigenetic represents one of the most promising fields
(Berdasco & Esteller, 2012). Epigenome-wide association studies (EWAS)
report that CpG island, mainly placed within genes promoter regions,
are hypermethylated in the elderly (Bell et al., 2012). In this study, we
analyzed the whole blood DNA methylation profile of 32 mother–
offspring couples using Illumina Infinium HumanMethylation450
BeadChip. The age range was 42–83 and 9–52 years for mothers and
offspring, respectively. ANOVA analysis identified 163 CpG sites differen-
tially methylated between these two groups. The top 5 significant loci
mapped within the CpG islands of ELOVL2, FHL2 and PENK genes, and
other loci within ELOVL2 and PENK had a P-value below the Bonferroni
threshold (Fig. 1A,B). The CpG islands of ELOVL2, FHL2, and PENK – all
located in the respective gene promoter – resulted hypermethylated in
mothers compared with offspring (Fig. 1C), with no sex or family-
associated bias. Spearman’s correlation analysis for the 3 genes showed
striking correlation values between methylation levels and age of the
subjects.
We replicated these results in a larger sex-balanced cohort using
Sequenom’s EpiTYPER assay. The analyzed samples included whole
blood DNA from 494 individuals (245 men and 249 women) ranging
from 9 to 99 years, plus 7 cord-blood DNA samples (3 males and 4
females). Depending on the sequence, the EpiTYPER assay returns the
methylation values of single CpGs or small groups of close CpGs (CpG
units). Samples were divided in 5 age classes, whose mean methylation
values for each CpG unit are reported in Fig. 2A. We then calculated
Spearman correlation between age and methylation level for each
CpG unit. The highest correlation values obtained were 0.92 (CpG_
11.12.13.14), 0.80 (CpG_9.10 and CpG_19.20), and 0.63 (CpG_23.24)
for ELOVL2, FHL2, and PENK, respectively (Fig. 2B). In all cases, the
considered sites tended to be hypermethylated with advancing age
(Fig. 2C, for FHL2 only the CpG_9.10 is shown). ELOVL2 displayed the
widest methylation range, from 7% to 91% (for FHL2 and PENK, they
were 12% to 53% and 1% to 27%, respectively, Fig. 2C).
In each gene, we identified a subset of CpG units, which displayed
high coefficients of correlation with age and whose methylation values
were closely correlated with each other (Fig. 2D). The subset of highly
correlated CpG units was used to perform principal components analysis
(PCA). The first principal component (PC1) was calculated, and boxplot
distributions of PC1 values in the 10 decades of age (Fig. 2E) showed an
increase in methylation level of the considered regions.
In this study, we identified and validated 3 genes, ELOVL2, FHL2, and
PENK, whose CpG islands methylation changes with age. FHL2 and PENK
showed very high correlation values, but with a small difference between
the different age classes. At variance, ELOVL2 displayed not only striking
correlation levels, but also an almost ‘on-off’ methylation trend between
the two extremes of life, ranging from 7% to 91% of methylation.
The hypermethylation of CpG islands during aging is well described
(Bell et al., 2012), and several DNA methylation biomarkers displaying a
good correlation with age have been described (Bocklandt et al., 2011).
In our study, taking advantage of a more dense DNA methylation
microarray technology, we identified and validated more striking and
reproducible age biomarkers. To date, the lack of highly reproducible
aging biomarkers is explained by the high levels of heterogeneity of
aging phenotypes (Cevenini et al., 2008), and only within this frame-
work it is possible to appreciate the extraordinary, progressive hyper-
methylation of ELOVL2 that continuously increases from the very first
stage of life to nonagenarians. We cannot exclude that this is due to
numerical alterations of specific blood cell subpopulations, and further
studies are needed to clarify this issue. Nevertheless, it is worth noting
Correspondence
Professor Claudio Franceschi, Department of Experimental Pathology, via
S. Giacomo, 12, I-40126 Bologna, Italy. Tel.: +39 051 209 4743; fax: +39 051
209 4747; e-mail: claudio.franceschi@unibo.it
Accepted for publication 03 September 2012
ª 2012 The Authors
Aging Cell ª 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
1
Aging Cell (2012) pp1–3 Doi: 10.1111/acel.12005
Ag
in
g 
Ce
ll
that in previous studies of gene expression in T cells, correlations with
gene expression patterns and changes of T subpopulations with age
were not observed (Remondini et al., 2010).
ELOVL2 encodes for a transmembrane protein involved in the
synthesis of long (C22 and C24) x3 and x6 polyunsaturated fatty acids
(PUFA) (Leonard et al., 2002), and it is mainly expressed in the liver,
while its expression and role in human blood cells have not been properly
addressed. Genome-wide studies identified ELOVL2 genetic variants
associated with serum metabolic profile, especially with the serum
concentration of specific n-3 PUFAs (Tanaka et al., 2009; Lemaitre et al.,
2011). To date, ELOVL2 has not been associated with aging. In light of
our results, and considering that PUFAs are involved in crucial biological
functions including energy production, modulation of inflammation, and
maintenance of cell membrane integrity, it is possible that ELOVL2
methylation plays a role in the aging process through the regulation of
different biological pathways.
The outstanding results obtained on ELOVL2 make it a strong
candidate for forensic applications aimed at identifying proband age. To
this purposes, other tissues, such as saliva and hair, should be
investigated. Secondly, ELOVL2 age-dependent hypermethylation is also
a promising candidate as biomarker for the evaluation of individual
fitness in elder people, with the potential for early diagnosis of age-
related diseases or for monitoring therapeutic intervention or disease
course.
In conclusion, (i) DNA methylation of CpG islands of ELOVL2, FHL2,
and PENK shows strong correlation with age and, in particular ELOVL2 is
the most extreme example of age-related hypermethylation, constituting
a bridge between the first developmental stages and the aging process.
(ii) ELOVL2 could be used in forensic sciences and in clinical applications.
(iii) Finally, ELOVL2 could be proposed as a sort of rheostat for aging –
the more is methylated, the more aged is the subject. Further studies are
needed to understand whether ELOVL2 hypermethylation only
represents an indicator of chronological age or rather is functionally
correlated with physiological status and specific clinical conditions.
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(A)
(B)
(C)
Fig. 1 EWAS study. (A) Manhattan plot of
genome-wide P-values from mother–
offspring comparison. (B) P-values and
Spearman correlation values of the selected
CpG sites in ELOVL2, FHL2, and PENK CpG
islands. The P-value of each probe was
ranked from the smallest to the largest, and
the position of the selected probes in the
list is reported in the first column.
(C) Methylation of the selected CpG sites
respect to age. Circles: mothers; triangles:
offspring.
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Fig. 2 Replication study. (A) Mean methylation values ± standard deviation in 5 age classes are reported for each CpG unit. (B) Spearman’s correlation coefficients for each
CpG unit. Highly correlated regions are marked in gray. (C) Methylation values of the CpG unit that better correlates with age in each gene. (D) Correlation between CpG
units within each CpG island. The most correlated CpG units are highlighted in yellow. (E) Distribution of PC1 values calculated in 10 age classes.
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INTRODUCTION 
 
DNA methylation is widespread across the genomes of 
different organisms and in mammals usually consists in 
the enzymatic addition of a methyl group to the carbon-
5 of cytosine ring of a CpG dinucleotide. Through the 
recruitment of methyl-binding proteins, this 
modification induces an inactive chromatin structure 
that represses transcription. While the bulk of human 
genome is generally methylated, the promoters of 
around 40% of genes contain CpG-rich regions, termed 
CpG islands, whose methylation status is strictly 
regulated during  development  and  cellular  differentia- 
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tion [1-3]. Deregulation in methylation patterns can lead 
to disease onset. More recently it has been shown that 
tissue- and disease-specific differentially methylated 
regions (DMR) are more frequent in CpG island shores 
rather than in CpG islands [4, 5]. 
 
Although DNA methylation is generally considered a 
stable modification, it is well established that 
methylation profiles vary in pathological conditions, 
and it is also accepted that external factors, such as diet, 
age, toxins and lifestyle, can induce quantitative hypo- 
or hyper- DNA methylation [6-13]. Only few studies 
have focused the effect of such factors on inter-
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Abstract: Little  is  known  about  the  impact  of  space  (geography/ancestry)  and  time  (age  of  the  individuals)  on  DNA
methylation  variability  in  humans. We  investigated DNA methylation  of  the  imprinted  IGF2/H19  locus  in:  i)  a  cohort  of
individuals homogeneous for age and gender (males with restricted age range: 30‐50 years) belonging to four Italian districts
representative of the major genetic clines, informative for the geographical dimension; ii) a cohort of monozygotic (MZ) and
dizygotic (DZ) twins of different ages (age‐range: 22‐97 years), informative for the temporal dimension. DNA methylation of
the analyzed regions displayed high levels of inter‐individual variability that could not be ascribed to any geographical cline. In
MZ  twins we  identified  two  IGF2/H19  regions where  the  intra‐couple variations  significantly  increased after  the age of 60
years. The analysis of twins’  individual  life histories suggests that the within twin pairs difference  is  likely the result of the
aging process itself, as sharing a common environment for long periods had no effect on DNA methylation divergence. On the
whole,  the data here  reported  suggest  that:  i) aging more  than population  genetics  is  responsible  for  the  inter‐individual
variability in DNA methylation patterns in humans; ii) DNA methylation variability appears to be highly region‐specific. 
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individual variability of DNA methylation patterns 
among human populations and subjects [14-17]. 
Regarding time/age, variations in methylation levels of 
the IGF2/H19 locus were observed in a cohort of 
newborn twins, both between individuals and within 
twin pairs [17]. In this study, dizygotic twins (DZ) 
resulted more discordant than monozygotic twins (MZ), 
suggesting that a heritable component can affects the 
epigenetic status of this locus. Moreover, Heijmans and 
colleagues [16] analyzed the variations in DNA 
methylation of the same IGF2/H19 locus in a cohort of 
adolescent and middle-aged twins (13-62 years of age) 
and demonstrated that a substantial part of the variation 
observed across individuals was ascribable to heritable 
factors and single nucleotide polymorphisms (SNPs) in 
cis, rather than to the cumulative effect of 
environmental and stochastic factors occurring with 
age. Although this study involved a high number of 
twins (N=372), it did not include old twin pairs, and 
therefore could not appreciate the possible epigenetic 
variability of the locus occurring later in life (after 
sixties).  
 
Regarding space/population, only few studies addressed 
the DNA methylation variability at the population level 
(population epigenetics) [18], despite its great potential 
interest owing to the interaction of both environmental 
and genetic variables in determining the DNA 
methylation architecture. To our knowledge, the only 
two available studies have investigated DNA 
methylation in multiethnic cohorts of healthy women 
[19] and of men affected by prostate cancer [20].  
 
To better understand the intricate relationship between 
spatial (geography/ancestry) and temporal (age of the 
individuals) dimensions on DNA methylation 
variability, we took advantage of two ad hoc models: i) 
Cohort 1, constituted of 376 individuals homogeneous 
for gender (males) and age (age range 30-51), but 
differing for ancestral geographical origin and place of 
living, i.e four Italian regions (Northern, Central and 
Southern Italy, and Sardinia); ii) Cohort 2, constituted 
of 31 monozygotic (MZ) and 16 dizygotic (DZ) twin 
couples of different ages, spanning from 22 to 97 years, 
homogeneous for geographic origin (Northern Italy, 
Bologna area). Both the models were analyzed for 
variations in DNA methylation status of 4 target regions 
in the imprinted IGF2/H19 locus, previously analyzed 
by other groups [16, 17].  
  
RESULTS 
 
Characterization of the IGF2/H19 target regions 
 
Four target regions (amplicons) in the IGF2/H19 locus 
were analyzed: IGF2AS, 3 kb from a CpG island, in 
exon 3 of IGF2AS transcript, within the IGF2 DMR 0; 
H19, upstream the transcription start site of H19 gene, 
partially overlapping a CpG island (H19 DMR); 
IGF2_island, within a CpG island in the last exon of 
IGF2 gene (DMR 2); IGF2_shore, in the shore 
upstream the island targeted by the IGF2_island 
amplicon (Figure 1A). IGF2AS and H19 have been 
previously analyzed by Heijmans et al. [16] and 
Ollikainen et al. [17], while IGF2_island and 
IGF2_shore were analyzed here for the first time. 
 
Mean methylation levels and inter-individual 
variability of IGF2/H19 locus 
 
Figure 1B reports mean methylation values and their 
standard deviations for the 4 target regions considering 
cohort 1 and 2 separately. For cohort 1 the mean DNA 
methylation levels observed in IGF2AS, IGF2_shore, 
IGF2_island and H19 were 49%, 60%, 43% and 36%  
respectively. These values are similar for cohort 2, 
where the mean methylation values in IGF2AS, 
IGF2_shore, IGF2_island and H19 were 49%, 62%, 
47% and 36%. Notably IGF2AS and H19 DNA 
methylation values were comparable to those previously 
reported in literature [16, 17]. 
 
Considerable inter-individual variation in DNA 
methylation values was observed within each CpG unit. 
Within a single amplicon, DNA methylation values of 
the CpG units were strongly correlated with each others, 
while correlation values were lower between CpGs 
belonging to different amplicons (Figure 1C). 
Intermediate correlation levels were observed only 
between IGF2_island and IGF2_shore, as expected 
because of their adjacent chromosomal position. 
 
Space/ancestry: geographical dimension 
 
The Italian cohort comprises 376 middle-aged males (age 
range: 30-51 years) representative of the four main Italian 
geographical areas: Northern Italy (141 samples), Central 
Italy (94 samples), Southern Italy (121 samples) and 
Sardinia (20 samples) (Figure 2A). We evaluated if the 
observed variability in methylation levels of the 
IGF2/H19 locus could be explained by ancestry and 
place of living of the four populations studied.  
 
Mean methylation levels of each CpG unit were 
calculated for the 4 geographical areas (Figure 2B). The 
results showed that the methylation patterns were 
comparable throughout all the samples. No evident 
differences were detectable according to sample 
ancestry/geography, except for few CpGs (i.e. CpG 20 
of IGF2_island amplicon).  
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Principal component analysis (PCA) was used to 
capture the most salient patterns of variation in each 
amplicon for the 4 geographical areas. The percentages 
of  variance  explained by  principal component 1 (PC1)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
values are reported in Figure 2C. No statistically 
significant difference was observed between PC1 
values, as confirmed by analysis of variance (ANOVA) 
(Table 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  1.  CpGs  spatial  localization  and  their  methylation  patterns.  (A)  Spatial
disposition of the amplicon analyzed  in relation  to  functional elements.  (B) Mean methylation
level with the corresponding standard deviation  for each CpGs considering the whole dataset.
(C) Correlation matrix of CpG sites of IGF2_shore, IGF2AS, H19 and IGF2_island amplicons 
Table 1. p_values from ANOVA on PC1 values 
calculated based on DNA methylation levels in 
samples belonging to different Italian districts 
   
 ANOVA – p_values 
IGF2_shore 0.93 
IGF2_island 0.45 
IGF2AS 0.80 
H19 0.44 
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Time/age: temporal dimension 
 
The twins cohort (cohort 2) includes 94 twins (62 MZ 
and 32 DZ) with age ranging from 22 to 97 years all 
recruited in the area of Bologna (Emilia Romagna, 
Italy).  Cohort 2 was divided into four age classes (20-
45, 46-60, 61-75, 76-97) and for each amplicon, mean 
methylation value and mean standard deviation were 
calculated (Figure 3). No significant variations in mean 
methylation levels were observed. In the first 2 age 
classes IGF2_shore was characterized by a minor range 
of variation if compared to the other amplicons. 
Moreover, while mean standard deviations in 
IGF2_island, IGF2AS and H19 were stable over the 
time, IGF2_shore showed a doubling in their values in 
the older age classes.  
 
In order to estimate DNA methylation variability within 
the MZ twins couples, Pearson’s correlation and 
Euclidean distance values for each twins pair were 
calculated. Pearson’s correlation was calculated 
considering methylation values  of  each  CpG  from  the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
same amplicon. The correlation values were then 
plotted against the age of the subjects (Figure 4). H19 
was characterized by a high degree of within-twin pairs 
correlation (Figure 4A) which was maintained up to old 
ages (Spearman’s correlation with age ρ= -0.094). 
IGF2_island also did not display variations of 
correlation levels with age (Spearman’s correlation with 
age ρ = -0.105). However, in this case the intra-couple 
correlation scores were lower, indicating that high 
levels of variability characterize the CpG island of IGF2 
(Figure 4B). Interestingly, both IGF2AS and 
IGF2_shore showed an age dependent trend 
(Spearman’s correlation ρ = -0.613 and ρ = -0.651 
respectively), with high correlation levels till the age of 
50, followed by a progressive decrease of correlation in 
the couples of older age (Figure 4C-4D). A possible 
threshold between the age of 56 and 60 years can be 
envisaged, and after such age limit the values of intra-
couple correlation levels are much more scattered.  
 
Then, the Euclidean distance between the CpG units of 
each amplicon. was calculated for each MZ twins pair.  
Figure 2. Methylation variation in cohort 1. (A) Number of samples from different Italian districts and 
corresponding groups made for the statistical analysis. (B) Mean methylation levels of each CpGs unit in the 
4 macroarea. (C) PC1 values plotted for each macro‐area and the corresponding percentage of variance. 
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Regarding H19 and IGF2_island the distance values did 
not show any age-dependent trend (Figure 5A and 5B, 
Spearman’s correlation ρ = 0.099 ρ = 0.216 respective-
ly). On the contrary, IGF2AS and IGF2_shore (Figure 
5C and 5D) showed an age-dependent increase in the 
intra-couple Euclidean distances (Spearman’s 
correlation ρ = 0.462 and ρ= 0.553 respectively), with a 
scatter of the distance values after the age threshold of 
60, as reported for Pearson’s correlation analysis.  
 
The data were also subdivided according to sex to 
exclude an influence on the patterns of correlation and 
distance values (Figure 4 and Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To confirm the previous observations, samples from 
cohort 2 were divided into 2 groups according to age 
(below and over 60 years old) and Student t-test on 
correlation and Euclidean distance values was performed. 
Significant differences between the 2 groups were found 
only for IGF2_shore and IGF2AS amplicons (Table 2).  
 
Evaluation of heritability and environmental 
influences on DNA methylation  
 
MZ and DZ twins were used to estimate the genetic and 
environmental influences on DNA methylation of the 
IGF2/H19 locus.  
Figure 3 Methylation variation in cohort 2. The twins cohort was divided in 4 age classes (20‐
45, 46‐60, 61‐75,76‐97). Mean methylation values and the corresponding standard deviation for the
4 analyzed amplicons (IGF2AS, IGF2_shore, IGF2_island and H19) are reported for each age‐class. 
Table 2. Student t‐test on correlation and Euclidean distance scores 
using 60 years old as age threshold 
 
Amplicon Age limit Values 
considered 
p_values 
IGF2_shore 60 Correlation 0.00047*** 
IGF2AS 60 Correlation 0.022* 
H19 60 Correlation 0.27 
IGF2_island 60 Correlation 0.77 
IGF2_shore 60 Euclidean 
distance 
0.0075** 
IGF2AS 60 Euclidean 
distance 
0.023* 
H19 60 Euclidean 
distance 
0.48 
IGF2_island 60 Euclidean 
distance 
0.57 
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Figure 4. Pearson  correlation values  calculated within  twin pairs  in  the 4 analyzed amplicons.  (A)
Correlation  values within MZ  twin  couple  in  H19  amplicon.  (B)  Correlation  values within MZ  twin  couple  in
IGF2_island. (C) Correlation values within MZ twin couple in IGF2AS. (D) Correlation values within MZ twin couple
in IGF2_shore amplicon. In each figure male individuals are indicated with squares and female using a triangle. 
Figure 5. Euclidean distance calculated using DNA methylation values within MZ twin pairs considering
the 4 considered amplicons. (A) Distance within twin pairs in H19 amplicon. (B) Distance values within twin pairs
in  IGF2_island amplicon.  (C) Distance values within  twin pairs  in  IGF2AS amplicon.  (D) Distance values within  twin
pairs in IGF2_shore amplicon. In each figure male individuals are indicated with squares and female using a triangle 
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Firstly for each amplicon intra-couple levels of 
correlation between MZ and DZ twins were compared. 
Like MZ, also DZ twins showed high values of 
correlation in the 4 amplicons (Figure 6), suggesting a 
strong epigenetic control on this locus. In IGF2AS, H19 
and IGF2_island, the intra-couple correlation in MZ 
was higher compared with that of DZ. Only in 
IGF2_shore median correlation values were similar 
among MZ (r=0.94) and DZ (r=0.90) twins. Falconer 
method confirmed this observation, showing that 
IGF2_shore is more influenced by environmental 
factors (h2=0.07) when compared with IGF2AS 
(h2=0.37), H19 (h2=0.34) and IGF2_island (h2=0.20). 
As IGF2_shore methylation seems to be more affected 
by environmental factors, the total lifetime in which the 
twins did not shared the same environment (i.e. the total  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
lifetime in which they did not live in the same house) 
was considered. As expected, an increase in percentage 
of life in which the twins lived separated (S = (years 
lived in a different house / age)*100) was observed for 
older couples (Figure 7A).  
 
Low Euclidean distance levels characterized twins with 
small S values, while a scatter after the threshold of 
S=35, which in our cohort corresponds to the age of 60, 
was observed (Figure 7B). There were 3 main 
exceptions, indicated with an arrow in Figure 7B. These 
subjects (aged 50, 56 and 74) were still living in the 
same house at the time of recruitment (small S values) 
but were characterized by high Euclidean distance 
values for IGF2_shore. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  6.  Comparison  between  intra‐couple 
correlation  (ICC)  in MZ  and DZ  twins.  Boxplot  of 
ICC for each amplicon dived on the basis of zygosity. 
Figure 7. Analysis of twins  individual histories.  (A) Percentage of years  lived separately  for each twin pairs  in
relation to their ages. (B) Euclidean distance within twin pairs related to years the twins lived separately in IGF2_shore
amplicon. S = (years lived in a different house / age)*100 
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DISCUSSION 
 
Our results indicate that the 4 analyzed regions in the 
IGF2/H19 locus show high inter-individual variability 
both in cohort 1 (spatial/population dimension) and in 
cohort 2 (temporal/aging dimension). IGF2AS and H19 
have mean methylation values comparable to previous 
reports [16, 17], indicating that methylation profiles are 
consistent among different populations and that the 
experimental technique used for methylation analysis is 
highly reproducible between independent laboratories. 
On the contrary, IGF2_island and IGF2_shore were 
analyzed for their methylation values here for the first 
time.  
 
Previous studies have analyzed methylation variability 
in multiethnic populations, but the enrolled subjects 
lived in the same geographical area and were therefore 
exposed to the same environmental factors [19, 20]. On 
the contrary, cohort 1 was selected in order to include 
individuals both belonging to different genetic clines 
and living in their original geographical area. Our 
results show that methylation variability in cohort 1 
cannot be explained on the basis of the geographic 
provenience of subjects. This implies that the genetic 
structure of the Italian population does not influence the 
methylation pattern of the analyzed loci. At the same 
time, it means that there are no environmental cues 
specifically associated with Italian macro-areas able to 
generate clear population epigenetic signatures in the 
IGF2/H19 locus.  
 
Methylation of IGF2 promoter has been shown to 
increase with aging [21]. On the contrary, mean 
methylation values of the 4 regions that we considered 
in IGF2/H19 locus do not change according to age in 
cohort 2. This suggests that methylation levels of 
different regions in the same locus are differently 
affected by the aging process. At the same time, in 
young individuals from cohort 2, DNA methylation 
variations is smaller in IGF2_shore respect to the other 
analyzed amplicons indicating a stricter control of its 
methylation levels. Accordingly previous studies have 
highlighted that the range of methylation variation 
depends on the genomic position [14]. Moreover, only 
in IGF2_shore the range of methylation values 
increases in the elderly suggesting a clear susceptibility 
of this region to epimutations that occur with aging. 
 
MZ twins model allowed the investigation of the 
maintenance of DNA methylation profiles during the 
lifespan. IGF2AS and IGF2_shore methylation levels 
were highly concordant within twin pairs, but only until 
the 60 years age threshold. Homogeneous methylation 
values in IGF2AS and IGF2_shore until the age of 60 
years can be in part due to the genetic identity and the 
sharing of intrauterine and neonatal environments. It is 
interesting to observe that the threshold of 60 years 
coincides with the end or with the significant reduction 
of the reproductive capacity of individuals. A loss in 
molecular fidelity after the threshold of 60 years has 
been described [22]. This can affect also the DNA 
methylation machinery, impairing its ability to maintain 
the methylation patterns across cellular divisions [23]. 
The extent and the rate of this process can be influenced 
by the genetic background of subjects [24], accordingly 
in our cohort, a subset of couples maintains the 
concordance in DNA methylation profiles also at old 
age. 
 
Comparison between MZ and DZ twins confirms a 
genetic component in the variability observed in 
IGF2/H19 locus in our cohort. These analysis highlight 
also an effect of non-genetic factor, which is stronger 
for IGF2_shore. This observation is supported by the 3 
old twins pairs that had always lived together, in the 
same house, sharing the same daily habits. They show 
high distance values in IGF2_shore, similar to those 
observed in the old couples that lived separately. This 
data suggests that age-related epimutations are 
independent from the shared environment and are more 
likely related to individual histories or stochasticity. A 
larger sample of old twins that lived together should be 
considered to confirm this hypothesis.  
 
Previous data show that different imprinted genes have 
different ability to maintain their methylation status 
[25]. Our results not only confirm these observations, 
but also show that within the same imprinted locus there 
are regions whose methylation maintenance is 
differently influenced by aging. 
 
It is interesting to highlight that, between the 4 regions 
that we have analyzed in IGF2/H19 locus, IGF2_shore 
is the one in which the scatter in methylation variability 
during aging is more evident. This result confirms 
recent evidences that indicate CpG shores as the regions 
most variable in terms of methylation levels across 
normal and pathological tissues and between different 
cell types [4].  
 
The ability of imprinted genes to maintain their 
methylation profile has been proposed as a marker of 
epigenetic stability [25]. In fact, although imprinted loci 
are under a strict epigenetic control, a relaxation in their 
regulation can be observed both in pathological [26] and 
normal conditions [27]. Further studies are needed to 
deepen our knowledge on age-related DNA methylation 
variability of imprinted genes, with specific attention to 
the shore elements. 
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In conclusion our data confirm the loss of control over 
DNA methylation maintenance with age only in specific 
genomic regions (shore). In particular we observe a 
sudden increase in intra-couple variability from the age 
of 60, when the reproductive capacities decline and, as a 
consequence, the effect of natural selection falls off. On 
one side this decline could be interpreted as a loss of 
capacities of transmitting the methylation patterns across 
cellular divisions. On the other side, as the weaker 
epigenetic control can result in a reduction of gene 
expression control, it is possible to speculate that this 
mechanism could represent a molecular strategy to 
counteract the physiological fitness decline that occurs 
during aging by offering a wider range of expression 
possibilities. 
  
MATERIALS AND METHODS 
 
Ethics statement. Informed consent was obtained from 
all partecipants and was approved by the Medical Ethics 
Committee of the S. Orsola-Malpighi Polyclinic 
(Bologna, Italy).  
 
Samples. Twins: The twins cohort was recruited between 
2004 and 2005 in Bologna and neighboring districts to 
reduce possible bias associated to different geographical 
origin of the samples. The cohort comprises 47 twin pairs 
(31 MZ an 16 DZ pairs) with a mean age of 55 years (age 
range: 22-97 years; Table 3). Italian population: in order 
to assemble the most representative and informative 
Italian sample, with an ancient regional ancestry in the 
area, and an adequate coverage for both the number of 
populations and the number of individuals within each 
population sample, an appropriate and accurate sampling 
strategy was built based on a preliminary surname-based 
study (Boattini et al., submitted). 
 
Groups of homogeneous provinces (“sampling areas”) 
were aggregated according to the surname-based 
clusters. Provinces (“sampling points”) were selected 
within  each  sampling  area  according  to  the  complex  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
geographic and historical Italian backgrounds. 
Individuals (“samples”) were chosen, within each 
province, based on two different strategies, the 
“grandparents criterion” and “founder surnames 
analysis”, so that were included into the study only 
those individuals whose four grandparents were born in 
the same sampling area, taking also into account the 
presence of founder surnames. 
 
Using this sampling strategy 378 male individuals from 
29 provinces scattered in 15 regions of Italy were 
collected (Figure 2A) .  
 
DNA methylation measurement and associated data 
cleaning. The level of DNA methylation was measured 
on genomic DNA using a MALDI-TOF mass 
spectrometry-based method (Epityper, Sequenom, San 
Diego, CA) as previously described [28]. DNA was 
extracted from whole blood (QIAamp 96 DNA Blood 
Kit, Qiagen, Hilden, Germany), quantified using 
Picogreen (Quant-iT dsDNA Broad-Range Assay Kit 
Invitrogen, Carlsbad, CA), and 1 μg was treated with 
sodium bisulfite using the EZ methylation kit (Zymo-
Research, Irvine, CA). The treatment converts non-
methylated cytosine into uracil, leaving methylated 
cytosine unchanged. In this way variations in the 
sequence are produced depending on DNA 
methylation status of the original DNA molecule. PCR 
amplification, addition of SAP solution and 
Transcription/RNase A cocktails were performed 
according to the protocol provided by Sequenom and 
the mass spectra were analyzed by EpiTYPER 
analyzer (Sequenom, San Diego, CA). IGF2_shore 
amplicon encompassed 276 bp (NCBI build 36, chr11: 
2 111 039 - 2 111 314). IGF2AS encompassed 338 bp 
(NCBI build 36, chr11: 2 126 035 - 2 126 372). H19 
encompassed 413 bp (NCBI build 36, chr11: 1 975 
948 - 1 976 360). IGF2_island encompassed 453 bp 
(NCBI build 36, chr11: 2 111 119 - 2 110 666). The 
primers sequences used to amplify this regions are 
listed in Table 4. 
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Table 3. Cohort 1 characteristics 
 
    Twins   All 
 Monozygotic Dizygotic Total samples 
N 62 (31 pairs) 32 (16 pairs) 94 (47 pairs) 
Mean age  
(SD; range) 
54.0  
(19.4; 22-97) 
57.8  
(12.8;36-79) 
55.3  
(17.4; 22-97) 
Male (%) 32 (51.6%) 20 (62.5%) 52 (55.3%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In this way, a total of 50 CpG units in the 4 gene 
regions were interrogated for their methylation level. A 
rigorous data cleaning process was performed to 
remove unreliable measurements before statistical 
analysis. Firstly, DNA samples for which methylation 
level could be established for <60% of the CpG sites 
were removed. Secondly, CpG sites with more than 
30% missing data points  within an  amplicon  were  not  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
analyzed. Finally CpG sites that show a bimodal 
pattern due to the presence of a SNP were removed. 
Six CpG sites on four fragments could not be 
measured independently because the fragments had the 
same molecular weight and were overlapping in the 
spectrum. After data cleaning, we were able to analyze 
a total of 39 CpG units in the 4 genomic regions 
(Table 4). 
Table 4. CpG Units considered after data cleaning and primers used to amplify the 4 target regions 
 
Amplicon 
Name 
CpG sites 
after data 
cleaning 
Total 
Cpg 
Units 
Primers sequences 
IGF2_ 
shore 
CpG 1,2 – 
CpG 3,4 - 
CpG 6 - 
CpG 7 - 
CpG 8 - 
CpG 
9,10,11 
6 Forward:  
aggaagagagGAAGGGGTTGGTTAGTAGGTGTTTGT 
Reverse: 
cagtaatacgactcactatagggagaaggctCCTAAACCCCTTTCCCACTCTCTAA 
IGF2_ 
island 
CpG 1,2 - 
CpG 4 - 
CpG 11,12 
- CpG 13 - 
CpG 14 - 
CpG 15 - 
CpG 16 - 
CpG 17 - 
CpG 18,19 
- CpG 20 - 
CpG 21 - 
CpG 25 - 
CpG 26 - 
CpG 27 
14 Forward: 
aggaagagagTATAGGGGTGGTTTGTTAGGTTAGG  
Reverse: 
cagtaatacgactcactatagggagaaggcTAAATCAAAAAAAACCCCAAAAAAAC 
IGF2AS CpG 1 - 
CpG 3 - 
CpG 4 - 
CpG 6,7 - 
CpG 8 
5 Forward: 
aggaagagagTGGATAGGAGATTGAGGAGAAA  
Reverse: 
cagtaatacgactcactatagggagaaggctAAACCCCAACAAAAACCACT 
H19 CpG 1 - 
CpG 2 - 
CpG 6 - 
CpG 7 - 
CpG 8 - 
CpG 9,10 - 
CpG 12 - 
CpG 13 - 
CpG 14,15 
- CpG 17 - 
CpG 18,19 
- CpG 20 - 
CpG 22 - 
CpG 24 
14 Forward: 
aggaagagagGGGTTTGGGAGAGTTTGTGAGGT  
Reverse: 
cagtaatacgactcactatagggagaaggctATACCTACTACTCCCTACCTACCAAC 
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Statistical analysis. All analysis were performed using R 
(http://cran.r-project.org)/). Prior to statistical analysis, 
methylation data were checked for complete bisulfite 
conversion using the MassArray package [29]. h2 values 
were calculated according to Falconer’s formula [30].  
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INTRODUCTION  
 
Many studies have demonstrated that human healthy 
ageing and longevity are familial traits inherited across 
generations [1-4]  and  that  centenarian  offspring  have  
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higher chances for healthy aging[5, 6]. To assess the 
factors that can contribute to this phenotype, many 
studies of long-lived families have been carried out 
from several perspectives, such as genomics [7], 
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Abstract The role that mtDNA heteroplasmy plays in healthy aging, familial longevity and the heritability patterns of low
levels heteroplasmy in the elderly are largely unknown. We analyzed the low levels of mtDNA heteroplasmy in blood in a
cohort of centenarians, their offspring and a group of offspring of non long‐lived parents, characterized by a less favorable
health phenotype. The aims of this study are to: (i) investigate the transmission of low level heteroplasmies in the elderly;
(ii) explore  the association of heteroplasmy with age and  longevity and  (iii)  investigate heteroplasmy patterns  in  these
three  groups. We  sequenced  a 853 bp mtDNA  fragment  in  88  individuals  to  an  average  coverage of  49334‐fold, using
quality control filtering and triplicate PCR analysis to reduce any methodological bias, and we detected 119 heteroplasmic
positions with a minor allele  frequency  ≥ 0.2%. The  results  indicate  that  low‐level heteroplasmies are  transmitted and
maintained within  families until extreme age. We did not  find any heteroplasmic variant associated with  longevity and
healthy aging but we  identified an unique heteroplasmy profile  for each  family, based on total  level and positions. This
familial profile suggests that heteroplasmy may contribute to familial longevity. 
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metabolomics [8], epigenetics [9], gut microbiome [8, 
10] and mitochondrial DNA (mtDNA) variability [11].  
Among these domains it is well established that the 
physiological decline of mitochondrial machinery plays 
a critical role in the aging process, given its role in 
providing energy to cells and tissues and the high 
production of reactive oxidative species. One factor that 
can contribute to age-related mitochondrial dysfunction 
is the accumulation of mtDNA mutations linked to 
errors in the replication machinery [12-14]. MtDNA 
heteroplasmy, i.e. intra-individual variation in mtDNA 
sequences, may be of relevance. 
 
Some studies have addressed the role that mtDNA 
heteroplasmy may play in promoting longevity [15-18]. 
A possible beneficial effect on healthy aging is that 
mtDNA heteroplasmy represents a reservoir of genetic 
variability, that can bring new functions and increase 
the capacity of cells to cope with environmental and 
physiological stressors during life [15, 17, 19, 20] but 
the forces that drive the fate of heteroplasmic mutations 
are still a matter of debate [21, 22]. Moreover recent 
studies demonstrated that the heteroplasmy pattern is 
inherited [23-26], including low-frequency 
heteroplasmic variants [27]. This new insight identifies 
heteroplasmy as a possible genetic contributor to 
familial longevity, but to date there are no data that 
show that the inherited heteroplasmic profile is 
conserved until extreme age. Various forces contribute 
to heteroplasmy, but the extent to which heteroplasmies 
are inherited or arise via new mutations is still 
uncertain, making the study of heteroplasmy in the 
extreme elderly even more pertinent. The heteroplasmy 
pattern observed in middle-age individuals is a mixture 
of both inherited and somatic mtDNA mutations that 
can potentially change according to tissue composition 
and cell clonality [28]. It is because of the bottleneck 
that occurs during postnatal folliculogenesis [29] and 
the somatic events that naturally occur during life [20, 
30] that the frequency of heteroplasmies can change 
from one generation to another [20]. 
 
A further challenge in the study of heteroplasmy and 
aging is represented by technological limits in 
heteroplasmy detection. Previous technologies (such as 
DHPLC or pyrosequencing) did not allow a high site-
specific resolution of very low-level heteroplasmic 
variants [31]. Thus, the advent of next-generation 
sequencing technologies, with the potential for very 
high coverage, seems ideal for investigating 
heteroplasmic events in very old people [27]. 
 
In the present study we analyzed 30 female centenarians 
(CENT), 30 offspring of these centenarians (CO) and a 
control group of 28 offspring of non-long-lived parents 
(ONLL), i.e. offspring of parents who died before 
reaching the average life expectancies for their cohort. 
We detected heteroplasmic positions by an ultra-deep 
re-sequencing method on the Illumina GA platform, 
focusing on 853 bp of the mtDNA control region 
(including HV1 and part of HV2). We focused on this 
region because heteroplasmies occur preferentially at 
positions with high mutation rates, in particular in the 
mtDNA control region, and because this region was 
already analyzed in previous studies of longevity [17, 
19, 32].  
 
The aims of this study are three-fold: (i) to address 
differences and similarities between centenarians 
(whose extended lifespan could be the result of a better 
adaptation to environmental stress and stimuli [33]), 
their offspring, characterized by a better health 
phenotype [34] and the offspring of non-long-lived 
parents; (ii) to describe mtDNA heteroplasmy patterns 
in extreme longevity; and (iii) to address if low levels of 
mtDNA heteroplasmy are trasmitted, maintained and 
detectable in very old mother offspring pairs 
(centenarians and their offspring) and how this 
mechanism could contribute to human longevity.  
 
RESULTS 
 
Reliability of mtDNA heteroplasmies detected by 
ultra-deep resequencing  
 
Many studies raise several doubts related to ultra-deep 
sequencing based on PCR amplicons [31, 35] such as a 
biased amplification of nuclear mitochondrial 
pseudogenes (numts), or a very high number of false 
positives linked to a high sequence error rate or biased 
PCR amplification. To reduce the possibility of 
amplifying numts we first tested the pair of primers by 
in silico PCR to exclude non-specific amplifications, 
then the PCR products were checked on agarose gels to 
exclude the presence of non-specific amplicons. 
Rigorous criteria were used to distinguish true 
heteroplasmies from sequencing error, such as double 
strand validation and filtering (Methods), previously 
implemented in other studies [36]. Most importantly, to 
evaluate the potential for PCR errors and to obtain an 
estimate of the number of false positives, 3 different 
PCR products from 12 samples were sequenced and the 
concordance of heteroplasmic sites (identified using 
0.2% as the lowest heteroplasmy threshold [24, 27]) 
between replicates checked. 
 
Thus sensitivity and specificity of heteroplasmy 
detection were calculated. Sensitivity (i.e. a measure of 
the proportion of heteroplasmic sites correctly identified 
as such) provides the false negative rate while 
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specificity (i.e., a measure of the proportion of 
homoplasmic sites correctly identified as such) provides 
the false positive rate. Because there is no suitable 
alternative method to detect very low levels of 
heteroplasmy (i.e. 0.2%), in the calculation of 
sensitivity and specificity levels a site was defined as 
“true heteroplasmic” if heteroplasmy was supported by 
at least 2 of the 3 observations. Mean sensitivity and 
specificity values were calculated as 0.95 ± 0.09 and 
1.00 ± 0.0025 respectively. These high values obtained 
here support the possibility to detect and quantify 
heteroplasmic point mutations with high accuracy (for 
detailed analysis see Table 1S).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Heteroplasmy profiling in centenarians, centenarian 
offspring and offspring of not long-lived parents  
 
After quality control (see Methods) there were results 
for 30 CENT, 30 CO and 28 ONLL. Heteroplasmy was 
defined with a minimum threshold of 0.2%, resulting in 
119 heteroplasmic positions in the 853 bp fragment 
analyzed (Figure 1). In particular, we identified 75 
heteroplasmic sites in CENT, 101 in CO and 72 in 
ONLL. We then performed a Fisher-exact test to assess 
if HV1 (positions: form 15978 to 16364), the 
intermediate region (positions: from 16365 to 72) and 
HV2 (positions: from 73 to 261) have similar 
proportions of heteroplasmic sites. The test showed that 
HV1 and HV2 are enriched in heteroplasmic sites (OR 
= 1.25; CI 95% 1.10-1.43 and OR = 1.66; CI 95% 1.43-
1.92 respectively) when compared to the intermediate 
region (OR = 0.24 CI 95% 0.18-0.32). Unsupervised 
hierarchical clustering was also performed to evaluate 
the distance between individuals (considering minor 
allele frequency); CENT, CO and ONLL individuals did 
not cluster according to group (Figure 1S). 
 
Since heteroplasmies occur preferentially at positions 
with high mutation rate [31, 32] we explored the 
correlation between the incidence of heteroplasmy and 
mutation rates (MR) in our cohort. Mean MR was first 
calculated considering all positions sequenced in this 
study (853 bp) and then considering all heteroplasmic 
sites (Table 1). Similarly we calculated the average MR 
in HV1, HV2 and the intermediate region considering 
all sites and then selecting only the heteroplasmic 
positions for each region.  
 
In order to combine information on both the incidence 
and the level of heteroplasmy, each position was plotted 
according to the number of heteroplasmic events and 
the mean heteroplasmy level in each group (Figure 2). 
The plot consists of four regions: the upper left quarter 
shows positions that occur frequently and are 
characterized by a low level of heteroplasmy; the upper 
right quarter is empty, indicating that there are no 
positions characterized by both a high frequency and a 
high level of heteroplasmy; the lower right quarter 
includes positions with high heteroplasmy levels but 
that occur in only a few individuals; and the lower left 
quarter includes most of the positions, which occur in 
only a few individuals and with a low heteroplasmy 
level.  
 
Pearson’s correlation between the number of 
occurrences in CENT, CO and ONLL and the MR of 
each position was calculated (r CENT = 0.43, p value 
CENT = 1.012*10-6; r CO = 0.46, p value CO = 
1.51*10-7; r ONLL = 0.47, p value ONLL = 5.442*10-8 
respectively).  
 
We then compared heteroplasmy levels in CO and 
ONLL and ANOVA was performed to determine if the 
level of heteroplasmy at each position differs between 
Figure 1. Overview of heteroplasmy pattern in the 853
bp region considered. Heteroplasmic positions are indicated
with different  colors  according  to  the  level of heteroplasmy.
Positions  are  reported  on  the  y‐axis  while  individuals  are
reported on the x axis. 
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the two groups. Only position 16131 showed a weak 
significant nominal p values  (p value = 0.0062)  that  is  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
not significant when corrected for multiple test 
comparisons (Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Heteroplasmic positions in the 3 groups. Heteroplasmic positions plotted according to
mean heteroplasmy level and number of occurrences in CENT (A), CO (B) and ONLL (C) respectively.  
Table  1.  Average  mutation  rate  calculated  in  all  sites  and  only  in 
heteroplasmic sites considering the entire region sequenced, HV1, HV2, 
and the intermediate region (from position 16365 to position 73).  
 
 
Average Mutation Rate 
All Sites Heteroplasmic sites 
Entire region (853bp) 3.6 15.9 * 
HV1 4.7 14.2 * 
HV2 6.2 30.9 * 
Intermediate region 1.6 6.4 
* p < 0.0001 (Mann Whitney test) 
Table 2. Significant results of the ANOVA considering the minor allele 
frequency site by site. 
 
mtDNA 
position p value Significant comparisons 
153 0.0299  CENT-ONLL  
204 0.047  CENT-ONLL  
16129 0.028 CENT-CO   
16131 0.025   CO-ONLL 
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We next compared each of the offspring groups (CO 
and ONLL) to centenarians (CENT) to assess whether 
heteroplasmy levels increase with age. Only positions 
153, 204 and 16129 showed weak significant nominal p 
values (< 0.05 in the ANOVA test) that are not 
significant when we corrected for multiple test 
comparisons (Table 2).  
 
To determine if heteroplasmy increases with age we 
compared the total number of heteroplasmic sites across 
the three groups by ANOVA; no significant differences 
among groups were detected (p value = 0.798). We 
tested for correlations between the age of all individuals 
(irrespective of group) and the heteroplasmy level for 
each site. Two positions showed a moderate trend with 
age: 204 (r = 0.20, p value = 0.06) and 16129 (r = 0.30, 
p value = 0.0054 ) (Figure 2S). In addition, the 
correlation between age and the number of 
heteroplasmic sites for each individual was not 
significant (r = 0.17, p value = 0.11). 
 
Heteroplasmy in centenarians and their offspring 
  
Total heteroplasmy analysis. One centenarian and one 
centenarian's offspring could not be considered in this 
analysis (for more details see Methods), therefore in the 
following analyses we considered 29 mother-offspring 
pairs. Total heteroplasmy was then calculated for each 
individual   (total  heteroplasmy  =  sum  of   minor  allele  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
frequencies at all heteroplasmic sites) to quantify the 
mutation load of the entire mtDNA genome. These total 
heteroplasmy values are significantly correlated between 
centenarians and their offspring (Figure 3A; r = 0.75, p = 
2.88*10-6). To further validate this result, the CENT and 
CO individuals were reshuffled 2000 times, matching 
centenarians with unrelated offspring, and the correlation 
values were calculated. This analysis (Figure 3B) 
indicates that the observed correlation between CENT 
and their true offspring in total heteroplasmy is indeed 
unlikely to arise by chance. In addition, correlation 
values of 2000 possible combinations of CENT-ONLL 
and CO-ONLL are centered around zero (Figure 3B), 
consistent with an absence of any correlation in these 
comparisons. This analysis suggests that the total 
heteroplasmy values are maintained in families. 
 
Number of heteroplasmic sites. Centenarians and their 
offspring were then analyzed to assess shared 
heteroplasmic positions. The total number of positions 
shared by CENT and CO over 29 families is 130 (total 
number of common sites, TNCS); the results for each 
family are depicted schematically in Figure 4A, and a 
detailed list is provided in Table 2S. The TNCS was 
recalculated 2000 times, matching randomly subjects of 
each the two groups (Figure 4B). This analysis indicates 
that more TNCS are shared by centenarians and their 
offspring than between any other combinations of 
individuals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Total heteroplasmy  in  centenarians and  their offspring and  reshuffling analysis.  (A)  Total
heteroplasmy  in centenarians and  their offspring. White bars: centenarians; black bars: matched offspring. The
dashed  line  and  shading  show  the  mean  level  and  standard  deviation  of  total  heteroplasmy  in  ONLL.  (B)
Frequency distribution of correlation values based on 2000 reshufflings of total heteroplasmy values for CENT and
unrelated CO, CENT and ONLL and CO and ONLL. Mean and standard deviation of the distribution is reported. The
black star indicates the observed correlation value matching each centenarian with her own offspring. 
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Figure 4. The number of common heteroplasmic sites shared by CENT and CO and frequency distributions
of TNCS in all the reshuffled pairs. (A) The white bar indicates the number of heteroplasmic position in CENT, the
black bar indicates the number of heteroplasmic sites in CO. CENT and CO are here matched according to consanguinity
(x‐axis).  The  red  bar  shows  the  number  of  shared  heteroplasmic  sites  in  each  parent‐offspring  pair.  (B)  Frequency
distributions of TNCS in all the reshuffled pairs considering CENT and unrelated CO, CENT and ONLL, and CO and ONLL.
Black star = total number of common heteroplasmic sites matching centenarians with their own offspring. 
Figure 5. CENT  and CO distances of positions  that  showed
heteroplasmy  in  both  individuals.  Distance  values  were
calculated  as  the  ratio  between  the  absolute  difference  between
CENT and CO MAF and the higher MAF value of the two (expressed
as percentage). (A) Heteroplasmy distances plotted for each position
and  colored according  to  the  scale bar on  the  right.  (B) Frequency
distribution of the distance values.  
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Heteroplasmy analysis site by site. To evaluate the 
similarity in minor allele frequencies (MAF) across 
sites between each CENT mother and her offspring, a 
site-by-site distance was calculated (Figure 3S). The 
ratio between the absolute difference in MAF 
(abs[CENT-CO]) and the highest MAF of the two was 
calculated as a measure of the “distance” between each 
CENT and CO (Figure 5A). Each pair shows private 
sites that are heteroplasmic in CENT and CO with 
variable values of concordance but different between 
pairs. Some positions, such as 146, 204 and 16129, are 
heteroplasmic in most pairs (public sites). The 
frequency distribution of all distance values is reported 
in Figure 5B; only positions that show heteroplasmy in 
both individuals were considered in this analysis. 
 
DISCUSSION 
 
To date, several studies have showed that hetero-
plasmies tend to accumulate during human aging in 
many tissues, such as brain, heart, skeletal muscles and 
blood [20, 27, 37-41], but there is still controversy 
regarding the cause of such age related accumulation of 
heteroplasmic mutations. The most recent hypothesis 
suggests that replication errors arise during life and 
accumulate by clonal expansion and genetic drift, 
placing the accumulation of ROS damage in the 
background [14, 42]. This scenario becomes even more 
intricate when we consider that even low-level 
heteroplasmies can be inherited [27]. Taking into 
account the high number of independent mtDNA 
copies, it is worthwhile to sum up the possible sources 
of mtDNA variability: (i) heteroplasmy derives from 
inherited variants and de novo mutations [20]; (ii) this 
variability originates prenatally, from the very first 
stages of cell divisions and it is modified subsequently 
during life by segregating events; and (iii) mother and 
offspring share similars pattern of somatic mtDNA 
variability.  
 
Given these assumptions we explored whether the 
inherited heteroplasmy profile is preserved in the 
elderly or if de novo mutations overcome the inherited 
variants. Moreover we assessed the correlation between 
heteroplasmy and longevity, and we focused on the 
identification of specific heteroplasmic profiles for 
centenarians, their offspring and offspring of non-long 
lived parents to highlight features linked to familial 
predisposition to longevity [9, 39, 43, 44]. Centenarian 
offspring have higher chances for healthy aging [5, 6, 
45] even when they share a similar lifestyle with the 
general population [46]. Moreover clinical [34] and 
molecular data [8-10] demonstrated that they are 
characterized by a better health status than offspring of 
non long lived parents. Applying next-generation 
sequencing to this cohort, we investigated human 
mtDNA heteroplasmy transmission and association with 
longevity. We obtained extremely high coverage 
(average 49334 fold per position) and replicates 
analysis demonstrates the possibility to detect very low 
levels of heteroplasmy (down to 0.2%).  
 
The main results of this paper indicate that low-level 
heteroplasmies in blood are detectable, transmitted and 
maintained within families until extreme age. Moreover 
we did not find any heteroplasmic variant associated 
with longevity and healthy aging but we identified an 
unique heteroplasmy profile for each family, resulting 
from a combination of total heteroplasmy level and 
specific heteroplasmic positions.  
 
Regarding the technological approach in the first 
analysis we considered triplicate samples to 
demonstrate the accuracy and reliability of the method 
used. We performed double strand validation that 
considerably reduces the impact of sequencing error 
[36] and then we used replicates to assess the level of 
sensitivity and specificity. Sequencing errors, assembly 
strategies, biased PCR amplification and stochastic 
effects are unlikely to produce false positives under our 
criteria for detecting heteroplasmy. The resulting data 
show that a small fraction of heteroplasmic sites could 
not be reproduced (possibly because they are false 
negative), but sites called as heteroplasmic are likely to 
be real mutations. Our results confirmed the possibility 
to detect with high accuracy a low level of mutation (< 
2% of minor allele frequency), as also shown in a recent 
study [27]. It is worthwhile to note that previous 
studies, with relatively high coverage, did not show the 
error rate, sensitivity and specificity and it is likely that 
these values are directly dependent on the mean 
coverage. From a technical point of view we can 
conclude that sequencing depth is very important to 
identify and to quantify low-level heteroplasmic 
variants with high accuracy.  
 
We analyzed heteroplasmies focusing on the non-
coding region (from position 15978 to position 261). 
We observed that HV1 and HV2 are enriched in 
heteroplasmic sites when compared to the intermediate 
region. We also observed that in our cohort 
heteroplasmies tend to occur in positions characterized 
by a high mutation rate. This phenomenon was 
described previously [31, 32] suggesting that mutation 
is the major driving force behind heteroplasmies and 
that subsequent drift to high frequencies in an individual 
can lead to polymorphisms among individuals [31]. 
  
We then analyzed heteroplasmy patterns in our groups 
(CENT, CO and ONLL). Comparing the minor allele 
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frequency between groups via ANOVA, the obtained p 
values were not significant, (when corrected for 
multiple test comparisons), indicating the overall 
absence of significant heteroplasmy differences 
between groups. We did not find any differences also in 
the number of heteroplasmic sites between groups. We 
also analyzed the heteroplasmic variation across ages 
and we find only two sites that showed a modest 
correlation with age, positions 204 and 16129. A 
previous study that measured heteroplasmies in blood of 
individuals with different ages (0-60 yrs) found several 
heteroplasmic sites whose frequency correlates with age 
[20]. However even if we did not observe a clear pattern 
of age-related heteroplasmy accumulation, we cannot 
exclude that heteroplasmies accumulate during life 
because of the limited age range here considered 
(average age = 80.7 ± 15.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regarding the heteroplasmy pattern in families (mother-
offspring pairs), we found a clear signature of 
heteroplasmy inheritance in consideration of the 
centenarians-offspring concordance of both total 
heteroplasmies levels and of the mutated loci 
(heteroplasmy profile). This concordance was tested 
and confirmed by reshuffling analyses. Our data suggest 
that families share a common core of heteroplasmic 
sites that could be divided, according to their frequency 
in the cohort, into (i) public heteroplasmic positions that 
all parent-offspring couples shared (such as positions 
146, 204 and 16129) and (ii) private heteroplasmic sites 
that are common to only one or few families. Figure 6 
simplifies the heteroplasmic profiles we observed. We 
note that public heteroplasmic positions may reflect 
recurrent mutations as well as inherited hetreroplasmies 
[47]. These data are consistent with previous studies 
[17, 19] that found that a high concordance of 
heteroplasmy can be observed within families whose 
ages are shifted toward the last decades of life. 
However, the use of DHPLC (Denaturating High 
Performance Liquid Chromatography) in these previous 
studies did not allow the precise identification of 
heteroplasmic positions, as we did in the present study. 
Taken together the groups comparison and the familial 
analysis suggested that the heteroplasmy profile is a 
partially inherited individual characteristic.  
 
In conclusion many findings showed that exceptional 
longevity runs in families [1-4], but to date genetic 
studies on longevity and healthy aging have shown that 
centenarians carry the same numbers of GWAS-
identified common disease variants of ordinary people. 
In this context rare and private variants seem to have a 
relevant role in buffering the presence of other variants 
[48]. Thus we reasoned that the long-term heteroplasmy 
inheritance, that we demonstrate in the present study, is 
a potential source of rare variants that could play a role 
in determining healthy aging and longevity. The issue is 
to demonstrate the effect of these patterns on longevity, 
but this limitation is also valid for all the rare variants 
that can be described in whole genome. 
 
Other studies had already shown that the description of 
heteroplasmy is complicated by the characteristics of 
the blood itself such as the origin of the cells, the rapid 
turnover and the high number of different cell types 
[27]. We can speculate that at the somatic level rare 
heteroplasmic mutations can expand or be lost, through 
segregation events. Thus in a given anatomical region 
such as muscle or brain, heteroplasmies expansion 
occurs and remains localized in the same physical area 
[37]. Similarly this may occur during hematopoietic cell 
expansion in the bone marrow but the local 
heteroplasmy profiles are diluted when the new cells are 
released in the bloodstream. This implies that the 
heteroplasmic variants that we describe at low 
frequencies in blood are compatible with the high 
heteroplasmy level detected in other tissues (such as 
skeletal muscle and brain). It is likely that low level 
heteroplasmies have the potential to increase in 
frequency in critical tissues. Further studies considering 
different tissues of the same individual are needed to 
experimentally test this last consideration and to 
differentiate between acquired or inherited 
heteroplasmic mutations [24]. Indeed the exact 
 
Figure  6.  Model  of  the  mechanism  of  heteroplasmic
patterns in blood of long‐lived families. The number and
thickness  of  each  rectangle  represents  the  different
heteroplasmic level of each site, while the sum of all numbers
represents the total heteroplasmy value. Total heteroplasmy is
more similar within parents‐offspring pairs than between pairs
(CENT1 = 13 and CO1 = 14 while CENT2 = 17 and CO2 = 16).
Each  family  shares  a  common  core  of  heteroplasmic  sites
(here marked  in blue). This core  is composed of two types of
heteroplasmic  sites  (i)  public  heteroplasmic  positions  that  all
pairs  share  (here  marked  with  a  yellow  shadow)  and  (ii)
private heteroplasmic sites that characterize each family.  
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mechanism of inheritance as well as the origin of these 
heteroplasmic events are not completely understood, 
and the forces that shape heteroplasmies are under study 
[29, 49, 50]. Evidence from mice and humans suggests 
that nonsynonymous protein-coding heteroplasmies are 
subject to negative selection during growth and aging 
[31, 50]. A further critical issue concerns the minimum 
percentage of detectable mutations compatible with the 
size of the bottleneck that can be observed in blood and 
the exact timing of these mutations. Many studies have 
attempted to estimate the size of the bottleneck [29, 51], 
but more data are necessary to answer, at least on a 
theoretical level, this question.  
 
Finally these findings add significantly to our 
knowledge of mechanisms of heteroplasmy 
transmission and association with longevity, and 
indicate that heteroplasmic events are an interesting 
candidate for further genetic studies on familial 
longevity. Our results are compatible with recent 
evidence that shows that the transmission of low levels 
of mtDNA heteroplasmy seems to influence offspring 
aging [37, 52], and by focussing on long-lived 
individuals and their offspring, adds a new perspective 
on the contribution of low level heteroplasmies to the 
genetics of longevity. 
 
METHODS 
 
Sample collection. A total of 90 Italians were 
sequenced, including 31 female centenarians (average 
age 101.6 ± 2.8), 31 female offspring of these 
centenarians (average age 69.9 ± 6.6) and 28 female 
offspring whose parents both died before the average 
life expectancy (average age 70.7 ± 4.8). The samples 
here analyzed were selected according to a stringent 
demographic strategy: centenarians and offspring were 
recruited with the constraint that also the other parent 
was long lived (born in the same birth cohort 1900-1908 
and died at an age > 77 years). Offspring of non-long 
lived parents were matched with centenarian offspring, 
with both parents born between 1900 and 1908 but 
dying before the average life expectancy calculated at 
15 years of age (67 years if male and 72 years if female) 
by the Italian mortality tables (see 
http://www.mortality.org/ - Max Planck Institute for 
Demography, Rostock, Germany). Both groups were 
comparable with respect to age but very different if we 
considered the probability of becoming long lived [34]. 
Indeed recent studies suggest that the offspring of 
centenarians have a significant survival advantage, a 
higher probability to become long-lived and a lower risk 
for age-related diseases (such as cardiovascular 
diseases) compared to control subjects [4, 5, 45, 53]. 
Individuals with cancer at the time of the interview or 
treated with immunosuppressive or anticoagulant 
therapies were excluded from this study.  
 
Genomic DNA was extracted from whole blood using 
the Wizard genomic DNA purification kit (PROMEGA, 
Madison WI, USA) according to the manufacturer’s 
standard protocols. 
 
Ethics statement. The study protocol was approved by 
the Ethical Committee of the Sant’Orsola - Malpighi 
University Hospital (Bologna, Italy). After obtaining 
written informed consent, a standard structured 
questionnaire was administered to collect information 
regarding health status. Past and current diseases were 
checked against the medical documentation. 
 
DNA amplification and sequencing. DNA was first 
quantified by NanoDrop (NanoDrop Products Thermo 
Scientific Wilmington, DE) and an 853 bp segment of 
the mtDNA control region (from position 15978 to 261, 
including HV1 and part of HV2) was amplified. We 
focus on this region because heteroplasmies occur 
preferentially at positions with high mutation rates, like 
the mtDNA control region, and also because this region 
was already analyzed in previous studies on longevity. 
Primers were selected after in silico PCR to avoid 
amplification of unspecific nuclear DNA (L15997, 
CACCATTAGCACCCAAAGCT and H242, 
GCTGTGCAGACATTCAATTG). Amplified 
fragments were then sheared using the Bioruptor UCD-
200 (Diagenode) to approximately 200 – 800 bps. 
Libraries were prepared following a previously 
published protocol [54]. Two different indexes were 
attached to individual samples by performing a PCR 
amplification using the Herculase Mastermix (NEB). 
Samples were pooled in equimolar ratios after indexing 
and subsequently sequenced in one lane of the Illumina 
GAIIx (Solexa) sequencer, with a paired-end run of 
76+7 cycles, which yielded ~45 million paired-end 
reads.  
 
Assembly and data analysis. Base quality scores were 
recalibrated by the IBIS software using spiked-in PhiX 
sequencing data as the training dataset [55]. The adaptor 
sequence was trimmed and paired-end reads were 
merged if they were completely overlapped. Reads were 
mapped to the revised Cambridge reference sequence 
(GenBank ID:NC_012920, the starting point was 
changed to 15978 on the original sequence) using BWA 
[56]; reads with mapping quality score lower than 20 
and bases with quality score lower than 20 were 
excluded from the analysis, resulting in a final average 
coverage of 49334-fold per position in the target region. 
Samples that showed low coverage (mean coverage 
<10000) were excluded from the analysis of 
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heteroplasmy. Mean coverage distribution is reported in 
Figure 4S. Initially 31 CENT, 31 CO and 28 ONLL 
were sequenced but 1 CENT and 1 unrelated CO did not 
pass the quality control (Figure 4S) and consequently 
for the centenarians-offspring paired analysis there were 
29 CENT-CO pairs. Analyses were performed using R 
version 3.0.1. We called heteroplasmic sites according 
to minor allele frequency even if some heteroplasmic 
positions were then filtered out after double strand 
validation, as described previously [36]. 
 
The heteroplasmy detection threshold was set to 0.2%; 
the sensitivity and specificity of detected heteroplasmies 
were determined from 12 samples (one sample was 
discarded after quality filters) whose levels of 
heteroplasmy were measured using 3 different PCR 
products. The concordance was used as a parameter of 
reliability in the definition of heteroplasmic sites. For 
this analysis we create a confusion matrix using the 
caret packages and in this calculation a site was defined 
as “true heteroplasmic” if heteroplasmy was supported 
by at least 2 of the 3 observations [57-59]. The 
overview of heteroplasmy pattern (Figure 1) was 
perfomed using the lattice graphics package [60]. The 
mutation rate was estimated for each site from Phylotree 
[61]. Unsupervised hierarchical clustering was 
performed on the basis of the complete linkage method, 
using the function heatmap.2 in the gplots package. 
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Figure  1S.  Unsupervised  hierarchical  clustering  using
heteroplasmy levels. CENT: gray bar; CO: black bar; ONLL: green bar.  
Figure 2S. Boxplots of minor allele frequencies across 3 different age classes. Age < 72 yrs;
N=31, age range: 72‐86 yrs; N=26 and age > 86 yrs; N=29 respectively for two heteroplasmic sites 
 
 
Figure 3S. Heatplot of minor  allele  frequencies,  colored  according  to  the  scale
bar, for each mother‐offspring pair. Rows are positions and columns are individuals. 
  
www.impactaging.com                   466                                           AGING, June 2014, Vol. 6 No.6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2S. List of common heteroplasmic positions  in each CENT‐
CO pair. Private heteroplasmic sites (i.e., not shared by other families) are
marked in gray.  
Figure 4S. Mean coverage distribution. Two samples with low
coverage (indicated in red) were excluded from the analyses.  
Table  1S.  Number  of  occurences  observed  for  each
possible outcome  in  the  replicates.  TP:  true  positives,  FP:
false positives, FN: false negatives, TN: true negatives.  
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The last 30 years of research greatly contributed to shed light on the role of mitochondrial DNA (mtDNA) vari-
ability in aging, although contrasting results have been reported, mainly due to bias regarding the population
size and stratiﬁcation, and to the use of analysis methods (haplogroup classiﬁcation) that resulted to be not suf-
ﬁciently adequate to grasp the complexity of the phenomenon.
A 5-years European study (theGEHAEUproject) collected and analyzed data onmtDNA variability on an unprec-
edented number of long-living subjects (enriched for longevity genes) and a comparable number of controls
(matched for gender and ethnicity) in Europe. This very large study allowed a reappraisal of the role of both
the inherited and the somatic mtDNA variability in aging, as an association with longevity emerged only when
mtDNA variants in OXPHOS complexes co-occurred. Moreover, the availability of data from both nuclear andmi-
tochondrial genomes on a large number of subjects paves the way for an evaluation at a very large scale of the
epistatic interactions at a higher level of complexity.
This scenario is expected to be evenmore clariﬁed in the next future with the use of next generation sequencing
(NGS) techniques, which are becoming applicable to evaluate mtDNA variability and, then, new mathematical/
bioinformatic analysis methods are urgently needed. Recent advances of association studies on age-related dis-
eases andmtDNA variability will also be discussed in this review, taking into account the bias hidden by popula-
tion stratiﬁcation. Finally, very recent ﬁndings in terms of mtDNA heteroplasmy (i.e. the coexistence of wild type
andmutated copies ofmtDNA) and aging as well asmitochondrial epigeneticmechanismswill also be discussed.
© 2014 Elsevier Inc. All rights reserved.
1. Introduction
In the past 30 years, a number of evidences have delineated the cen-
tral role of mitochondria in aging (Capri et al., 2013; Salvioli et al., 2008;
Wallace, 2005) and todayGWAS studies on age-related diseases, such as
type 2 diabetes and obesity, have identiﬁed some nuclear loci implicat-
ed in mitochondrial bioenergetics (PPARγ, PGC-1α, UCPs), providing
further support to this idea (Jia et al., 2010; Manning et al., 2012;
Morris et al., 2012; Wallace, 2013).
Mitochondria are involved in energy production (oxidative phos-
phorylation, OXPHOS) and in various cellular processes such as heat
production, lipid metabolism, apoptosis regulation, and cellular differ-
entiation. They are also responsible for the production and regulation
of the most important byproduct of the cellular metabolism, reactive
oxygen species (ROS), which have been posed as the pillar of the free
radical theory of aging (Harman, 1957; for a review see Passarino
et al., 2010; Wallace, 2010). A critical analysis of the history of this the-
ory is not the purpose of this review and it has been recently well de-
scribed elsewhere (Lagouge and Larsson, 2013). However the latest
theories and hypotheses state that ROS generation is not a cause of
aging, but rather a consequence of age-dependent damage. In fact, a se-
ries of experimental results suggests that ROS could be more likely
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“mediators” of the stress response to age-dependent damage acting as
signaling molecules, by an adaptive response commonly deﬁned
“mitohormesis” (Hekimi et al., 2011; Lagouge and Larsson, 2013;
Ristow and Zarse, 2010; Tapia, 2006). Although there is an open debate
on this issue, it is well known that mtDNA mutations accumulate with
age and recent ﬁndings show that this accumulation could be due to er-
rors in replication machinery or to unrepaired damages, placing the ac-
cumulation of damage by ROS in the background. Two studies support
this hypothesis: (1) a study by Trifunovic et al. (2004) showed that de-
fects in the proofreading function ofmtDNApolymerase (polγ) lead to a
high accumulation of mtDNA mutations; (2) more recently, a study by
Kennedy et al. (2013) showed that in human brain the mtDNA muta-
tions during aging are comprised predominantly of transition muta-
tions, consistent with misincorporation by polγ or deamination of
cytidine and adenosine as the primary mutagenic events in mtDNA.
In this review, we will focus on the results obtained by genotyping
the mtDNA in an unprecedented number of samples of long living
(N90 years) sibpairs, and a comparable number of controls, recruited
in the frame of the GEHA (Genetics of Healthy Aging) European Project
(Skytthe et al., 2011). This very large study contributed to a reappraisal
of the role of both the inherited (Raule et al., 2013) and the somatic
mtDNA variability (Rose et al., 2010) in aging, and paves the way for
an evaluation at a very large scale of the epistatic interactions between
different mtDNA loci as well as between mitochondrial and nuclear ge-
nomes. A focus on next generation sequencing (NGS) techniques ap-
plied to mitochondrial variability evaluation and, then, on the need for
new mathematical/bioinformatic methods will also be discussed. Re-
cent advances of association studies on age-related diseases and
mtDNA variability will also be discussed, taking into account the bias
hidden by population stratiﬁcation. Finally, very recent ﬁndings in
terms of mtDNA heteroplasmy (i.e. the coexistence of wild type and
mutated copies ofmtDNA) and aging aswell asmitochondrial epigenet-
ic mechanisms will also be reviewed.
2. Inherited and somaticmtDNAmutations in aging: the GEHA study
It is worthwhile to note that various components contribute to
mtDNA variability in aging and longevity. In the ﬁrst section of the re-
view we will try to elucidate (1) how certain variants present at high
frequency or low frequency in individuals are inherited in human pop-
ulations and how these are associated positively or negatively with
aging (2) the link between aging and somatic variants and (3) the role
played by combinations of these variants (somatic and inherited) in
healthy aging.
2.1. Inherited mtDNA variability
Most of the about 1500 proteins shaping the biology ofmitochondria
are encoded by the nuclear genome (nDNA), but 13 subunits of the
OXPHOS are encoded by the mtDNA. Thus, many studies conducted in
model organisms and in humans have addressed the effects of nuclear
and mtDNA variability (and of the interaction between the two ge-
nomes) on mitochondrial functioning and aging (Greaves and
Turnbull, 2009; for a review see Lagouge and Larsson, 2013). In particu-
lar in humans, the role played by the mtDNA common variability in
modulating the processes inﬂuenced by mitochondrial activity, and
their effects on degenerative diseases and aging, has been addressed
bymany studies that have been carried out mainly by taking advantage
of themtDNA inherited variants (Bellizzi et al., 2006; Brown et al., 1997;
De Benedictis et al., 1999; Ivanova et al., 1998;Montiel-Sosa et al., 2006;
Niemi et al., 2003; Rose et al., 2002; Ross et al., 2001; Ruiz-Pesini et al.,
2000; van der Walt et al., 2003; Santoro et al., 2006; Wallace, 2005).
An association of haplogroup J with longevity has been reported for
different European populations, being this haplogroup more frequent
in centenarians than in ethnically matched younger controls in North-
ern Italy (De Benedictis et al., 1999), Ireland (Ross et al., 2001), and
Finland (Niemi et al., 2003). Recently, cells with mtDNA molecules be-
longing to haplogroup J were found to produce less ATP and less ROS
than cells with different mtDNA molecules (Bellizzi et al., 2012). Inter-
estingly, haplogroup J was also reported to be strongly associated with
Leber's HereditaryOptic Neuropathy (LHON), increasing the penetrance
of speciﬁc mutations that are signiﬁcantly less harmful when occurring
in mtDNAmolecules of different haplogroups (Brown et al., 1997; Man
et al., 2004; Torroni et al., 1997). Therefore, it seems that the mutations
found in the haplogroup J (laying in the genes for subunits of OXPHOS
complex I), put the cell in a situation of instability, where further simul-
taneous mutations can determine a disease (such as LHON) or, on the
contrary, healthy aging (Rose et al., 2001).
In agreement with this hypothesis, it has been reported that the
Asian haplogroup D (characterized as haplogroup J by mutations affect-
ing complex I) is overrepresented in Japanese centenarians (Tanaka
et al., 1998, 2000). However, these results were not conﬁrmed when
the studies were replicated in other geographic areas (Collerton et al.,
2013; Dato et al., 2004; Pinós et al., 2012), suggesting not only that
the possible effect of mtDNA on longevity might be population-
speciﬁc, but also that the interaction with the nuclear genetic back-
ground can hide or minimize it. If this should be the case, it is likely
that the association between mtDNA variability and longevity can
reach statistical signiﬁcance only when a very large number of samples
is analyzed. The GEHA project, studying over 2200 subjects older than
90 years coming from different European populations and a similar
number of younger controlsmatched for gender and geographic origins,
allowed us to determine that recurrent or sporadic mutations accumu-
lated in speciﬁc genes, not detected by haplogroup analysis, may
inﬂuence longevity. These ﬁndings derived from the haplogroup classi-
ﬁcation (through D-loop sequencing) for nearly 3000 samples and from
the complete sequencing of other 1200 samples [650 ultra nonagenar-
ians (90+) and a comparable number of controls, coming from
Denmark, Finland, Southern Italy and Greece]. The analysis of a large
number of complete mtDNA sequences from European 90+ and geo-
graphically matched younger controls collected in the frame of GEHA,
has allowed us to shed light on this subject (Raule et al., 2013). Indeed,
the analysis of complete sequences, bymeans of speciﬁc analyses based
on evaluating the burden of non-synonymous mutations in different
mtDNA regions (Wu et al., 2011), made possible to appreciate the ag-
gregate effects of rare or repeated mutations unaccounted for in
haplogroup analysis. More speciﬁcally, the mutations falling on
mtDNAmolecules of long lived subjects have been aggregated and com-
paredwith those harbored bymtDNAmolecules of younger subjects, by
means of SKAT, a supervised and ﬂexible regression method to test for
the association between rare variants in a gene or genetic region with
a continuous/dichotomous trait (Wu et al., 2011). This analysis allowed
us to emphasize the effects ofmutations (including raremutations) fall-
ing in a speciﬁc region, as each of thosemutations can have an effect (in
most cases a small effect) on longevity but none of them can reach the
statistical signiﬁcance in a case control comparison. This has pointed
out that the burden of non-signiﬁcant mutations in mtDNA genes cod-
ing for subunits of OXPHOS is different in 90+ subjects and controls
for genes of mitochondrial subunits of the OXPHOS complexes I, III
and V. In particular, it has emerged that the presence of mutations on
complex I may be beneﬁcial for longevity, while the co-occurrence of
mutations on both complexes I and III or on both I and V might lower
the individual's chances to reach longevity. As haplogroup J is character-
ized bymutations in complex I genes, this result might explain previous
contrasting ﬁndings emerged from association studies on J haplogroup
and longevity, as discussed above. Indeed, it can be hypothesized
that populations where no association between haplogroup J and lon-
gevity was found can be characterized by higher frequency of non-
synonymous mutations in complexes III and V. This is indeed the case
for Danish and Southern European populations (Raule et al., 2013). It
is worth mentioning that the analysis of mtDNA sequences in 90+
and controls has also shown that many mtDNA mutations associated
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with degenerative diseases are as frequent in 90+ as in younger con-
trols, supporting the idea that the effect of mtDNA mutations is greatly
inﬂuenced by the individual-speciﬁc genetic background (nuclear ge-
nome and combination of mtDNA mutations), as well as by stochastic
events (Moilanen et al., 2003; Rose et al., 2001; Wallace, 2010). On the
whole, the analysis of mtDNA sequences in GEHA samples has shown
that the effect of mtDNA variability on longevity is mainly due to the
co-occurrence of rare, privatemutationswhich cannot be fully analyzed
by haplogroup analysis, but which cannot be analyzed one by one ei-
ther. An example of this variability is reported in Fig. 1. Only the aggre-
gate analysis of themutations falling in a givenmtDNA regionmay help
to understand the effect of these mutations on longevity. It is also
important to say that the effect of these mutations is quite small and
then only a very large sample can give the statistical power to under-
stand the effects of these mutations.
Very recently, a study showed that cybrids carrying a mtDNA be-
longing to J haplogroup have signiﬁcantly altered the expression of
eight nuclear genes of the alternative complement, inﬂammation and
apoptosis pathways with respect to cybrids carrying haplogroup H
(Kenney et al., 2013, 2014). This result, combinedwith the reported dif-
ferences in ATP and lactate production between J and H haplogroup
cybrids, suggests that J haplogroup mtDNA variants within cells can
affect not only energy pathways but also other pathways not directly re-
lated to mitochondrial metabolism such as complement activation, in-
ﬂammation and apoptosis. Furthermore, these data suggest that
mitochondria can affect a number of cellular functions previously
thought to be independent from them (Kenney et al., 2014).
The study of heteroplasmy is a challenge, as heteroplasmy patterns
observed in adulthood are a mixture of both inherited and somatic
mtDNAmutations,making themhard to detect because of the relatively
low frequencies of eachmutation and in consideration that the different
tissues can harbor (and produce) different patterns of mutations as ex-
empliﬁed in Fig. 2 (Wallace, 2010). Regarding inherited mutations, it
should also be considered that a low level of heteroplasmy can be
inherited, meaning that some variants can be found in heteroplasmic
state in both mother and child (Payne et al., 2013). This could favor fur-
ther accumulation of heteroplasmy with age.
2.2. Somatic mtDNA variability
Many studies (Corral-Debrinski et al., 1992; Michikawa et al., 1999;
Wang et al., 2001) show an accumulation of heteroplasmy in aging in
different tissues (such as muscle and brain). A study of Sondheimer
et al. (2011) analyzed the variations of heteroplasmy in 138 sites on a
cohort of more than 2400 subjects of different ages (from 0 to
60 years old). This study identiﬁes two types of sites, some tend to be-
come more heteroplasmic with aging, and others on the contrary dis-
play a loss of variability and thus an increase of homoplasmy. This is
the ﬁrst study that considers a wide range of ages and highlights that
the level of heteroplasmy increases with age, and not only with
senescence.
Some studies, such as the above mentioned GEHA EU project, have
linked heteroplasmy to healthy aging and longevity (Castrì et al.,
2009; Rose et al., 2007, 2010). Previous studies had shown a high inci-
dence of the C150T transition in leukocytes from centenarians, thus hy-
pothesizing a remodeling of mtDNA replication origin associated with
this mutation (Niemi et al., 2005; Zhang et al., 2003). The GEHA EU Pro-
ject results showed that the statistically signiﬁcant high incidence of
DLoop somatic point mutations, and the consequent heteroplasmy, in
themtDNA control region of long-lived subjects was not only restricted
to the C150T transition but also affected additional positions correlated
with mtDNA replication as well as the C150T transition (Rose et al.,
2007, 2010). Moreover, these studies, carried out on sibships or on par-
ent offspring groups, were allowed by permutation analysis to ﬁnd out
that the levels of heteroplasmy at position 150 and at other Dloop posi-
tions are similar among relatives and correlate in parent–offspring pairs,
thus suggesting that they are modulated by a genetic component (Rose
et al., 2007, 2010).
Moreover recent studies showed that the frequency of heteroplasmic
variants may be different from one generation to another because of the
bottleneck that occurs duringpostnatal folliculogenesis (Wai et al., 2008)
and the somatic events that occur during life (Wallace, 2010;
Sondheimer et al., 2011). The transmission of mtDNA heteroplasmy
seems to be a central point in the study of aging. In fact, a recent study
(Ross et al., 2013) supports the notion that a combination of maternally
transmitted and somatic mtDNA mutations can lead to disorders (such
as Alzheimer's disease and Parkinson's disease). This study is very inter-
esting if combined with the innovative notion that even low level of
heteroplasmy can be inherited as previously mentioned.
It is important to note that the dynamic of accumulation and the type
of mutations seem to vary according to tissues and cell types. Moreover,
recent studies indicate that the response to a mitochondrial dysfunction
can be communicated to the nucleus via yet unidentiﬁed mediators and
propagated to the whole organism via one or more putative signaling
molecules indicated asmitokines (Nunnari and Suomalainen, 2012) cre-
ating a sort of crosstalk between mitochondrial genome of different tis-
sues and organs of the same individual.
2.3. New methodological insights into mtDNA-related studies
2.3.1. The “explosion” of complete mtDNA sequences
The signiﬁcant drop in costs and time commitment required to ob-
tain a complete mtDNA sequence caused a burst in the number of avail-
able samples in both private and public databases. Genbank (Benson
et al., 2013) currently hosts ~22,000 complete human mtDNA se-
quences, of which ~5000were published after 1st January 2013. This ac-
counts for about the 22% of thewhole database, whichwas deposited in
roughly last 12 months, with a submission rate that is way greater than
the one observed in the previous years. This allows researchers to lever-
age an unprecedented number of samples that can be exploited inmany
different ways, for example to strengthen studies somewhat missing
statistical power, or to assemble cohorts that no real project could
even imagine to have. Such methods, however, must be preceded by a
careful inspection for errors, both in the sequences themselves and in
their annotation (Yao et al., 2009).
Often not all the biological questions can ﬁnd an answer looking in-
side the database of previously published data. For such cases, sequenc-
ing of new samples is needed, and in these days this can be achieve in
two ways: using NGS to speciﬁcally target mtDNA (Sosa et al., 2012)
or extracting off-target reads obtained in experiments targeting other
Fig. 1. Common (haplogroup) and privatemutations in a population. Each individual is char-
acterized by (i) variants that deﬁne the haplogroup –here marked in black – and (ii) private
variants, that are rare in the population – here marked in red.
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molecules (i.e. whole genome sequencing, exome sequencing). The lat-
ter approach, ﬁrst suggested by Picardi and Pesole (2012), is now rou-
tinely adopted in the ﬁeld: obtained coverage level allows to easily
call variants, albeit a precise estimation of low heteroplasmies is out of
reach (Sosa et al., 2012). Fictitious detection of low percentage
heteroplasmies may also be caused by NUMTs (Hazkani-Covo et al.,
2010; Li et al., 2012) that must be ﬁltered out to obtain high-quality re-
sults. MitoSeek (Guo et al., 2013) represents the best answer to this
problem to date.
2.3.2. Variants calling and annotation
Independently from the pipeline or software used to obtain them,
sequences must be further analyzed to identify and annotate variants.
Specialized software called variant callers are used to detect mutations
from the aligned reads. The two most famous, freely accessible and
open source packages in the ﬁeld are GATK (DePristo et al., 2011;
McKenna et al., 2010) and SAM tools (Li et al., 2009). Identiﬁed variation
must then be extensively ﬁltered to reduce the number of candidate
variants (or genes) that may answer the biological question under in-
vestigation. mtDNA analysis thus encounters mainly the same issues
that a nuclear-based study has: researchersmust ﬁnd good data sources
(e.g. primary databases) for annotating variants, crunch them together
and leverage this augmented information to pull out from the plethora
ofmutationswhich detected only the handful of them that is relevant to
the problem.
Fortunately, much of the toolset and resources routinely adopted in
nuclear genomics can also be directly applied tomtDNA. dbSNP (Sherry
et al., 2001) is the NCBI-provided database which hosts the known
human (and non-human) variability, which hosts 2000mtDNA variants
in the latest release. OMIM (Online Mendelian Inheritance in Man,
Cusick-Nathans Institute of Genetic Medicine, Johns Hopkins Universi-
ty) represents the most widely recognized source about manually
curated information regarding mutations causing human diseases.
Mitochondrial-focused databases, such as MITOMAP (Ruiz-Pesini
et al., 2007) ormtDB (Ingman and Gyllensten, 2006) indeed exist, how-
ever they may be difﬁcult to fully exploit programmatically due to the
lack of an API-based querying system. Independent on the source used
to obtain the raw annotations, software such as ANNOVAR (Wang
et al., 2010) or SnpEff (Cingolani et al., 2012) can help in disentangling
the problem of merging all this information together in a single place
and use this new, combined database to provide an efﬁcient and as
much comprehensive annotation as possible to the mutations under
analysis.
2.3.3. Statistical methods
Relating the mutation on the mtDNA to the aging process requires
some carefulness, as the ideal analysis would be a longitudinal study
that correlates the survival time to the presence of mutations. Being
this kind of study impractical for the long time and costs involved, one
is forced to used transversal studies in a study-control setting. This
kind of analysis is performedwith a logistic regression, linking the pres-
ence of SNPs to the longevity of the individual via a regression of the log
of the odds of being long-lived. This approach is as powerful as danger-
ous, as several confounding effect should be taken into consideration.
First of all, this classiﬁcation problem suffers from the base rate fallacy,
where trying to identify a category (long-lived versus normal) can in-
troduce a bias in the power of each regressor if one of the two categories
is far less common than the other (Pepe et al., 2004).
Fig. 2. Different scenarios of mtDNA heteroplasmy. One heteroplasmic mutation can be somatic or inherited – depending on the cell/tissue in which it originates. Somatic variants are
marked in green while inherited variants are marked in red.
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Issues may also arise from the strategy applied to study single SNPs:
assigning an odd ratio to each of them and selecting the most relevant
one on the basis of this value (Gail, 2008) is known to be a method
prone to selection of non-relevant SNP. On the other side, as the aging
process is probably regulated slightly by several interacting factors,
the little amount of information can be easily confounded by the huge
amount of different features tested, especially given the typically small
dimension of the sample (from a statistical point of view) (Greenland,
2000; Marchini et al., 2005; Tranah, 2011). This problem is especially
relevant for the interaction between SNPs, as the number of possible in-
teractions grows quadratically with the number of mutations under
study. Additionally, the small number of patients involved can also
lead to an overestimation of the correlation betweenmutations, forcing
a re-evaluation of the estimated risk factors.
Several methods are available to select the relevant set of SNPs on
which performing the statistical analysis for the prediction, each
exploiting various strategies to select a plausible optimal subset of
SNPs (Chen et al., 2013). These subsets are explored employing different
search strategies and the most promising one are selected, typically
using an associated based scoring (Chuang et al., 2013; Piriyapongsa
et al., 2012; Zhang and Liu, 2007). To help this selection process and cor-
rect for spurious observation previous biological knowledge can be
injected into the statistical analysis, for example via interaction maps
and pathway analysis (Hua et al., 2012; Jamshidi and Palsson, 2006;
Liu et al., 2012). This is especially helpful in the interaction studies
with the nuclear genome, where the number of possible interactions
would otherwise explode. Other selection methods are obviously avail-
able, as for example the ﬂux balance analysis which can be useful to
infer how sensible a metabolic pathway is to changes in the structure
or amount of a protein (Orth et al., 2010). This allows to consider not
only the statistical relevance but also the biological one, due to the dif-
ferent non-linearity of the network kinetic.
2.3.4. The missing bricks
mtDNA analysis can adopt the nuclear genome toolbox for its own
needs, but these tools do not allow takingmtDNApeculiarities into con-
sideration (i.e. heteroplasmy) in the analysis. Thus, a new generation of
dedicated algorithms is needed to successfully investigate the mito-
chondrial genome. In the last years this gap progressively started to
close with the release of a series of algorithms mainly focused on the
haplogrouping process and, only in part, on the identiﬁcation and anno-
tation of the variability contained in the submitted samples. Successful
examples in this ﬁeld are MITOMASTER (Brandon et al., 2009),
HaploGrep (Kloss-Brandstätter et al., 2011), HaploFind (Vianello et al.,
2013) and HmtDB (Rubino et al., 2012). Nonetheless, these applications
usually answer only to the ﬁrst part of the problem: promising
indentiﬁed mutations must then be analyzed to identify statistical sig-
niﬁcance with the phenotype under investigation. This probably repre-
sents the most “desert” area in the mitochondrial genome ﬁeld: de-
novo algorithms, or even re-implementations of nuclear-derived ones,
which analyze the mtDNA data in innovative ways, going further
down the road of identifying the processes or phenotypes where mito-
chondria have a role.
3. Age-related diseases and mtDNA
Defects of OXPHOS compromising mitochondrial functionality are
indeed key players in the aging process and in the pathophysiology of
different age-associated diseases (Wallace et al., 2010; Chinnery and
Hudson, 2013). The triggering factors of these damages are copious,
and alsomtDNA sequence variation could contribute to a shift of energy
balance facilitating aging and disease susceptibility (Wallace, 2005). Be-
sides aging, the involvement of mtDNAmutations and haplogroups has
also been investigated in several age-related neurodegenerative dis-
eases such as Parkinson's Disease (Hudson et al., 2013; Pyle et al.,
2005) and Alzheimer's disease (AD) (Lakatos et al., 2010; Santoro
et al., 2010), cardiovascular diseases (Strauss et al., 2013), cancer (Lam
et al., 2012; Weigl et al., 2013), metabolic diseases like type 2 diabetes
(T2D) (Achilli et al., 2011; Nardelli et al., 2013) and age-relatedmacular
degeneration (Udar et al., 2009) among others. All these studies report-
ed controversial results and no consensus has been reached so far. Here-
after wewill discuss themain data obtained for AD and T2D, as they are
not only among the most frequent age-related diseases, but also
because of the prominent pathogenic role played by mitochondria in
these pathologies. Actually, mitochondria produce ROS and are β-
amyloid targets within neuronal cells, while in metabolic diseases the
energy metabolism is deeply deranged including mitochondrial
dysfunction.
The sporadic form of AD (SAD) is the leading cause of dementia
among elderly. SAD has a complex etiology due to environmental and
genetic factors that can interact with each other in different combina-
tions to prime the disease (Sosa-Ortiz et al., 2012). Also, mitochondrial
dysfunction plays a consistent role and mitochondrial variants, both
mtDNA haplogroups or speciﬁc mtDNA polimorphysms, have been re-
ported to be associated to AD (Chinnery and Hudson, 2013). Among
the 9 European haplogroups, haplogroups T and J (Chagnon et al.,
1999), U and K (Fesahat et al., 2007; Lakatos et al., 2010; van der Walt
et al., 2004) and H (Coto et al., 2011; Fesahat et al., 2007; Maruszak
et al., 2009; Ridge et al., 2012; Santoro et al., 2010) have been found to
be associated to a higher or lower risk of SAD, while many other studies
failed to ﬁnd any association (Chinnery et al., 2000; Elson et al., 2006;
Hudson et al., 2012; Krüger et al., 2010; Mancuso et al., 2007; Pyle
et al., 2005; van derWalt et al., 2005). Table 1 summarizes these results.
The reasons for these differences are presently unclear but are at least in
part ascribable tomethodological issues such as sample size, the ethnic-
ity and the number ofmarkers used to deﬁne haplogroups. Recently, we
identiﬁed in a large cohort of Italian patients and controls sub-
haplogroup H5 as a risk factor for AD (Santoro et al., 2010) indepen-
dently from the APOE4 status. The strength of this studywas the resolu-
tion level (analysis of complete D-loop sequencing and speciﬁc markers
along the coding sequence) and the quite large number of subjects
(1712) of homogeneous ethnicity (central-northern Italy). Another
group found that H haplogroup is a risk factor for AD in a Spanish pop-
ulation (Coto et al., 2011), and it is associated with APOE4 risk, while
Ridge et al. (2012) reported that two sub-branches of haplogroup H
(H6a1a and H6a1b) are protective factors for AD and are not related
to APOE4 allele. In the attempt to conﬁrm these results, Hudson et al.
(2012) performed the analysis of 138 mtDNA SNPs in 3 Caucasian pop-
ulations followed by a meta-analysis of the available data failing to rep-
licate any association. Also the correlation with APOE needs further
investigation. In fact, some studies found a signiﬁcant protective effect
of haplogroups U and K in patients carrying the APOE4 allele (Carrieri
et al., 2001), while others identiﬁed a risk effect of haplogroup H
(Ridge et al., 2012), and others found that the effect of mtDNA
haplogroups on AD risk is independent of APOE status.
T2D is a common metabolic disorder affecting a large part of the
aged population and its risk is increasing in the last years. Several vari-
ants in the nuclear genome have been identiﬁed (De Silva and Frayling,
2010; Dimas et al., 2013), however given the small effect of these vari-
ants in this complex phenotype, many other susceptibility factors are
likely present. Mutations in mtDNA cause several syndromes that in-
volve hyperglycemia (Amaral et al., 2008). Many studies tried to ﬁnd a
correlation between mtDNA haplogroups and T2D, with controversial
results (see Table 1). Yet,most studies did notﬁnd associations between
T2D and mtDNA variability, or reported conﬂicting results (Chinnery
et al., 2007; Hsouna et al., 2013; Saxena et al., 2006). Interestingly, our
group, analyzing the mtDNA variations in a large cohort of Italian pa-
tients and controls (Achilli et al., 2011), found signiﬁcant associations
between haplogroups H, H3, U3 and V and diabetes complications
such as neuropathy, retinopathy, nephropathy and renal failure. On
the same line a previous study found that haplogroup T was associated
with retinopathy in Europeans (Koﬂer et al., 2009).
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Summarizing, like in AD, the scenario regarding the involvement of
mtDNA haplogroups in T2D is far from being elucidated and additional
studies at a high level of phylogenetic resolution in large populations
with similar haplogroup/subhaplogroup proﬁles are required. Also the
stratiﬁcation for complications should be included in the analyses.
Moreover functional analyses could help to unravel the role of mtDNA
mutation in a speciﬁc molecular pathway of the pathogenesis. To this
purpose Hwang et al. (2011) recently explored the protective effect of
Asiatic haplogroup N9a and the risk effect of haplogroup D5 and F
using cybrid cell lines having the same nuclear background (Hwang
et al., 2011). Notably, the risky haplogroups were associated with a
down-regulation of oxidative phosphorylation and an up-regulation of
glycolysis compared to the protective haplogroup. These results suggest
that variations inmtDNA can affect the expression of nuclear genes reg-
ulating mitochondrial functions or cellular energetics.
Since AD and T2D are common age-related disorders, even a small
risk associated with mtDNA haplotype could have major causative im-
plications at a population level. It is therefore critically important to de-
termine the role of mtDNA polymorphisms by studying large cohorts of
subjects at a level of molecular and phylogenetic resolution as ﬁne as
possible. In this attempt, the combination of new NGS methodologies
such as GWAS, high-throughput whole genome and whole exome
sequencing on nuclear genome and the complete resequencing of the
mitochondrial genome applied to very large cohorts of patients and
carefully matched controls will provide an efﬁcient approach to detect
common and rare variation contributing to disease risk. In this frame,
we sequenced a high number of ultra-nonagenarians (90+) and youn-
ger controls and found that the frequency of mutations previously re-
ported to be associated with degenerative diseases is higher in 90+
than in controls (Raule et al., 2013). These results support the idea
that certain mtDNA inherited mutations could contribute to longevity
or disease according to population- and individual-speciﬁc genetic
backgrounds (nuclear genome and combination of mtDNA mutations),
as well as stochastic events (Moilanen et al., 2003; Rose et al., 2001;
Wallace, 2010).
Finally, an aspect that has to be taken into accountwhen performing
association studies betweenmtDNA variants and age-related diseases is
that certain diseases can be more frequent in distinct populations than
in others, and it is well known that mtDNA exhibits, along with Y chro-
mosome, strong signals of geographic genetic differentiation, due to the
demographic history, sex biased human migrations and other cultural
factors.
4. mtDNA Damage Repair and Aging
mtDNA is packaged into multimeric complexes called nucleoids
made up of proteins and nucleic acids (Chen and Butow, 2005). These
proteins protect the mtDNA molecules that are otherwise particularly
exposed to ROS, as mentioned, and also include factors that help
mtDNA to repair and replicate. This review is not focused on these pro-
cesses, nevertheless from a mechanistic point of view it is becoming
more and more clear that the accumulation of mutations with age oc-
curs via alterations of the systems that ensure mtDNA integrity to be
maintained over time, rather than increased level of damage, e.g. oxida-
tive stress (Itsara et al., 2014).Moreover, it is worth to underline the im-
portance of these factors to better understand the epistatic phenomena
that can take place between nuclear and mitochondrial genomes. As an
example, a key molecule for mtDNA stability is polγ, which is the sole
mitochondrial polymerase and plays an essential role in both replication
and repair of the mtDNA (Kaguni, 2004). As previously mentioned, a
polγ defective in proofreading activity has been associated to a pheno-
type of accelerated aging in a murine model (Kujoth et al., 2005;
Trifunovic et al., 2004). Alterations in the polymerase and exonuclease
activity of polγ induce an increase in the frequency ofmtDNAmutations
(Van Goethem et al., 2002: Copeland et al., 2003) and mutations of
POLG1 gene are associated with a number of diseases (Cohen et al.,
Table 1
Studies on mtDNA haplogroups and complex traits (type 2 diabetes and Alzheimer's disease). mtDNA haplogroups and/or clusters having higher frequency in cases than controls (over-
represented) are considered to have a positive associationwith the trait, while those under-represented are considered to have a negative associationwith the trait. D,H, I, J, K, T, U,W, and
X refer to haplogroup nomenclature as reported in MITOMAP (http://www.mitomap.org/).
Complex trait N. cases vs controls Results Ethnicity Reference
Type 2 diabetes 762 vs 402 Over-represented: J Finnish Mohlke et al. (2005)
347 vs 350 Over-represented: J and T Caucasian-Brazilian Crispim et al. (2006)
3304 vs 3304 No association Swedish, Scandinavian, Canadians, Polish and American Saxena et al. (2006)
897 vs 1010 No association English Chinnery et al. (2007)
1289 vs 1617
732 vs 633
Under-represented: N9a Japanese
Korean
Fuku et al. (2007)
227 vs 1527 Over-represented: T (complications) Europe Caucasian Koﬂer et al. (2009)
466 vs 438 Under-represented: H1
Over-represented: H, H3, U3 and V (complications)
Italian Achilli et al. (2011)
184 vs 288 Over-represented: J
Under-represented: T
Spanish (Canary Islands) González et al. (2012)
859 vs 1151 Over-represented: B
Under-represented: D
Chinese Liou et al. (2012)
64 vs 77 No association Tunisian Hsouna et al. (2013)
Alzheimer's disease 69 vs 83 Under-represented: T
Over-represented: J
French-Canadian Chagnon et al. (1999)
185 vs 179 No association English Chinnery et al. (2000)
644 vs 180 Under-represented: U Caucasian females van der Walt et al. (2004)
345 vs 148 Over-represented: U Caucasian males van der Walt et al. (2004)
190 vs 340 No association Old Order Amish van der Walt et al. (2005)
185 vs 447 No association English Pyle et al. (2005)
75 vs 64 No association US Americans; English Elson et al. (2006)
70 vs 64 No association
30 vs 100 Over-represented: H and U Iranian Fesahat et al. (2007)
209 vs191 No association Italian Mancuso et al. (2007)
222 vs 252 Over-represented: HV Polish Maruszak et al. (2009)
128 vs 99 No association Finnish Krüger et al. (2010)
936 vs 776 Over-represented: H5 Italian Santoro et al. (2010)
170 vs 188 Over-represented: UK Caucasian Lakatos et al. (2010)
500 vs 500 Over-represented: H Spanish Coto et al. (2011)
632 vs 101 Under-represented: H6a1a and H6a1b US Americans, Utah Ridge et al. (2012)
4133 vs 1602 No association English; US Americans; German Hudson et al. (2012)
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2010; Longley et al., 2005). Data also suggest that polγ is likely involved
in the aging process (Kujoth et al., 2007) and in the pathogenesis of a se-
ries of diseases inwhichmtDNA instability plays a pathogenic role, such
as age-associated sarcopenia and Parkinson's Disease (Fayet et al., 2002;
Luoma et al., 2004). Nevertheless, the molecular details by which polγ
ensures mtDNA integrity are still to be elucidated. TFAM is another
very important factor for mtDNA stability, since it is part of the nucleoid
packaging and it is involved in mtDNA transcription and replication
(Kang and Hamasaki, 2005). Moreover, TFAM is responsible for
mtDNA replication and therefore controls mtDNA copy number. How-
ever, it has been reported that TFAM can bind preferentially to damaged
mtDNA and inhibits the in vitro incision activity of 8-oxoguanine DNA
glycosylase (OGG1), uracil-DNA glycosylase (UDG), apurinic endonu-
clease 1 (APE1), and nucleotide incorporation by pol γ (Canugovi
et al., 2010). Its role in mtDNA maintenance in aging has not yet been
clariﬁed, but some studies in animals suggest that it could be implicated
in accumulating mtDNA mutations (Zhong et al., 2011). It has been re-
ported that p53 also plays a role in themaintenance of mtDNA integrity
(Achanta et al., 2005; Bakhanashvili et al., 2008; Canugovi et al., 2010;
de Souza-Pinto et al., 2004). p53 can translocate at mitochondrial level
in response to oxidative stress (Bonafé et al., 2004; Marchenko et al.,
2000; Mihara et al., 2003) where it can bind to polγ, TFAM and other
factors such as GSK3b modulating the amount of mtDNA copy number
and mutations (Achanta et al., 2005; Altilia et al., 2012; de Souza-Pinto
et al., 2004; Vadrot et al., 2012; Wong et al., 2009; Yoshida et al.,
2003). Moreover, studies in p53 knock out animals collectively demon-
strated a reduced number of mtDNA copies, a reduced base excision re-
pair activity and, as a whole, a reduced mitochondrial activity (Achanta
et al., 2005; Bartlett et al., 2014; Chen et al., 2006; de Souza-Pinto et al.,
2004). Interestingly, the interaction of p53 with TFAM alleviates TFAM-
induced inhibition of BER proteins (Canugovi et al., 2010). In our labwe
were able to demonstrate that different p53 isoforms, p53P72 and
p53R72 (resulting from a common polymorphism that causes a
Proline-to-Arginine substitution at position 72), have a different capa-
bility to localize at mitochondrial level and bind to polγ (Altilia et al.,
2012). Accordingly, it was found that subjects carrying different p53
codon 72 genotypes were characterized by different amounts of
heteroplasmy at the level of D-loop, as detected by DHPLC techniques.
However, while a plethora of data suggests thatmtDNAmutations accu-
mulate with age, it is still a matter of debate whether such an accumu-
lation is a cause of aging. It has been reported thatmtDNAdeletions, but
not point mutations, are associated with premature aging and lifespan
inmicewith defective polγ (Vermulst et al., 2007, 2008). However, a re-
cent report suggests that germline-transmitted mtDNA mutations may
aggravate the aging phenotype of adult animals (Ross et al., 2013).
These authors speculate that this phenomenon may also be relevant
for human aging. It is however to note that while cells containing clon-
ally expandedmtDNAmutations appear to be ubiquitous in postmitotic
tissues of aged humans, even in the very old they only represent a small
minority of cells (b5%). It is therefore not clear whether the mutations
actually contribute to the aging process or are minor bystanders
(Keogh and Chinnery, 2013). However, it is possible that small levels
of inherited heteroplasmy while not compromising germ line function,
can prime and potentiate the effect of mtDNA mutations on aging
(Keogh and Chinnery, 2013).
5. Perspectives
Strong evidences support the idea thatmitochondria are involved in
the aging process and in longevity. As discussed, it is not totally clear
whether this is also the case for mtDNA. Actually, ﬁndings that emerged
in the framework of the GEHA EU project have highlighted that the con-
tribution of mtDNA variability is strongly dependent on the interaction
between different loci of themtDNA itself (Raule et al., 2013). In partic-
ular, the analysis of the mutations occurring in mtDNA OXPHOS genes
shows a complex scenario with a different mutation burden in
ultranonagenarian subjects with respect to younger controls. Quite un-
expectedly, mutations in the subunits of the OXPHOS complex I seem to
have a beneﬁcial effect on longevity, but if they occur simultaneously
with mutations in complexes III and V seem to be detrimental. It can
be further hypothesized that the interaction between themitochondrial
and the nuclear genomes is even more important. The availability of
data for both genomes obtained from a large number of long living sub-
jects within the GEHA project will allow the reaching of a sufﬁcient sta-
tistical power needed for the evaluation of such mito-nuclear genetic
interaction (epistasis). Moreover, we surmise that, in order to get
more insights on longevity, it will be useful to study the subjects that
reached the extreme limits of human age, i.e. centenarians, semisuper-
centenarians and super-centenarians, who are likely provided with a
genetic background predisposing to long life (Garagnani et al., 2013;
Perls and Terry, 2003; Tan et al., 2008). Therefore, the analysis of
mtDNA variability and of the interactions between mitochondrial and
nuclear genomes performed on those exceptional subjects will contrib-
ute signiﬁcantly to the identiﬁcation of the combination of genetic de-
terminants (from both genomes) that lead to longevity. At variance,
the analysis of patients suffering by AD or T2D could help in identifying
patterns associated with an increased risk for these diseases.
Two new research topics that could have functional effects on aging
and longevity are emerging in the ﬁeld of the regulation of mtDNA tran-
scription: the mitochondrial epigenetics and the mitochondrial small
and long non coding RNAs.
The correlation between mtDNA and epigenetics has been investi-
gated for the central role of mitochondria in energy production. Indeed,
this has suggested that the variability of mtDNA affecting energy pro-
duction may also affect epigenetic changes, as energy production mod-
ulates the activity of methionine adenosyltransferase (MAT), the
enzyme responsible for S-adenosylmethionine (SAM) synthesis from
L-methionine and ATP (Wallace and Fan, 2010). Indeed, the analysis of
a population sample revealed that methylation levels were higher in
the subjects carrying the J haplogroup than in non-J carriers. Consistent-
ly, cybrids with J haplogroup mtDNA, where over expression of the
MAT1A gene and low ATP were observed, showed higher methylation
levels than other cybrids. Theseﬁndings conﬁrmed that speciﬁc interac-
tions between mitochondria and the nucleus, partly modulated by
mtDNA variations, regulate epigenetic changes, possibly through its ef-
fects on oxidative phosphorylation efﬁciency (Bellizzi et al., 2012).
Although some authors suggested the absence of methylation in
mtDNA (Hong et al., 2013 and references therein), data indicating that
also mtDNA can undergo methylation are emerging. Indeed, different
amounts ofmethyl cytosines have been observed inmtDNA ofmany or-
ganisms, although the distribution of the methylated cytosines has not
been determined in any of these species (Nass, 1973; Pollack et al.,
1984; Rebelo et al., 2009; Shmookler Reis and Goldstein, 1983a,
1983b; Ŝimková, 1998). Then, Shock et al. (2011) demonstrated an en-
richment of mtDNA sequences by immunoprecipitation against
5methylcytosine and 5hydroxy methylcytosine and the translocation
of DNA (cytosine-5-)-methyltransferase 1 (DNMT1) into themitochon-
dria. More recently Bellizzi et al. (2013) reported evidences for epige-
netic modiﬁcations in mtDNA, as methylated and hydroxymethylated
cytosines were detected within the mitochondrial D-loop in DNA sam-
ples extracted from blood and cultured cells of both humans and
mouse. A peculiar aspect of these data is that the majority of the meth-
ylated cytosines were located outside of CpG nucleotides in an asym-
metrical pattern previously reported for plants and fungi. Of note is
also the existence of intercellular variability for -both CpG and nonCpG
methylation, with higher methylation levels in human blood and HeLa
cells with respect to ﬁbroblasts and osteosarcoma cells. The same pat-
tern was observed in mouse, supporting the notion of tissue speciﬁcity
of DNAmethylation. In both human andmouse samplesmethylated cy-
tosines were identiﬁed in the promoter region of the heavy ﬁlament
(PH) and within conserved sequence blocks (CSBI-III), which are highly
conserved sequences located at the 5′ end of the D-loop and considered
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to be implicated in the processing of the RNA primer during the replica-
tion of the H ﬁlament. Therefore, it is possible to hypothesize that D-
loop methylation might play an important role in modulating either
replication or transcription of mtDNA, two processes widely described
as physically and functionally correlated. Indeed, the regions found
methylated are involved in forming the DNA-RNA hybrid due to the
transcription of the leading (H)-strand origin. It is of note that the for-
mation of this hybrid occurs to initiate the H strand replication. Likely,
the methylation of L-strand, displaying complementary sequence to
RNA primer, may be involved in regulating the formation of the hybrid
or stabilizing its persistence. As to the mechanisms responsible for the
methylation of mtDNA molecules, DNA methyltransferases were ob-
served within the mitochondria, but the inactivation of Dnmt1,
Dnmt3a, and Dnmt3b in mouse embryonic stem (ES) cells resulted in
a reduction of the methylation of CpG, while the methylation of non-
CpG resulted not affected (Bellizzi et al., 2013). This suggests that D-
loop epigenetic modiﬁcation is only partially established by these en-
zymes. Further studies are needed to clarify this point.
Recently it has been observed that certain microRNA (miRs) can
translocate from cytosol into the mitochondria, for this reason they
are calledmito-miRs, and their role in physiological function such as ap-
optosis, proliferation and cell senescence, is reviewed elsewhere in the
present issue. Many studies suggest that mitochondria are one of the
destinations of pre- andmature miRs, and recently a unique population
of small RNAs (sRNAs) including miRs that are associated with mito-
chondria has been identiﬁed in two human cell lines by deep sequenc-
ing (Sripada et al., 2012). Interestingly, it was observed that, among the
many hundreds of miRs identiﬁed in this study, 4 known and 24 puta-
tive novel miRs aligned to mitochondrial genome at different positions
corresponding to 16S rRNA, tRNA and subunits of complex I. Therefore,
the authors suggest that these miRs may regulate mitochondrial tran-
scripts involved in ribosome assembly and electron transport chain. Au-
thors also do not exclude that these miRs could be encoded by mtDNA,
but this speculation has yet to be demonstrated. However, should these
data be conﬁrmed, they will open a new perspective on the ﬁne tuning
of mtDNA expression, much more similar to nuclear gene regulation
than previously thought. Accordingly, not only small RNA, but also
long non coding RNAs (lncRNAs) are generated from the mitochondrial
genome and regulated by nuclear-encoded proteins as shown by
Rackham et al. (2011) in human cell lines, thus suggesting a much
more complex nuclear-mitochondrial cross-talk. This cross-talk needs
to be more deeply investigated by comparing different tissues with
massive parallel sequencing analysis in order to evaluate the differences
among organs with various levels of metabolism or energy consump-
tion, and further, to assess age-dependent effects on such a cross-talk.
In conclusion, as it happened for the studies of genetics of aging and
longevity regarding nuclear genes, also in the ﬁeld of studies of mito-
chondrial genetics and aging there is still a lack of understanding due
to the fact that mitochondrial genome acts in tight connection with
the nuclear one and, perhaps, like the nuclear one, is regulated also at
an epigenetic level. Therefore, it is envisaged that in order to shed
light and disentangle this complex scenario, studies of nuclear/mito-
chondrial epistasis and mtDNA epigenetic regulation (methylation,
binding with regulatory elements) will be necessary.
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